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Abstract 
Enterohaemorrhagic and enteropathogenic Escherichia coli (EHEC and EPEC) are 
enteric pathogens that cause disease through intimate attachment and subversion of 
intestinal epithelial cells. This strategy depends on a type III secretion system (T3SS) to 
translocate effector proteins into host cells. EspJ is a T3SS effector protein that inhibits 
opsono-phagocytosis through an unidentified mechanism. This study aimed to determine 
the mechanism of action of EspJ through analysis of the protein itself and its effects on 
eukaryotic cell signalling.  
Bioinformatic analysis of EspJ revealed a predicted ADP-ribosyltransferase (ART) 
domain which mediates transfer of ADP-ribose from NAD on to a target protein. 
Through structural comparison with known ARTs, mutations were designed targeting 
predicted key ART domain residues. NMR analysis revealed that EspJ binds NAD and 
also that this interaction was disrupted by ART domain mutations. Mutation of the ART 
domain also disrupted inhibition of opsono-phagocytosis by EspJ. Further analysis of 
phagocytosis revealed that EspJ inhibits actin polymerisation and tyrosine 
phosphorylation during FcγR-mediated phagocytosis.  
During infection, EPEC and EHEC use the translocated effector Tir to initiate actin 
polymerisation pathways leading to the formation of actin rich pedestals on cultured 
cells. TirEPEC signalling is similar to that of the FcγR and so the impact of EspJ on 
pedestal formation was analysed. EspJ inhibited the tyrosine phosphorylation-dependent 
TirEPEC-mediated actin pedestal assembly but not the phosphorylation-independent 
TirEHEC signalling. Inhibition of EPEC pedestals correlated with reduced tyrosine 
phosphorylation and recruitment of the SH2-adaptor Nck. Importantly, an absence of Src 
 4 
family kinases (SFK) was observed in the presence of EspJ. EspJ inhibited FcγRIIa 
tyrosine phosphorylation suggesting that this effector acts at the initial stages of tyrosine 
kinase dependent actin polymerisation pathways preventing receptor phosphorylation by 
SFKs. Importantly, an intact ART domain was required for EspJ mediated inhibition of 
tyrosine phosphorylation and downstream actin polymerisation. 
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Chapter 1 - Introduction 
 
 
 
 Chapter 1 - Introduction 
Host cell signalling 
1.1  The actin cytoskeleton 
The actin cytoskeleton is a versatile framework for cellular processes providing structural 
scaffolds, generating mechanical force and determining cell shape (Pollard & Cooper, 
2009). The rapid polymerisation and depolymerisation of actin allows the formation of a 
diverse array of structures in response to intra or extra-cellular stimuli. These dynamic 
structures include sheet-like lamellipodium, finger-like projections such as filopodium 
and microvilli as well as adhesion sites, stress fibres, ruffles, endocytic pits and 
phagocytic cups (Fig. 1A). As such the actin cytoskeleton is central in migration, 
cytokinesis, morphogenesis and internalisation. Manipulation of the actin cytoskeleton is 
also important during infection where pathogenic bacteria and viruses promote their 
internalisation or cell-cell spread, or alternatively inhibit actin polymerisation pathways 
to remain extracellular (Carabeo, 2011; Welch & Way, 2013).  
 
1.1.1  Actin polymerisation 
Actin is one of the most abundant proteins in eukaryotic cells. In its monomeric 
(globular, G-actin) form, actin is a 42 kDa ATP binding protein, which can then self-
assemble to form helical filaments (F-actin) (Pollard, 2007). Actin filaments are polar 
due to the orientation of subunit addition and have pointed and barbed ends. Filament 
extension is ten fold faster at barbed ends and in general filaments polymerise at the 
barbed end and dissociate from the pointed end (Pollard, 1986). Once ATP bound 
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monomers have been incorporated in to a filament, actin hydrolyses ATP releasing Pi and 
generating a slight alteration in conformation.  
The regulation of actin polymerisation relies on >100 accessory proteins with diverse 
functions including stabilising or destabilising filaments, sequestering or delivering 
monomers, nucleating polymerisation, capping or severing filaments, and crosslinking 
filaments into networks or bundles (Fig. 1B). These include profilin, ADF/cofilin and 
coronin and gelsolin. Profilin has many roles including promoting G-actin exchange of 
ADP for ATP and sequestering/releasing monomers for polymerisation (Witke, 2004). 
ADF/Cofilin inhibits this ADP-ATP exchange and also functions as a filament severing 
protein promoting depolymerisation which generates free branched ends for further 
polymerisation or disassembly (Carlier et al., 1997; Chan et al., 2009; Ghosh et al., 
2004). Coronin can inhibit Arp2/3 nucleation activity but also either binds and protects 
filaments from ADF/cofilin or promotes filament severing depending on nucleotide state 
of the F-actin (Gandhi et al., 2009; Humphries et al., 2002). Gelsolin is a multifunctional 
protein and has actin filament binding, capping and severing activities (Sun et al., 1999). 
 
1.1.2  Actin nucleators 
Although actin filaments can rapidly self-assemble, the initial nucleation of dimeric or 
trimeric complexes is kinetically unfavourable. This means nucleation factors are 
required to facilitate the formation of new filaments. There are several classes of 
nucleaction factors including the Arp2/3 complex, formin and spire classes, which differ 
both in mechanism of nucleation and in the organisation of formed filaments 
(Campellone, 2010).     
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A 
 
B 
 
Figure 1. The actin cytoskeleton 
(A) Diagram showing the diverse structures formed by the actin cytoskeleton. 
(B) Diagram showing the modulation of the actin cytoskeleton in response to external stimuli 
including nucleation by the Arp2/3 complex and formins. Images taken from (Rotty et al., 2013) 
and (Pollard, 2007) respectively.  
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i. The Arp2/3 complex 
The Arp2/3 complex is a 220 kDa complex made up of seven polypeptides; actin related 
protein (Arp) 2, Arp3 and ARP2/3 complex subunits (ARPC) 1-5. Arp2 and 3 are 
thought to mimic an actin dimer thereby nucleating filament extension. The Arp2/3 
complex binds to pre-existing actin filaments and initiates new filament assembly at 
angle of 70° forming a ‘Y’ conformation and remains at the junction of the original 
filament and the pointed end of the newly formed branch. Repeated Arp2/3-mediated 
filament assembly therefore creates a branched dendritic network of F-actin. The Arp2/3 
complex is regulated in a number of ways, and requires further activation for efficient 
nucleation. Binding to existing filaments and phosphorylation of Arp2 both increase 
activity but perhaps most influential is the interaction with nucleation promoting factors 
(NPFs) (Campellone, 2010; LeClaire et al., 2008).  
ii. Formin and Spire 
In contrast to the Arp2/3 complex, formin and spire-mediated actin nucleation results in 
linear actin formations. There are ~ 15 mammalian formins split in to 7 subclasses. One 
such subclass is the widely expressed mammalian Diaphanous related formins (mDia). 
Formins are multi-domain proteins made up of a single polypeptide with modular 
organisation (Campellone, 2010). They function as dimers interacting through their 
formin homology domain 2 (FH2). FH2 domains are sufficient to nucleate actin 
polymerisation in vitro (Moseley et al., 2004). Formins act by stabilising actin dimers 
and also preventing access of capping proteins by remaining bound at the barbed end of 
the filament and moving progressively with filament extension. Additionally, formin 
FH1 domains interact with profilin enhancing delivery of actin monomers. Some can also 
bundle or sever actin filaments. Regulation of formins involves intramolecular 
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interactions, mediated by auto-regulatory domains, which results in a closed 
conformation inhibiting actin polymerisation. These interactions can be disrupted by 
direct Rho GTPase binding which thus facilitates formin activation (Lammers et al., 
2005). 
Spire is a single polypeptide containing four actin binding WASP homology 2 (WH2) 
motifs and nucleates actin by stabilising longitudinal actin tetramers or side-to-side 
formations (Quinlan et al., 2005).  
 
1.1.3  Nucleation promoting factors (NPFs) 
NPFs are required for activation of the Arp2/3 complex. The majority of mammalian 
NPFs are class I acting via a WCA/VCA domain. The WCA consists of one or more 
actin binding WASP-homology 2 (WH2) motifs (W)(also called verprolin homology 
domain (V)), an amphipathic connector (C) that can bind actin and Arp2/3, and an acidic 
peptide (A) that binds Arp2/3 complex. The WCA domain therefore brings actin and the 
Arp2/3 complex into close proximity to facilitate actin polymerisation. WCA binding to 
the Arp2/3 complex also induces conformational changes in the Arp2/3 complex required 
for its activation (Rodal et al., 2005).  
Class I NPFs include Wiskott-Aldrich syndrome protein (WASP), neuronal-WASP (N-
WASP), and WASP-family verprolin homologue (WAVE). These proteins share a 
carboxy-terminal WCA domain but differ in the amino-terminal regions allowing 
differential regulation (Campellone, 2010).  
i. WASP/N-WASP 
WASP is specifically expressed in haemopoietic cells, and WASP-deficient patients 
exhibit immunodeficiencies including defective cell migration, phagocytosis and T cell 
 23 
signalling (Bosticardo et al., 2009). The related N-WASP is widely expressed and shares 
similar domain architecture but has a second WH2 motif in the WCA domain. WASP 
and N-WASP are multi domain proteins with an amino-terminal WASP homology 1 
(WH1) domain, a central GTPase binding domain (GBD) made up of a basic region, a 
Cdc42 and Rac interactive binding (CRIB) domain and autoinhibitory motif followed by 
a proline rich domain (PRD) and the carboxy-terminal WCA domain. It normally exists 
in an auto-inhibitory state through intra-molecular interactions between the CA and the 
autoinhibitory region of the GBD. Activation of N-WASP signalling occurs via different 
upstream elements for example by binding of the Rho GTPase Cdc42 to the GBD leading 
to the release of the WCA domain (Rohatgi et al., 2000)(Fig. 2A). Tyrosine 
phosphorylation of GBD residues acts to further stabilise the active conformation (Torres 
& Rosen, 2006). Phosphoinositol-4,5-biphospate (PI(4,5)P2) enhances activation through 
binding to the basic region (Rohatgi et al., 2000). Additionally, activation can be 
mediated by interaction of adaptor protein SH3 domains with the N-WASP PRD. These 
include non-catalytic kinase (Nck) 1 and Nck2 (Rohatgi et al., 2001) and Abl interactor 1 
Abi1 (Innocenti et al., 2005). The WASP interacting protein (WIP) binds the WH1 
domain contributing to regulation and protects N-WASP from calpain degradation (de la 
Fuente et al., 2007). Although reported to stabilise the inactive conformation in resting 
cells (Martinez-Quiles et al., 2001), WIP also acts in complex with N-WASP promoting 
actin polymerisation (Ho et al., 2004; Moreau et al., 2000). In addition to allosteric 
methods of activation, it has been shown that oligomerisation of N-WASP significantly 
increase its affinity for the Arp2/3 complex enhancing activity (Padrick et al., 2008). 
ii. WAVE 
In contrast to WASP/N-WASP, WAVE NPFs are not auto-inhibited but rather are 
regulated through trans-interactions (Fig. 2B). There are three WAVE isoforms, 
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WAVE1-3 which are broadly expressed. They consist of an amino-terminal SCAR 
homology domain (SHD) followed by a basic peptide, a central PRD and carboxy-
terminal WCA. Regulation occurs through a complex containing HSP300 (BRICK1), 
Abi1/Abi2 (ABIZ), Nck-associated protein 1 (NAP1) and specifically Rac-associated 1 
(SRA-1) which interacts with the SHD (Gautreau et al., 2004). Signals from the Rho 
GTPase Rac and Nck are transmitted through SRA-1 and NAP1 within the complex to 
activate WAVE (Eden et al., 2002). Further activation is promoted through SH3 domain 
containing proteins binding to WAVE PRD, and phosphoinoitol-3,4,5-triphosphate 
(PI(3,4,5)P3) binding to the basic peptide (Suetsugu et al., 2006). Additionally, 
oligomerisation of WAVE and tyrosine phosphorylation of WAVE or Abi1 by Abl 
increase activity and actin polymerisation (Leng et al., 2005; Padrick et al., 2008; Stuart 
et al., 2006). 
 
Figure 2. Regulation of nucleation promoting factors 
Inhibitory conformation and regulatory inputs for N-WASP (A) and WAVE (B). Image taken 
from (Rotty et al., 2013). 
 
 
1.1.4  The Actomyosin system 
Myosin family proteins act as molecular motors in the cell and interact with actin to form 
the actomyosin system. They hydrolyse ATP generating force on actin filaments to drive 
motility and contraction, and function in various processes including cytoskeletal 
reorganisation, organelle and vesicle transport, and phagocytosis (Sellers, 2000). 
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They are composed of one or two heavy chains; the N terminal head domain which 
hydrolyses ATP and binds actin, the regulatory neck region and the more variable C 
terminal ‘tail’ domain. The neck region binds myosin light chains which are calmodulin 
family proteins that function in stabilisation or regulation of the myosins. Essential light 
chains (ELC) stabilise the lever arm in the head domain of the heavy chain. Regulatory 
light chains (RLC) are phosphorylated by myosin light chain kinase (MLCK) in non-
muscle cells, (Ushakov, 2008). Phosphorylation of RLCs activates myosins promoting 
the assembly of actomyosin filaments (Amano et al., 1996).  
 
1.2  Modulating the actin cytoskeleton 
1.2.1  Rho GTPases 
Rho GTPases are small monomeric GTP binding proteins of the Ras superfamily. They 
function as key mediators of signal transduction with important roles in gene 
transcription, cell cycle progression, actin dynamics and adhesion (Jaffe & Hall, 2005). 
There are ~22 members of the family that share a characteristic G-domain structure, 
responsible for GTP binding and hydrolysis, and flexible domains Switch I and II which 
convey conformational changes depending on the bound nucleotide (Vetter & 
Wittinghofer, 2001). Rho GTPases act as molecular switches cycling between an inactive 
GDP-bound form and an active GTP-bound form. When active they transmit signals by 
recruiting or activating downstream effectors. The inherent but slow GTP hydrolysis 
activity of these proteins returns them to the GDP-bound form. GTPase activating 
proteins (GAPs) can increase the rate of hydrolysis, by stabilising the transition state, and 
promote the inactivation of Rho GTPases (Rittinger et al., 1997). Guanosine nucleotide 
dissociation inhibitors (GDIs) can then come in to play to retain Rho GTPases in their 
inactive state. Rho GTPases are post translationally modified by the addition of lipid 
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moieties to their carboxy terminal CAAX motif allowing them to interact with 
membranes (Roberts et al., 2008). GDIs bind to the Switch regions and the lipid moiety 
inhibiting both GDP-GTP exchange and membrane localisation (Hoffman et al., 2000). 
Guanosine nucleotide exchange factors (GEFs) function in Rho GTPase activation by 
promoting the exchange of GDP for GTP. Most mammalian GEFs are Dbl family 
consisting of a Dbl homology (DH) catalytic domain and a plecsktrin homology (PH) 
domain that binds phosphoinostides and modulates DH activity (Schmidt & Hall, 2002). 
The DH domain interacts with Switch I and II regions imposing a conformational change 
that expels GDP leaving the nucleotide pocket available for GTP loading (Vetter & 
Wittinghofer, 2001).  
The best characterized Rho GTPases are RhoA, Rac and Cdc42 which have major roles 
in the reorganisation of the cytoskeleton directing stress fibre, lamellipodia/ruffle and 
filopodia formation respectively (Hall, 1998). Key effectors downstream of RhoA are the 
formin mDia and Rho kinase (ROCK). Stress fibre formation as a result RhoA activation 
requires mDia for actin nucleation (Watanabe et al., 1999). ROCK phosphorylates both 
myosin light chains and myosin light chain phosphatase promoting actomyosin assembly 
and contraction (Amano et al., 1996). In addition, ROCK targets LIM kinase (LIMK), 
which then phosphorylates and inhibits cofilin activity promoting the stabilisation of 
actin filaments (Maekawa et al., 1999).  
Rac and Cdc42-dependent actin polymerisation predominantly proceeds via the Arp2/3 
complex. They both initiate actin polymerisation by activating NPFs, although Rac 
signals to WAVE through SRA-1 and Cdc42 activates N-WASP through direct binding 
(Eden et al., 2002; Rohatgi et al., 2000). Rac and Cdc42 are thought to activate the 
members of the p21 activated kinase (PAK) family of Ser/Thr kinases (Bishop & Hall, 
2000). PAK phosphorylates LIMK, again impacting upon cofilin activity (Edwards et al., 
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1999) and MLCK. MLCK phosphorylation inhibits its activity and thereby decreases 
MLC phosphorylation and actomyosin assembly (Sanders et al., 1999).  
 
1.2.2  Phosphoinositides 
Phosphatidylinositol and phosphorylated derivatives (phosphoinositides, (PI)) act as 
regulatory molecules, and are involved in directing membrane dynamics and actin 
polymerisation (Saarikangas et al., 2010). Phosphatidylinositol consists of an inositol 
ring linked to diacylglycerol through a phosphate group. The inositol ring can be 
phosphorylated at positions 3, 4 and 5 generating phosphatidyl inositol mono-, bis-, or 
tris-phosphates. A total of seven species are generated by the activities of a range of 
kinases and phosphatases with particular specificities and localisations. For example the 
kinase type I PIPK localises to the plasma membrane and generates PI(4,5)P2 which is 
enriched at cell edges (Doughman et al., 2003). While PI(4,5)P2 is one of the most 
abundant phosphoinositides and present in resting cells, PI(3,4,5)P3 is generated in a 
localised manner following activation of PI3 kinases (PI3K) (Hawkins et al., 2006) . 
PI(4,5)P2 and PI(3,4,5)P3 localise to the plasma membrane where they function in 
cytoskeleton rearrangements (Hilpela et al., 2004). 
PI derivatives can signal through the recruitment of a number of key proteins via 
interaction with pleckstrin homology (PH) domains, phox homology (PX) domains and 
FYVE (conserved in Fab1, YOTB, Vac1, EEA1) domains providing a membrane binding 
platform (Saarikangas et al., 2010). PIs contribute to the control of GTPases through the 
recruitment and activation of GAPs and GEFs. For example, the GEFs Sos-1 and Vav are 
activated by PI(3,4,5)P3, and conversely Vav has been shown to be inhibited by PI(4,5)P2 
(Das et al., 2000; Han et al., 1998). However, PI(4,5)P2 is enriched at sites of actin 
polymerisation and contributes to the process in a number of ways. PI(4,5)P2 can bind N-
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WASP cooperating with Cdc42 in its activation to promote actin polymerisation (Rohatgi 
et al., 2000). To further favour polymerisation PI(4,5)P2 acts to inhibit a number of actin 
depolymerising and severing factors including ADF/cofilin and gelsolin (Janmey & 
Stossel, 1987; van Rheenen et al., 2007). PI(4,5)P2 has also been shown to inhibit 
binding and/or to remove capping proteins (eg. CapZ) thus providing free branched ends 
(Kim et al., 2007b). Activation of Rho GTPases can also lead to increased levels of 
PI(4,5)P2 as Rho, Rac and Cdc42 activate PI4P-5K kinases further enhancing actin 
polymerisation (Weernink et al., 2004).  
 
1.3 Tyrosine kinases 
Phosphorylation is a rapidly reversible post-translational modification that plays a central 
role in host cell signalling. It allows the propagation of signals from numerous stimuli to 
generate an appropriate response often involving changes in gene expression and/or cell 
shape. Tyrosine phosphorylation provides docking sites for Src homology (SH) 2 
domain-containing proteins allowing further protein recruitment and activation 
(Waksman et al., 1993). Residues carboxy-terminal to the phosphorylation site provide 
the specificity of these interactions interacting with a second pocket of the SH2 domain 
(Songyang & Cantley, 1995).  
The human genome encodes 90 tyrosine kinases, 58 of which are receptor tyrosine 
kinases and 32 non receptor kinases split into ten families (Robinson et al., 2000). Two 
important kinase families are the Src and Abl families which function in the responses to 
a diverse array of receptors. The central role of Src and Abl family kinases in control of 
cellular processes including cell division, motility and morphogenesis is illustrated by 
their oncogenic potential. Indeed, cellular genes for the founding members of both 
families were identified from their deregulated forms in cancer. Cellular c-src was 
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identified from the transforming v-Src of the oncogenic retrovirus Rous sarcoma virus 
(Brugge et al., 1979). Similarly, the c-abl gene was identified from Abelson murine 
leukemia virus oncogene v-abl (Wang et al., 1984). Furthermore in chronic myelogenous 
leukemia (CML) a chromosomal translocation results in a fusion between c-abl and 
breakpoint cluster region (BCR) gene leading to a constitutively active BCR-Abl fusion 
protein (de Klein et al., 1982).  
 
1.3.1 Structure and regulation 
i. Src family kinases 
There are nine Src family kinases (SFKs); Src, Fyn and Yes are ubiquitously expressed; 
Blk, Fgr, Hck, Lck, Lyn are expressed in haematopoietic cells and Yrk is present only in 
chickens (Robinson et al., 2000; Thomas & Brugge, 1997). SFKs are multi domain 
proteins with an amino-terminal membrane-targeting region (with a myristoylation site 
and in some cases a palmitoylation site), a unique region then SH3 and SH2 domains for 
protein-protein interactions followed by an SH1 kinase domain and a short carboxy-
terminal tail with an inhibitory phosphorylation site (Boggon & Eck, 2004)(Fig. 3). The 
SH1 domain has a typical bilobal kinase fold with the catalytic site in the cleft between 
the small N lobe and large C lobe (Knighton et al., 1991). Given their important role in 
signalling it is no surprise that SFKs are strictly regulated, existing in a compact auto-
inhibitory state. Phosphorylation of the carboxy-terminal tail Y527, mediated by the 
carboxy-terminal Src kinase (Csk), initiates intramolecular interactions through binding 
of the SFK SH2 domain to pY527 (Cooper et al., 1986; Nada et al., 1991). The SH1-SH2 
linker region interacts with the SH3 domain resulting in a compact structure with the 
SH2 and SH3 domains packed against the kinase domain (Sicheri et al., 1997; Xu et al., 
1997). Although the catalytic site is not blocked in this conformation the orientation of 
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the lobes is constrained and critically the catalytically important C helix is displaced. 
Additionally the activation loop, which contributes to substrate binding, forms a helical 
structure blocking the activating phosphorylation site, Y416. Neither the SH2 nor the 
SH3 intra-molecular binding sites are optimal and so ligands for either domain can 
effectively outcompete these interactions and disrupt the compact structure. Indeed, 
mutations disrupting the binding sites prevent the inhibitory configuration and activate 
SFKs (Briggs & Smithgall, 1999; Moarefi et al., 1997). Release of the SH2/SH3 
enforced distortions is thought to allow the activation loop to become disordered 
allowing substrate binding and autophosphorylation of Y416. pY416 is associated with 
maximal activity and promotes correct positioning of the C helix (Smart et al., 1981; Xu 
et al., 1997). Activation of SFKs can therefore occur through dephosphorylation of Y527 
and/or binding of SH2/SH3 ligands (Sicheri et al., 1997). Importantly, this allows kinase 
activation to be coupled to protein targeting to appropriate substrates.  
 
 
Figure 3. Structure and regulation of Src and Abl familiy kinases 
Domain organisation and compact inhibitory conformations of Src and Abl kinases. Image taken 
from (Harrison, 2003). 
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ii. Abl family kinases 
The Abl family is made up of Abl and Abl related gene (Arg), both of which can be 
differentially spliced producing a and b isoforms (Pendergast, 2002). Abl and Arg b 
isoforms are myristoylated while the a isoforms are not. The amino-terminal half of Abl 
kinases are highly similar to the SFKs sharing SH3, SH2, SH1 domain organisation and 
~47% amino acid identity (Nagar et al., 2003)(Fig. 3). The carboxy-terminal differs 
significantly and includes proline rich sequences, nuclear localisation and export signals, 
DNA binding motifs and actin binding domain. Although Abl kinases lack an inhibitory 
phosphorylation site akin to Y527 in Src, they also form intra-molecular interactions 
forming a compact auto-inhibitory state (Nagar et al., 2003). Indeed, superimposition of 
inhibitory states of Src and Abl reveals a remarkably similar structure (Levinson et al., 
2006; Nagar et al., 2003). In contrast to the SFK pY527-SH2 domain interaction, the Abl 
autoinhibited state is stabilised by the amino terminal myristoyl group binding a deep 
pocket in the C lobe of the kinase domain. It is thought that for the non-myristoylated a 
forms of the kinases, the amino-terminal cap residues may interact with the C lobe. 
Indeed, deletion of the amino-terminal cap region results in activation of the kinase (Pluk 
et al., 2002). This interaction alters the conformation promoting an interaction between 
the C lobe and the SH2 domain which does not involve a phosphorylated tyrosine. The 
SH3 domain packs against the N lobe stabilised by interactions between SH2-SH1 linker 
sequence PxxY, the proline of which interacts with the SH3 and the tyrosine with the N 
lobe. These intramolecular interactions facilitate the packing of the SH2 and SH3 
domains against the kinase domain as observed with SFKs (Fig.3). In this conformation 
the kinase domain is open but critical catalytic residues in the activation loop are flipped 
precluding activity.  
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As for SFKs, mutations disrupting the SH3 domain promote activation of the kinase 
suggesting ligands for the SH2 and SH3 domains can disrupt the structure promoting 
activation (Barila & Superti-Furga, 1998). Tyrosine phosphorylation, through SFK 
activity or auto-phosphorylation, also plays an important role in activation of Abl/Arg 
(Brasher & Van Etten, 2000; Tanis et al., 2003). For example phosphorylation of the 
tyrosine (Y245) within the SH2-SH1 linker sequence activates the kinase, disrupting the 
intra-molecular interaction with the kinase domain. Additionally, phosphorylation of 
Y412 within the kinase domain is associated with maximal activity. 
 
1.3.2 Cytoskeleton associated signalling 
Src and Abl kinases function in many signalling pathways linking receptor activation to 
cytoskeletal outputs including growth factor signalling and integrin mediated adhesion 
and phagocytosis (Lewis et al., 1996; Parsons & Parsons, 2004). For example, both Src 
and Abl function downstream of the platelet derived growth factor (PDGF) receptor in 
the formation of Rac-dependent dorsal ruffles (Plattner et al., 1999; Ting et al., 2001). In 
this context, Src activates Abl through tyrosine phosphorylation within the kinase 
domain. Following stimulation, Abl phosphorylates and thus activates the Rac GEF Sos-
1 promoting actin polymerisation (Sini et al., 2004). Key cytoskeletal associated targets 
of Src include focal adhesion kinase (FAK), paxillin and p130CAS (which both recruit 
Crk) and cortactin (Glenney & Zokas, 1989; Kanner et al., 1990; Parsons & Parsons, 
2004). Abl can also contribute cytoskeletal morphogenesis through phosphorylation of 
paxillin, p130CAS and Crk (Lewis et al., 1996; Mayer et al., 1995; Woodring et al., 
2003) as well as phosphorylating and activating N-WASP and WAVE2 when it’s in a 
complex with Abi1 (Burton et al., 2005; Stuart et al., 2006).  
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 1.4 Phagocytosis 
Phagocytic signalling provides an excellent example of the co-ordination of signalling 
events for cellular morphogenesis. Phagocytosis is a complex process by which cells 
mediate the internalisation of large particles greater than 0.5 µm. It is a receptor driven 
process whereby recognition and binding of particles initiates signalling pathways for the 
rearrangement of the actin cytoskeleton, membrane delivery and contractile forces 
required for the cell to extend around and engulf an attached particle (Flannagan et al., 
2012). Following internalisation to form the membrane bound phagosome, a series of 
fusion and fission events with subcompartments of the endocytic pathway facilitates 
maturation culminating in the formation of the phagolysosome (Desjardins et al., 1994). 
This acidic, oxidative and degradative environment destroys the internalised particle or 
microbe.  
Phagocytosis plays key roles in normal tissue homeostasis and remodelling through 
clearance of dead cells, and in the immune response to pathogens during infection. 
Although many cells have limited phagocytic capacity and can internalise neighbouring 
apoptotic cells, professional phagocytes of the immune system such as neutrophils, 
macrophages and dendritic cells are specialised for this function. These cells have 
important roles in immune surveillance and in the clearance of foreign bodies. Indeed, 
through actin rich protrusions they are constantly surveying their environment for target 
particles (Flannagan et al., 2010; Patel & Harrison, 2008). In addition to the clearance of 
such microbes, phagocytes can also initiate further immune responses by recruiting 
immune cells through cytokine secretion and providing peptides for presentation on 
MHC molecules for the priming of the adaptive immune response (Mantegazza et al., 
2013). As such, they function both in the rapid recognition and response characteristic of 
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innate immunity, and in influencing the more specific adaptive arm of the immune 
system.  
Phagocytosis is initiated by the engagement of surface receptors recognising a variety of 
ligands. Phagocytic receptors can detect pathogens directly through recognition of 
features conserved between groups of microbes or indirectly through recognition of 
immune opsonins coating the target. For example, the yeast cell wall polysaccharide β-
glucan is directly recognised by the phagocytic receptor Dectin-1 (Herre et al., 2004) and 
lipopolysaccharide (LPS) present on the surface of Gram-negative bacteria binds to 
Scavenger receptor A (Peiser et al., 2000). In addition, soluble opsonins can attach to the 
surface of microbes and promote their uptake through generic receptors. These are most 
commonly immunoglobulins (Ig), the constant region of which are recognised by Fc 
receptors (Anderson et al., 1990), and components of the complement cascade 
recognised by integrin family receptors (Ross et al., 1992). Internalisation has been 
described as proceeding via a zipper-like mechanism with progressive engagement of 
surface receptors, and indeed, stalled internalisation has been observed for partially 
opsonised targets (Griffin et al., 1975). Although under physiological conditions several 
phagocytic receptors would be involved in pathogen recognition and internalisation, 
receptors have been analysed individually to allow dissection of the downstream 
signalling pathways. The two best charaterised phagocytic receptors are FcγRIIa and 
Complement Receptor 3 (CR3) which recognise IgG and the complement component 
C3bi respectively.  
1.4.1 FcγRIIa-mediated phagocytosis 
FcγRIIa-mediated phagocytosis is characterised by extensive cytoskeleton 
rearrangements and pseudopod formation to engulf IgG-opsonised particles and 
culminates in a pro-inflammatory response (Allen & Aderem, 1996). Complex signalling 
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pathways are initiated upon receptor engagement including tyrosine kinase, Rho GTPase, 
phospholipid and myosin based activities (Groves et al., 2008). 
i. Fcγ receptors 
The FcγR family belongs to the immunoglobulin superfamily due to the 
immunoglobulin-like domains in the extracellular portion of the receptors. They are 
expressed on the cell surface of a number of myeloid and lymphoid immune cells, and 
can mediate phagocytosis, antibody dependent cell cytotoxicity (ADCC) and modulatory 
functions (Sanchez-Mejorada & Rosales, 1998). The family includes FcγRI, FcγRIIa, 
FcγRIIb, FcγRIIIa, FcγRIIIb and FcγRIV which differ in their IgG binding affinities and 
signalling. FcγRI has a high affinity for IgG and is the only member that binds 
monomeric IgG (Hulett & Hogarth, 1994). FcγRIIa has a low affinity for IgG and so IgG 
coated targets are required for sufficient avidity to induce downstream signalling. As 
such, particles coated with a low concentration of IgG were shown to be insufficient to 
trigger phagocytosis (Zhang et al., 2010). FcγRIIb mediates inhibitory signalling through 
an immunoreceptor tyrosine-based inhibitory motif (ITIM) downregulating the activating 
signals through other FcγRs as well as BCR and TCR (Ravetch & Lanier, 2000). The 
other FcγRs signal through an immunoreceptor tyrosine-based activation motifs (ITAM); 
FcγRIIa is unique in that it comprises an ITAM-containing cytoplasmic tail whereas the 
other members non-covalently associate with Fcγ chain for ITAM signalling.  
ITAMs are responsible for FcγR, TCR and BCR signalling and are comprised of two 
YxxL/I motifs separated by 6-12 amino acids (Isakov, 1997). Clustering of ITAM 
containing receptors within the membrane, and possibly recruitment to lipid rafts, leads 
to phosphorylation of the ITAM tyrosines (Sobota et al., 2005; Suzuki et al., 2000). This 
phosphorylation event is mediated by SFKs and is essential for phagocytosis to occur 
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(Fitzer-Attas et al., 2000; Greenberg et al., 1993). Hck, Lyn and Fyn are the predominat 
SFKs expressed in myeloid cells (Lowell, 2004). Although several SFKs, including Src 
and Fyn, can phosphorylate ITAM in vitro and in vivo (Bewarder et al., 1996; Huang et 
al., 1992), Lyn has been shown to co-precipitate with the FcγR and is suggested to be the 
most likely candidate for in vivo phosphorylation of the FcγR in immune cells (Bewarder 
et al., 1996; Ghazizadeh et al., 1994; Jankowski et al., 2008). FcγR-mediated 
phagocytosis is severely abrogated in cells lacking hck, fyn and lyn (Fitzer-Attas et al., 
2000) and following chemical inhibition of SFK activity (Allen & Aderem, 1996; 
Cougoule et al., 2006). However, some internalisation does occur in SFK knockout cells 
suggesting other kinases may also phosphorylate the receptor (Fitzer-Attas et al., 2000).  
ii. Adaptor proteins 
The phosphorylated ITAM tyrosines provide docking sites for SH2 domain containing 
proteins (Fig. 4). One of these central to phagocytic signalling is the kinase Syk which 
contains two SH2 domains (Kiefer et al., 1998). Although Syk can also phosphorylate 
the ITAM in some circumstances (Zoller et al., 1997), phagocytosis is stalled at a later 
stage in cells lacking Syk than hck-/-fyn-/-lyn-/- cells suggesting Syk acts downstream of 
SFKs (Crowley et al., 1997; Fitzer-Attas et al., 2000). Syk-/- cells or chemical inhibition 
of Syk with piceantanol revealed that although particle internalisation was inhibited, 
actin polymerisation could still be detected (Cougoule et al., 2006; Crowley et al., 1997). 
Following its recruitment, Syk is itself phosphorylated and activated, which leads to 
further protein recruitment and signal propagation (Crowley et al., 1997). For example 
the adaptor proteins linker of activation of T cell (LAT) and hence Grb2 and Gab2 rely 
on Syk activity for recruitment (Tridandapani et al., 2000). A number of adaptors 
including Gab, Grb, 14-3-3 and Crk family proteins co-precipitated with the FcγR 
suggesting a role in the formation of a signalling complex (Jankowski et al., 2008). The 
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SH2 containing CrkII has been shown to be essential for phagocytosis and interacts with 
the bi-partite GEF DOCK180-ELMO1 contributing to Rho GTPase activation (Lee et al., 
2007). The adaptor Nck is also recruited to the phosphorylated ITAM and contributes to 
actin polymerisation pathways through N-WASP recruitment (Dart et al., 2012a).  
iii. Actin polymerisation and Rho GTPases 
Actin polymerisation is essential for phagocytosis as demonstrated by the inhibition of 
internalisation by cytochalasin B treatment (Axline & Reaven, 1974). Arp2/3 is recruited 
to the forming phagocytic cup and overexpression of WAVE WCA domain, which binds 
Arp2/3, prevents Arp2/3 recruitment and actin polymerisation (May et al., 2000). The 
RhoGTPases Cdc42, Rac1 and Rac2 are recruited to and activated at the forming 
phagocytic cup (Hoppe & Swanson, 2004). Studies using dominant negatives and toxins 
showed Cdc42 and Rac are essential for this pathway (Caron & Hall, 1998). siRNA 
analysis showed a requirement for Cdc42 and Rac2, as well as RhoG, but that Rac1 was 
not essential (Tzircotis et al., 2011). Furthermore, macrophages from rac2-/- or rac1-/-, 
rac2-/- knockout mice showed impaired phagocytosis (Hall et al., 2006). Interestingly, 
although inhibition of either Cdc42 or Rac abrogated internalisation, inhibition of both 
was necessary to abolish actin polymerisation (Cougoule et al., 2006). This suggests 
complementary functions although spatio-temporal differences have been described. 
Cdc42 is active at the advancing edge and inactivated shortly after, whereas Rac1 is 
active throughout the phagosome, and Rac2 shows delayed activation and is localised to 
the base of the cup (Hoppe & Swanson, 2004). Active Cdc42 and Rac activate the actin 
nucleation promoters WASP/N-WASP and WAVE respectively and WASP has been 
shown to localise to and be required for forming cups (Lorenzi et al., 2000). 
Additionally, WASP-deficient patients’ macrophages display defective actin 
accumulation and phagocytosis (Lorenzi et al., 2000). Interestingly, clustering of Cdc42 
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facilitated actin polymerisation but not internalisation whilst clustering of Rac facilitated 
particle internalisation albeit with unusual morphology (Castellano et al., 1999; 
Castellano et al., 2000).  
Several RhoGEFs have been implicated in FcγR-mediated phagocytosis. p115RhoGEF 
was shown to co-precipitate with the receptor, and DOCK180-ELMO1 is recruited via 
the adaptor protein CrkII (Jankowski et al., 2008; Lee et al., 2007). The involvement of 
the Rac and Cdc42 GEF Vav is more controversial. Although phsophorylated and 
recruited by Syk following receptor ligation, analysis of vav-/- cells showed no defect in 
FcγR-mediated phagocytosis (Hall et al., 2006). Conversely, dominant negative Vav 
inhibited both Rac activation and phagocytosis suggesting a key role for this GEF in 
phagocytic signalling (Patel et al., 2002). 
iv. Membrane delivery 
In addition to the Rho family GTPases facilitating actin polymerisation, Arf1 and Arf6 of 
the ADP ribosylation factor (ARF) family are required. They function in mediating the 
delivery of intracellular vesicles providing the additional membrane surface required for 
phagocytosis (Braun et al., 2007; Niedergang et al., 2003). While Arf6 is activated early, 
Arf1 shows delayed and prolonged activation suggesting they have different roles within 
cup formation (Beemiller et al., 2006). Recycling endosomes and late endosomes have 
been shown to be sources of additional membrane during phagocytosis based on the 
presence of specific markers vesicle associated membrane protein 3 (VAMP3) and TI-
VAMP/VAMP7 respectively (Bajno et al., 2000; Braun et al., 2004). The role of ER 
derived membrane is less clear; although the ER markers calnexin and calreticulin have 
been detected in forming phagosomes (Gagnon et al., 2002) others have shown that ER 
and the phagocytic cup never fuse (Touret et al., 2005).   
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Figure 4. FcγRIIa-mediated phagocytosis 
Schematic showing the signalling pathways involved in FcγRIIa-mediated phagocytosis. FcγRIIa 
is clustering in the membrane through binding of an IgG-opsonised target initiating signalling. 
The FcγRIIa ITAM tyrosines are phosphorylated by SFKs providing docking sites for SH2 
containing proteins including Syk, Crk and Nck. Syk phosphorylates and activates the Rac GEF 
Vav while Crk recruits the GEF Dock180/Elmo1 contributing to Rac-dependent actin 
polymerisation pathways. Nck, PIP2, and Cdc42 contribute to WASP/N-WASP activation to 
promote actin polymerisation at the leading edge. PIP2 is depleted by PI3K and PLCγ which both 
rely on Syk for recruitment. Membrane delivery is coordinated by Arf1 and Arf6 while myosins 
provide the contractile forces required for closure of the cup. See the text for further details and 
references. 
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v. Myosins 
A strong contractile force is also involved in phagocytosis as observed in the constriction 
of RBC when caught between two phagocytes (Swanson et al., 1999). Myosins provide 
this contractile force and have been shown to localise to the phagocytic cup and to 
function in phagocytosis. Myosin II and IXb concentrate at early cup structures while 
myosin IC accumulates at later time points (Swanson et al., 1999). Myosin V was also 
shown to accumulate during phagosome formation and to play a role in phagosome 
movement (Al-Haddad et al., 2001; Swanson et al., 1999). Additionally, the inhibition of 
myosin II phosphorylation prevents phagocytic cup closure (Olazabal et al., 2002). 
Myosin 1G and Myosin X have both been shown to be recruited to forming phagosomes 
and required for maximal pseudopod extension (Cox et al., 2002; Dart et al., 2012b).  
vi. Phosphoinositides 
Membrane lipids play a central role in the coordination and advancement of phagocytic 
signalling. The lipid modifying enzymes PI4P-5K, PI3K, PLC, PTEN and SHIP-1 have 
all been shown to be involved in phagocytosis (Swanson & Hoppe, 2004). In particular 
phosphinositide (PI) signalling is implicated at several stages of phagocytosis. Following 
FcγR ligation the membrane PI(4,5)P2 concentration increases transiently in forming 
pseudopods before PI(4,5)P2 depletion and a dramatic rise PI(3,4,5)P3 levels, which 
persist until after phagosome closure (Botelho et al., 2000; Marshall et al., 2001; 
Swanson & Hoppe, 2004). PI(4,5)P2 is generated by PI4P-5K, the inhibition of which 
abrogates phagocytosis (Coppolino et al., 2002). PI(4,5)P2 present at the leading edge 
cooperates with Cdc42 in the activation of WASP/NWASP leading to actin 
polymerisation (Rohatgi et al., 2000). However, removal of PI(4,5)P2 is required for 
actin depolymerisaton at the base of the cup (Scott et al., 2005). This is mediated by 
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PI3K which converts PI(4,5)P2 to PI(3,4,5)P3, and phospholipase C (PLC)γ which 
converts PI(4,5)P2 to DAG and IP3. Both PI3K and PLCγ rely on Syk for recruitment to 
the forming phagocytic cup (Flannagan et al., 2012). Syk interacts with the regulatory 
subunit of PI3K, p85, which is subsequently phosphorylated leading to activation of the 
enzyme (Moon et al., 2005). Interestingly, inhibition of PI3K shows a size dependent 
phenotype, with inhibition of larger particle, but not small particle internalisation (Cox et 
al., 1999). This has prompted the suggestion that small particles are already internalised 
by the time PI(3,4,5)P3 dependent mechanisms are initiated. PI(3,4,5)P3 has been 
suggested to be responsible for directing focal exocytosis for membrane delivery perhaps 
via PI3K dependent regulation of Arf1 and Arf6 (Beemiller et al., 2006). PI(3,4,5)P3 can 
increase GEF activities including that of the ARF nucleotide binding site opener (ARNO) 
and Vav (Han et al., 1998; Venkateswarlu & Cullen, 2000). PI3K-generated PI(3,4,5)P3 
also recruits Myosin X through its PH domain, which has been shown to be essential for 
internalisation of large particles (Cox et al., 2002). PI(3,4,5)P3 is depleted by 
phosphatase and tensin homolog (PTEN) and Src homology 2 domain-containing inositol 
5’-phosphatase (SHIP) which both localise to phagocytic cups (Huang et al., 2003; Kim 
et al., 2002). Indeed, overexpression of constitutively active SHIP-1 inhibits 
internalisation whilst dominant negative SHIP-1 enhanced phagocytosis (Cox et al., 
2001). SHIP-1 has more recently been shown to be activated downstream of the FcγRIIa 
presumably to regulate signalling, but it also mediates the inhibitory signalling resultant 
from FcγRIIb ligation (Huang et al., 2003). 
vi. Additional kinases 
In addition to SFK and Syk, several other kinases have been implicated in FcγR 
phagocytosis. PLC generated DAG activates protein kinase C (PKC) which has been 
shown to enhance phagocytosis (Larsen et al., 2002). The tyrosine kinase Tec has been 
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shown to co-precipitate with cross-linked FcγR (Jankowski et al., 2008) and the Abl/Arg 
inhibitor Iminitab (Gleevec) significantly abrogates FcγR-mediated internalisation 
(Wetzel et al., 2012). In addition, PAKs are suggested to have several role in 
phagocytosis; PAK1 phosphorylates LIM kinases (LIMK), which in turn phosphorylates 
and regulates cofilin (Edwards et al., 1999), PAK1, 2 and 4 have been shown to impinge 
upon Myosin II activity through phosphorylation of myosin light chain (MLC) or MLC 
kinase (MLCK) (Bright & Frankel, 2011; Sanders et al., 1999), and PAK-dependent 
phosphorylation of RhoGDI can release and activate Rac (DerMardirossian et al., 2004).  
Thus a combination of GTPases, kinases and PI signalling is involved in this complex 
process to co-ordinate the actin polymerisation and membrane delivery required for 
phagocytosis.  
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Bacterial pathogenesis 
Successful bacterial pathogens require strategies for colonising their host, replicating 
within this niche and promoting their subsequent dissemination. In order to do this, the 
bacteria must overcome host cell responses, and often a complex interplay between the 
bacteria and host proceeds. Some bacteria can prove harmless to healthy hosts whilst 
causing severe infections in immunocompromised patients or following access to 
alternative niches, e.g. skin lesions or burns. Others have acquired potent toxins or 
effector proteins that have profound effects even on healthy people.  
 
1.5 Escherichia coli  
Escherichia coli is a Gram negative facultative anaerobe of the Enterobacteriaceae 
family. It is one of the most abundant bacteria in the commensal flora of the human gut 
colonising the mucous layer of the colon. Due to the ease of growth and genetic 
manipulation, E. coli has been extensively studied in the laboratory and exploited as a 
host for general molecular biology techniques. Although most E. coli are beneficial, 
several clones have acquired the ability to cause disease in healthy hosts. These 
pathogenic E. coli cause a range of disease including diarrhoea, meningitis/septicaemia 
and urinary tract infections (Kaper et al., 2004). As such E. coli is a very versatile species 
capable of colonising and thriving in a variety of niches. Pathogenic ability can be 
conferred upon commensal strains by the insertion of mobile genetic elements encoding a 
range of adhesins and virulence factors. This acquisition of genetic material is coupled 
with gene loss resulting in the adaptation to a new lifestyle. Genetic analysis of the 
laboratory strain E. coli K-12 strain MG1655, Enterhaemorrhagic E. coli (EHEC) strain 
EDL933 and uropathogenic E. coli (UPEC) strain CFT073 revealed that only 39.2% of 
the combined set of proteins are shared between all three (Welch et al., 2002). Indeed, 
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EHEC has an additional 1.4 Mb DNA not present in K-12 and lacks 0.53 Mb of K-12 
DNA (Hayashi et al., 2001).  
Acquired virulence factors that promote pathogenic ability can include novel adhesins, 
secretion systems for the delivery of bacterial proteins, and effector proteins or toxins 
that subsequently manipulate host cell processes. Secretion systems and the manipulation 
of post-translational modifications are discussed further as examples of virulence factors 
important both in E. coli and more broadly in bacterial pathogenesis. 
 
1.6 Secretion systems 
Bacteria use a range of secretion systems for the delivery of membrane proteins and 
release of proteins that are integral both to mutualistic and pathogenic interactions with 
eukaryotic cells (Tseng et al., 2009). Importantly, there is no known energy source at the 
outer membrane of Gram negative bacteria and so multiple elegant systems have evolved 
to overcome this problem allowing transfer of hydrophilic proteins across the outer 
membrane. There are six secretions systems (Type I to VI) described in Gram negative 
bacteria as well as the ubiquitous Sec and Tat pathways (Fig. 5). The type VII secretion 
system has been described in some Gram positive bacteria and Mycobacterium, but is not 
discussed further here (Tseng et al., 2009). 
 
Figure 5. Bacterial secretion systems 
Summary of the bacterial secretion systems highlighting key components. See text for further 
details. Image taken from (Tseng et al., 2009). 
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1.6.1 Sec and Tat pathways 
Sec and Tat pathways are conserved across bacteria and eukaryotes and are often referred 
to as part of the general export/secretion pathways (Desvaux et al., 2004). In Gram 
negative bacteria, proteins are translocated across the inner membrane via Sec and/or Tat 
and are then delivered to secretins in the outer membrane for secretion. For example, 
several secretion systems (e.g. Type II, chaperone-usher and Type V) follow general 
export pathways across the inner membrane but use divergent mechanisms for transport 
outside of the cell. The Sec translocase transports unfolded proteins across the inner 
membrane in a post-translational or co-translational manner (Papanikou et al., 2007). The 
signal sequence consists of an amino-terminal acidic region followed by a hydrophobic 
region and a cleavage site if required. The hydrophobic sequence is bound by a 
homotetramer of the SecB chaperone, which delivers the substrate to the SecA 
component of the translocase. Alternatively, membrane proteins or extremely 
hydrophobic signals are delivered to the FtsY receptor via the signal recognition particle 
for co-translational transport. The polypeptide is fed through a membrane channel made 
up of SecY, SecE and SecG with energy from the proton motor force and the SecA 
ATPase. Each successive round of ATP hydrolysis facilitates the movement of around 20 
residues of the pre-protein (Schiebel et al., 1991). Unless the protein is to remain 
membrane associated, the signal sequence is then cleaved by the signal peptidase, 
releasing the protein into the periplasm.  
The twin arginine translocation (Tat) pathway mediates the transfer of folded proteins, 
for example those requiring co-factors, across the cytoplasmic membrane (Palmer & 
Berks, 2012). Remarkably, substrates with a diameter up to 70 Å are translocated whilst 
maintaining membrane barrier properties (Teter & Theg, 1998). The signal sequence is 
amino-terminal with a twin-arginine motif and the consensus S-R-R-x-F-L-K where x is 
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a polar residue. The Tat translocase is made up of three membrane proteins TatA, TatB 
and TatC. No clear structure has been determined and is thought that varying 
stoichiometries exist depending on the size of pore required. A TatBC complex binds the 
substrate via the signal sequence initiating oligomerisation of TatA to form a channel. 
Translocation through this system is energized solely by the proton motive force (Yahr & 
Wickner, 2001). 
 
1.6.2 Chaperone usher pathway 
Following Sec translocation, many bacterial surface structures are secreted via the 
chaperone usher pathway. The P pili of uropathogenic E. coli is the prototypic example 
of this pathway (Waksman & Hultgren, 2009). The unfolded pilus subunits are bound by 
the periplasmic chaperone, which assists in protein folding and delivery to the outer 
membrane usher PapC. Binding of the pilus:chaperone to a PapC dimer releases the 
chaperone and opens one of the PapC pores. Secretion does not require any energy input 
but folded pilus subunits polymerise once the chaperone is released allowing 
translocation through the usher and incorporation in to the filament. 
 
1.6.3 Type I secretion system 
The Type I secretion system (T1SS) delivers unfolded proteins across the inner and outer 
membranes in a single step without release in the periplasm. Type I secretion requires 
three main components; an inner membrane ATP binding cassette (ABC), an outer 
membrane protein (OMP) and a membrane fusion protein (MFP) that links the inner and 
outer membrane channels. The signal sequence is located at the carboxy-terminal, often 
including glycine rich repeats, and is recognised by the ABC protein (Delepelaire, 2004). 
The prototypic system is that of the E. coli α-haemolysin (HlyA) in which the dimeric 
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ABC, HlyB, has two ATP binding and two integral membrane domains. The ABC 
functions in substrate recognition and ATP hydrolysis to energise the system. In the case 
of Hly, the ABC-MPF (HlyB-HlyD) complex interacts with the substrate, whereas 
substrate interaction is mediated solely by the ABC in other systems (Letoffe et al., 1996; 
Thanabalu et al., 1998). Substrate binding initiates formation of a channel through the 
periplasm to the OMP: TolC for HlyA. TolC assembles into a trimeric complex forming 
a beta-barrel membrane channel. Thus secretion depends on the formation of a channel 
spanning the inner-membrane, periplasm and outer-membrane in response to substrate 
recognition. 
 
1.6.4 Type II secretion system 
The type II secretion system (T2SS) refers to one of the branches of outer membrane 
translocation following general export across the inner membrane. Examples of proteins 
secreted through this system include E. coli heat labile toxin and Pseudomonas 
aeruginosa Exotoxin A (Korotkov et al., 2012; Tauschek et al., 2002). Proteins are 
secreted following folding in the periplasm, and as such the secretion signal is thought to 
be conformational rather than linear. Interestingly, the majority of the 12-15 T2SS 
components are associated with the inner membrane with only 2 components forming the 
secretin in the outer membrane; the dodecomeric GspD channel and accessory 
lipoprotein GspS (Korotkov et al., 2012). A cytoplasmic ATPase GspE supplies the 
energy for the system, inducing conformational changes in inner membrane proteins 
which are then passed on to periplasmic pseudopilus components. It is hypothesised that 
this then leads to extension of the pseudopilus thereby pushing proteins through the outer 
membrane channel (Douzi et al., 2011).  
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1.6.5 Type III secretion system 
The type III secretion system (T3SS) is a multi-component injection system allowing the 
secretion of effector proteins directly from the bacterial cytoplasm to host cells (Cornelis, 
2006). Although also present in non-pathogenic bacteria and functioning in mutualistic 
relationships, the T3SS is central to the pathogenesis of several Gram negative pathogens 
including Yersinia spp., Salmonella spp. as well as enteropathogenic E. coli (EPEC) and 
EHEC (Ghosh, 2004). The general apparatus is highly conserved and is composed of 20-
25 constituent proteins arranged in to inner and out membrane rings connected through 
the periplasm to form a hollow conduit for protein secretion (Tampakaki et al., 2004). 
This structure is extended with an external needle structure and terminal translocators 
that form a pore in target cell membranes for protein translocation. The core membrane 
related ring structure closely resembles that of the flagellar basal body suggesting a 
common evolutionary ancestor (Blocker et al., 2003).   
The EPEC T3SS inner membrane rings are comprised of EscD and EscJ and the outer 
membrane ring of EscC (Izore et al., 2011). Structural analysis of T3SS basal complexes 
suggests that the OM ring has a ‘neck’ region extending in to the periplasm linking to the 
inner membrane components (Izore et al., 2011). However, the EPEC component EscJ 
has been shown to form an extended structure capable of spanning the periplasm (Crepin 
et al., 2005a). Following completion of the basal membrane spanning complex, the 
export apparatus components EscR, EscS, EscT, EscU and EscV are added to the inner 
membrane ring, and EscQ forms a cytoplasmic facing (C) ring providing a binding site 
for the ATPase EscN. The conserved T3SS ATPase is thought to promote the release of 
T3SS substrates from chaperones (Akeda & Galan, 2005). The external needle is then 
formed through secretion and subsequent polymerisation of the needle subunit. The 
EPEC needle, composed of EscF, is unusually short but precedes an additional long 
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filament of polymerized EspA subunits. This hollow filament extends up to 260 nm away 
from the cell and functions in host cell adhesion as well as providing a channel for 
protein secretion (Crepin et al., 2005b; Knutton et al., 1998). The pore-forming 
translocon components EspB and EspD are subsequently translocated before a switch 
from secretion of translocators (EspA,B,D) to secretion of effector proteins. This switch 
is thought to be controlled by the SepD and SepL cytoplasmic regulators, which are 
required for efficient translocator secretion (O'Connell et al., 2004). The historically 
accepted model has been that the translocon components form a pore in the host cell 
allowing direct protein translocation through the T3SS (Büttner & Bonas, 2002). 
However, some recent reports have suggested an alternative or concurrent two step 
model in which translocators and effectors are initially secreted and associate with the 
bacterial surface (Akopyan et al., 2011; Edgren et al., 2012). Following host cell 
detection they are then released and the translocators form a pore in a manner analogous 
to bacterial pore forming toxins, allowing translocation of effectors in to host cells. 
Either way, translocation through this system allows bacteria to subvert host cell 
signalling processes through the translocation of an array of effector proteins. 
 
1.6.6 Type IV secretion system 
The type IV secretion system (T4SS) is another multiple component organelle capable of 
delivering effector proteins directly from the bacterial cytosol to target eukaryotic cells 
and is ancestrally related to bacterial conjugation systems (Zechner et al., 2012). 
Interestingly, T4SS can mediate secretion of diverse substrates including proteins and 
nucleoprotein complexes, as well as DNA uptake and release. The type A Agrobacterium 
tumefaciens VirB T4SS system transfers oncogenic DNA to target plant cells whereas the 
type B Legionella pneumophilia Dot/Icm system transfers >250 effector proteins in to 
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host cells (Zechner et al., 2012; Zhu et al., 2011). The genetic locus encoding L. 
pneumophila T4SS is referred to as dot/icm through independent naming as defect in 
organelle trafficking (dot) or intracellular multiplication (icm.). All T4SS include a 
channel for crossing the inner and outer membranes, a T4 coupling protein (T4CP) which 
binds substrates and directs them to the channel, and an ATPase required for the release 
of substrates from their chaperones allowing translocation. In the current L. pneumophila 
Dot/Icm model, DotH forms a pore in the outer membrane which is stabilized in the outer 
membrane by the lipoproteins DotC and DotD (Nagai & Kubori, 2011). DotG is an 
intergral inner membrane protein but is thought to form a channel to the DotH-DotC-
DotD complex. DotF extends from the cytoplasm to the periplasm and interacts with 
DotG whereas DotL and DotB function as the T4CP and energizing ATPase respectively 
(Nagai & Kubori, 2011). Further integral membrane proteins (e.g. IcmF/DotU) stabilise 
the system. Interestingly, in some circumstances, e.g. Pertussis toxin, proteins can also be 
directed to the T4SS from the periplasm following Sec dependent inner membrane 
translocation (Zechner et al., 2012).  
 
1.6.7 Type V secretion system 
The type V secretion system (T5SS) is another important method for outer membrane 
translocation following general export across the inner membrane. In contrast to other 
secretion systems, the protein itself includes the functional elements required for its 
secretion rather than being delivered to an exogenous apparatus. The canonical T5SS 
autotransporter is the Neisseria gonorrhoeae autotransporter IgA1 protease, although 
many other secreted toxins and surface adhesins use this mechanism (Henderson et al., 
2004). The amino-terminal of the IgA1 protease includes a signal sequence for Sec-
dependent inner membrane translocation followed by a central passenger domain and the 
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carboxy-terminal region forms a beta-barrel channel in the outer membrane for the 
translocation of the passenger domain (Pohlner et al., 1987). T5SS have been subdivided 
into Va, Vb and Vc where the canonical autotransporter constitutes subtype Va, the beta-
barrel and passenger domains are separate polypeptides in subtype Vb, and Vc systems 
require trimerisation to form the beta-barrel channel (Henderson et al., 2004). 
 
1.6.8 Type VI secretion system 
The type VI secretion system (T6SS) was identified more recently through analysis of 
homologues of the T4SS gene icmF and the Vibrio cholerae and Pseudomonas 
aeruginosa systems most extensively studied (Mougous et al., 2006; Pukatzki et al., 
2006). Interestingly T6SS play diverse roles from pathogenic and anti-pathogenic effects 
on eukaryotic cells to antimicrobial interactions (Records, 2011). Although the T6SS 
includes IcmF/DotU homologues, the remainder of the apparatus is distinct and 
resembles the bacteriophage tail spike injectisome. The T6SS locus generally encodes 13 
essential genes although the organisation of the locus is highly variable (Boyer et al., 
2009). The secretion apparatus is comprised of channels in the inner and outer 
membranes with a tubular extension for delivery proteins directly to cytoplasm of target 
cells. DotU/IcmF is located in the inner membrane along with the ClpV AAA+ family 
ATPase. IcmF has a Walker A motif typical of ATPases and may energise the system. 
The ClpV ATPase is essential for energizing the system but is thought to act in the 
remodeling of VipA and VipB which form a tubular structure providing a channel 
through the periplasm (Bonemann et al., 2009). Hcp and VgrG proteins were initially 
shown to be secreted dependent on the T6 locus but are now thought to also act as 
structural components of the apparatus (Mougous et al., 2006; Pukatzki et al., 2007). Hcp 
shares structural and sequence homology with the phage tail component, which forms a 
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channel for DNA delivery and has been shown to form hexameric rings that polymerise 
in to tubular structures (Mougous et al., 2006). VgrGs share homology with the phage 
tail spike proteins, which form a pointed complex for puncturing the bacterial envelope 
(Pukatzki et al., 2007). Thus the T6SS is thought to function as an inverse bacteriophage 
tail-spike, puncturing the target cell for delivery of effector proteins through the Hcp 
channel. Interestingly, some VgrGs have carboxy-terminal extensions which act as 
effector domains. For example, V. cholerae VgrG1 cross-links actin in macrophages 
preventing internalisation (Pukatzki et al., 2007).   
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1.7 Bacterial manipulation of post-translational modifications 
Post-translational modifications (PTM) add another layer of complexity to the proteome 
allowing proteins to be regulated depending on the presence or absence of a 
modification. As discussed above, phosphorylation can promote conformational changes 
inactivating/activating SFKs and also allows recruitment of interacting proteins through 
SH2 domains. Yersinia interfere with phosphorylation with the effector YopH which 
dephosphorylates host proteins and disrupts signalling (Andersson et al., 1996). There 
are many other PTM regulation cycles that occur in eukaryotic cells and bacterial 
pathogens that take advantage of these systems. For example, other PTMs exploited by 
pathogens include glycosylation, acetylation, AMPylation and ADP-ribosylation. 
Yersinia YopJ acetylates MAP kinase kinase (MAPKK) and IκB kinase (IKK) 
preventing their subsequent phosphorylation and activation, which results in inhibition of 
MAPK and NFΚB signalling (Mittal et al., 2006; Mukherjee et al., 2006). GTPases are 
frequent targets of PTM by bacterial toxins and effector proteins. For example, the 
Clostridium difficile Toxins A and B glycosylate Rho GTPases, adding glucose onto 
residues within the Switch region, inactivating signalling with cytotoxic effects (Aktories 
& Just, 1995; Sehr et al., 1998). The L. pneumophila effector protein DrrA catalyses 
AMPylation, the addition of an adenosine monophosphate (AMP) moiety, of Rab 
GTPases disrupting vesicle trafficking (Muller et al., 2010). Moreover, 
phosphocholination activity was recently shown for the L. pneumophila effector AnkX, 
further contributing to the disruption of intracellular trafficking (Mukherjee et al., 2011).  
 
1.7.1 ADP-ribosylation 
ADP-ribosylation is used by a wide range of pathogens to disrupt host cell signalling and 
involves the transfer of an ADP-ribose moiety from β-nicotinamide adenine dinucleotide 
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phosphate (NAD) on to a target protein. The first discovered bacterial ADP-
ribosyltransferase (ART) was diphtheria toxin (DT) of Corynebacterium diptherium, one 
molecule of which can kill a mammalian cell (Yamaizumi et al., 1978). DT acts by ADP-
ribosylating elongation factor 2 (EF-2) at a diphthamide, a modified histidine, residue 
(Collier, 1967; Collier, 2001; Van Ness et al., 1980). ADP-ribosylation at this site blocks 
EF-2 function and inhibits protein synthesis.  
Mammalian cells encode a number of proteins that catalyse ADP-ribosylation and ADP-
ribose hydrolases to remove the modification, a prerequisite for reversible regulation 
(Corda & Di Girolamo, 2003). The best known are the poly-ADPribose polymerase 
(PARPs) which facilitate the addition of chains of ADP-ribose onto glutamate residues. 
The original member of the PARP family, PARP-1, functions in DNA repair binding to 
damaged DNA and ADP-ribosylating itself and other nuclear proteins initiating repair, 
although more diverse functions are now being recognised (Smith, 2001). PARP family 
proteins are distinct from the enzymes catalysing mono-ADPribosylation (referred to as 
ARTs). Several mammalian ARTs are ectoenzymes acting on the external surface of the 
cell and can modify antimicrobial peptides and integrins (Paone et al., 2002; Zolkiewska 
& Moss, 1993). These enzymes are thought to modulate immune responses as their 
inhibition disrupts inflammatory responses (Del Vecchio & Balducci, 2008). Intracellular 
ADP-ribosylation has also been detected and is thought to be involved in control of a cell 
signalling and the cytoskeleton (Corda & Di Girolamo, 2003). Although a number of 
intracellular ARTs have been identified the full extent of their role and the range of 
substrates is not yet established. Indeed, knowledge of bacterial ARTs which target host 
cell proteins is much further developed.  
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i. Structure and catalysis of bacterial ARTs 
Analysis of the sequence and structure of bacterial ARTs revealed that although they lack 
significant sequence homology they share a conserved β-sheet core (Koch-Nolte et al., 
2001). This is made up two sets of almost orthogonal anti-parallel β-sheets each with an 
adjacent helix. The groove between the β-sheets forms the NAD binding pocket while 
loops linking the β-sheets are implicated in substrate binding (Bell & Eisenberg, 1996; 
Han et al., 2001).  
ARTs generally fall into two classes dependent on sequence motifs: Class 1 ‘H-Y-E’ 
(e.g. DT, ExoA) and Class II ‘R-S-E’ ARTs (e.g. C. botulinum C2, C3) which differ in 
their NAD binding motifs (H-Y or R-S), but both rely on a catalytic glutamic acid (E) 
(Hottiger et al., 2010). The His of the H-Y-E (His 21 in DT) forms hydrogen bonds with 
the adenine ribose as well as stabilising other pocket residues contacting NAD and the 
conserved Tyr residue stacks with the nicotinamide ribose within the binding pocket 
(Bell & Eisenberg, 1996). For R-S-E class ARTs, the Arg is thought to interact with the 
phosphate groups of NAD while key Ser residues of an STS motif contact the 
nicotinamide ribose and stabilise the binding pocket (Han et al., 2001). Mutation of these 
key residues has been shown to disrupt NAD binding and ADP-ribosylation (Barth et al., 
1998; Blanke et al., 1994a; Blanke et al., 1994b; Perelle et al., 1996). 
A conserved glutamic acid (Glu 148 in DT) is shared by both classes and has been shown 
to essential for catalysis and specifically labeled with nicotinamide following a 
photoaffinity reaction (Carroll & Collier, 1984; Tweten et al., 1985). Thus the catalytic E 
was hypothesised to be the only essential residue for ADP-ribosylation (Hottiger et al., 
2010). However, the bacterial ARTs Mycobacterial Arr (ADP-ribosylating the antibiotic 
rifampin (Baysarowich et al., 2008)) and Pseudomonas syringae HopF2 (ADP-
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ribosylating MAPKK (Wang et al., 2010)) were recently shown to rely on a catalytic 
aspartic acid for activity. 
The ADP-ribosylation reaction proceeds via an nucleophilic substitution SN1 type 
mechanism whereby the enzyme binds NAD enforcing a constrained state which 
destabilises the glycosidic bond between nicotinamide and the nicotinamide-ribose (Bell 
& Eisenberg, 1996; Tsuge et al., 2003). Following scission of the glycosidic bond and 
dissociation of nicotinamide the carboxylate group of the essential acidic residue is 
thought to stabilise the positively charged transition state (Bell & Eisenberg, 1996). The 
ADP-ribose is then transferred on to the incoming nucleophile of the target protein. 
Although modification of arginine is common, other ARTs target diphthamide, cysteine, 
lysine, aspartate, glutamate and threonine residues of their target proteins. 
 
 
 
 
Figure 6. Schematic of ADP-ribosylation  
During the ADP-ribosylation reaction ADP-ribose is transferred on to the target protein releasing 
nicotinamide. 
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ii. Manipulation of the actin cytoskeleton by bacterial ARTs 
Although there are several bacterial ARTs that modify EF-2 (DT, P. aeruginosa ExoA, 
V. cholerae cholix toxin) to disrupt protein synthesis, many others target components or 
regulators of the cytoskeleton (Yates et al., 2006). P. aeruginosa T3SS effector ExoT 
ADP-ribosylates the Crk adaptor proteins (Sun & Barbieri, 2003) which are involved in 
phagocytosis (Lee et al., 2007). The Clostridium botulinum ADP-ribosylating toxins C2 
and C3 target monomeric actin and Rho GTPases respectively (Aktories et al., 1986; 
Vogelsgesang et al., 2007). C3 ADP-ribosylates RhoA, B and C at Asn41 which 
enhances their affinity for GDIs and so they are maintained in inactivate state (Genth et 
al., 2003). C2 ADP-ribosylates actin on Arg177, a site that is also targeted by Salmonella 
effector SpvB and C. perfringens iota toxin (Margarit et al., 2006; Vandekerckhove et 
al., 1987; Vandekerckhove et al., 1988). Modification of this residue on G-actin causes 
steric hindrance preventing actin polymerisation at the barbed end of actin filaments 
although it can bind to the pointed end where it acts as a capping protein. Toxins and 
effectors acting in this way prevent further polymerisation and cause a breakdown of the 
cytoskeleton (Aktories et al., 2011). Conversely, it was recently shown that the 
Photorhabdus luminescens toxins TccC3 and TccC5 ADP-ribosylate actin and Rho 
GTPases leading to enhanced polymerisation and clustering of actin, which also inhibits 
phagocytosis (Lang et al., 2010). 
ADP-ribosylation is often fundamental for the pathogenesis of bacteria that have 
exploited this system. Indeed, symptoms of diphtheria are mainly attributed to the effects 
of DT (Collier, 2001). Additionally, although the mechanism is unclear the Salmonella 
effector SpvB which targets actin has been shown to be required for virulence (Roudier 
et al., 1992). Thus PTMs, including ADP-ribosylation, are a key component of bacterial 
strategies for subverting the host cell.  
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1.8 Diarrheagenic E. coli 
Diarrhoea remains one of the leading causes of mortality in children under five with over 
750 000 deaths each year (Liu et al., 2012). E. coli strains are grouped into pathotypes 
which share virulence mechanisms and resultant disease. There are eight such E. coli 
pathotypes that cause diarrhoeal disease with markedly different pathologies and 
infection strategies. These include six long-established pathotypes: Enterotoxigenic E. 
coli (ETEC), Enteroaggregative E. coli (EAEC), Diffusely adherent E. coli (DAEC), 
Enteroinvasive E. coli (EIEC), Enteropathogenic E. coli (EPEC) and EHEC, as well as 
two more recently identified pathotypes: Adherent invasive E. coli (AIEC) and Shiga 
toxin (Stx) producing Enteroaggregative E. coli (STEAEC). As enteric E. coli constitute 
part of the commensal micorflora of many animals, human infections result from the 
consumption of contaminated food or water or additionally from person-to-person/fecal-
oral transmission. In the developing world, infection is spread due to inadequate 
sanitation and water supplies with ETEC, EPEC and EAEC being most the prevalent 
pathotypes. In contrast, in the industrialised world enteric E. coli infections are 
associated with outbreaks from contaminated food sources. In this setting EHEC and 
more recently STEAEC are the most common E. coli pathoypes associated with food 
poisoning (Clements et al., 2012). 
In addition to grouping in to pathotypes, E. coli strains are characterised by O 
(lipopolysaccharide, LPS) and H (flagellar) antigens where O antigen defines serogroups 
and O:H defines a serotype. However, some serotypes can belong to more than one 
pathotype and so serotyping does not always establish pathogenesis or predicted 
outcome.  
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Figure 7. Diarrheagenic E. coli 
Summary of the main pathogenic mechanisms of the six established diarrheagenic E. coli 
pathotypes. See text for further details. Image taken from (Kaper et al., 2004). 
 
1.8.1 Enterotoxigenic E. coli ETEC 
ETEC is a major cause of infantile and adult diarrhoea in the developing world and is 
also the main cause of travellers’ diarrhoea (Qadri et al., 2005). Symptoms can range 
from mild watery diarrhoea to cholera-like profuse diarrhoea. Pathogenesis relies upon 
colonization factors (CFs) mediating adhesion to epithelial cells of the small intestine and 
subsequent secretion of enterotoxins. Over 25 antigenically distinct fimbrial or fibrillar 
CFs have been identified, although the majority of human ETEC express either CFA/I, 
CFA/II or CFA/IV (Qadri et al., 2005; Wolf, 1997). However, 30-50% of isolates do not 
express any known CFs indicating many CFs remain to be characterised.  
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Diarrhoea caused by ETEC is attributed to the secretion of heat-labile (LT) and/or heat-
stabile (ST) entertoxins, which increase intestinal secretion of water and electrolytes 
(Qadri et al., 2005). LTs are AB5 toxins, composed of one A subunit and five B subunits, 
and are related to cholera toxin. The B subunits bind to cell surface ganglioside receptors, 
GM1 and GD1b, while the A subunit is an ADP-ribosyltransferase and modifies the α 
subunit of stimulatory guanine nucleotide binding protein (Gsα). This activates adenylyl 
cyclase raising cAMP concentrations and so activating protein kinase A (PKA). PKA 
then phosphorylates and activates the cystic fibrosis transmembrane conductance 
regulator (CFTR) chloride channel increasing Cl- secretion (Spangler, 1992).  
STs are small toxins; STa is associated with human disease and is a 18-19 amino acid 
peptide that mimics the intestinal hormone guanylin (Nair & Takeda, 1998). It therefore 
activates the guanylate cyclase receptor, increasing intracellular cGMP levels leading to 
CFTR phosphorylation, and again disrupting normal secretion and absorption 
(Vaandrager, 2002).  
 
1.8.2 Enteroaggregative E. coli (EAEC) 
EAEC is the second most prominent cause of travelers’ diarrhoea and causes persistent 
diarrhoea in the developing world (Clements et al., 2012). Pathogenesis relies upon 
adherence to epithelial cells of the large or small intestines followed by secretion of 
enterotoxins and cytotoxins. However, genomic heterogeneity amongst strains as to 
encoded adhesins and toxins complicates molecular characterization of pathogenesis. 
The characteristic aggregative ‘stacked brick’ configuration, seen following infection of 
HEp-2 cells, is mediated by the aggregative adhesive fimbriae (AAF) (Nataro et al., 
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1992). The secreted dispersin counteracts the negative charges of the LPS, preventing its 
interaction with AAF, and thus freeing AAF to act as an adhesin (Sheikh et al., 2002). 
The pAA plasmid encodes both AAF and the entertoxin enteroaggregative E. coli ST 
(EAST1) which shares 50% identity with STa, and increases cGMP levels impacting 
upon ion exchange (Savarino et al., 1993). Two further toxins are of the Serine protease 
autotransporter of Enterobacteriaceae (SPATE) family; Pet is a cytotoxin that cleaves 
spectrin, disrupting the actin cytoskeleton leading to exfoiliation (Villaseca et al., 2000) 
(Navarro-Garcia et al., 1998), and Pic which has mucinase activity and may aid 
colonization by degrading the mucus layer (Henderson et al., 1999). The Shigella 
enterotoxin 1 (ShET1) toxin is encoded on the opposing strand to Pic and is thought to 
contribute to diarrhoea (Harrington et al., 2006) (Fasano et al., 1995). 
 
1.8.3 Shiga toxin (Stx) producing Enteroaggregative E. coli (STEAEC) 
STEAEC has an emerging role in E. coli infections and it was only recently suggested to 
be recognised as a new pathotype (Clements et al., 2012). STEAEC O104:H4 was 
responsible for the Germany 2011 outbreak and is associated haemolytic uremic 
syndrome and bloody diarrhoea with high morbidity and mortality. STEAEC are EAEC 
strains that have acquired typical EHEC virulence factors. The Germany outbreak strain 
encoded AAF, dispersin, Pet, Pic and ShET1 common to EAEC, but also Stx and IrgA 
homolgoue adhesin (Iha), which are virulence factors associated with EHEC 
(Bielaszewska et al., 2011; Mellmann et al., 2011; Tarr et al., 2000). The severity of 
infections was suggested to result from the increased adherence of EAEC compared to 
EHEC, enhancing Stx delivery.  
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1.8.4 Diffusely adhering E. coli (DAEC) 
DAEC has been implicated in diarrhoea in children >18 months in some studies, 
although others have found no differences in DAEC prevalence between diarrhoea 
patients and controls (Gunzburg et al., 1993; Scaletsky et al., 2002). Additionally, the 
importance of DAEC is unclear due to cross-reactivity of a commonly used detection 
probe with EAEC (Snelling et al., 2009). DAEC is characterised by diffuse adherence on 
HEp-2 cells. Pathogenesis proceeds mainly through the effects of adhesin-enterocyte 
interactions but also via the secreted SPATE Sat, expressed in some diarrhoea-causing 
strains.   
Most DAEC strains express afimbrial (Afa) and fimbrial (Dr) adhesins encoded in the 
same operon (Bilge et al., 1989). Afa-Dr adhesins bind to Delay accelerating factor 
(DAF) and some strains also bind CEACAM; both of which are then relocalised around 
attached bacteria (Guignot et al., 2000). Binding triggers formation of cellular 
protrusions that wrap around the bacteria and activation of several cell signalling 
pathways including Ca2+ dependent signalling leading to disruption of the microvilli 
(Servin, 2005). The secreted SPATE Sat has multiple effects on enterocyte cytoskeleton 
and adhesion. Sat cleaves spectrin disrupting the actin cytoskeleton (Maroncle et al., 
2006) and leads to rearrangement of the tight junction (TJ) proteins ZO-1, ZO-3 and 
occludin and the focal adhesion (FA) proteins vinculin and paxillin. This disruption of 
TJs and FAs leads to increased paracellular permeability and cell detachment 
respectively (Guignot et al., 2007; Lievin-Le Moal et al., 2011). 
 
1.8.5 Adherent invasive E. coli (AIEC) 
AIEC was considered as a new E. coli pathotype after an interplay was suggested 
between E. coli strains and the pathogenesis of Crohn’s Disease (CD), an inflammatory 
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bowel disease (Darfeuille-Michaud, 2002). E. coli strains isolated from CD patients were 
shown to have unusual ability to adhere to mammalian cells, to invade non-phagocytic 
cells and to survive and replicate within macrophages (Boudeau et al., 1999; Giaffer et 
al., 1992; Glasser et al., 2001). Thus these strains were named adherent invasive E. coli. 
However, much of the genetic basis for this infection strategy is still unknown. 
Interestingly host susceptibility is also required and so bacterial virulence factors and 
host genetic disposition are involved in pathogenesis. 
Type 1 pili are implicated in AIEC colonization, binding to the CEACAM6 receptor 
which is overexpressed on the ileal mucosa of CD patients (Barnich et al., 2007). 
Additionally, a long polar fimbriae has been is thought to be involved in adhesion to 
Peyer’s patches (Chassaing et al., 2011). AIEC secrete OMV which are thought to be 
required for invasion (Rolhion et al., 2005). Although the contents are not entirely 
defined, the OMV contain OmpA which can bind to the ER stress response protein Gp96, 
which is also overexpressed on the apical surface of the ileal mucosa in CD patients 
(Rolhion et al., 2010).  
 
1.8.6 Enteroinvasive E. coli (EIEC) 
EIEC is genetically and pathogenically related to Shigella species (Peng et al., 2009; Wei 
et al., 2003). Shigella is a major cause of infantile death in the developing world. 
Symptoms range from watery diarrhoea to dysentery, a severe diarrhoea with blood and 
mucus and associated fever and abdominal cramps. In contrast to other E. coli 
pathotypes, pathogenesis does not rely on adhesins and colonization factors but 
progresses through invasion of enterocytes and an intracellular lifestyle. A T3SS is 
central to this virulence strategy, secreting over 50 effector proteins that target many host 
cell pathways manipulating the actin cytoskeleton, cell adhesion, cell cycle progression 
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and immune responses (Sasakawa, 2010). Shigella are transcytosed through intestinal 
microfold M cells and taken up by macrophages eliciting a strong pro-inflammatory 
response. Following replication and induction of macrophage cell death, Shigella invade 
the epithelium through the basolateral surface dependent on T3SS effectors (Carayol et 
al., 2013). Once internalised, they lyse the endocytic vacuole and replicate in the 
cytoplasm. Using actin polymerisation for propulsion Shigella move within the host cell 
and invade neighbouring cells by protrusion of the cell membrane and subsequent 
internalisation. In addition to the T3SS, Shigella strains have acquired toxins which 
contribute to pathogenesis. The secreted serine protease SepA is shown to contribute to 
virulence (Benjelloun-Touimi et al., 1995) and Shigella dysenteriae type I encodes the 
Stx toxin responsible for extensive cellular damage (Mark Taylor, 2008).  
 
1.8.7 Enteropathogenic E. coli and Enterohaemorrhagic E. coli (EPEC and EHEC)  
 EPEC and EHEC both rely on a T3SS for pathogenesis but differ in terms of their 
epidemiology, adhesion and toxin production (Spears et al., 2006). EPEC is 
predominantly a pathogen of the developing world and an important causal agent of 
infantile diarrhoea. EPEC is estimated to be responsible for ~ 10 % childhood diarrhoeal 
episodes in the developing world making it an important enteric pathogen (Boschi-Pinto 
et al., 2008; Ochoa et al., 2008). Infection with EPEC is associated with profuse watery 
diarrhoea, vomiting and fever following transmission through the fecal-oral route (Nataro 
& Kaper, 1998). The lack of invasion or toxin production led to skepticism as to whether 
EPEC was truly pathogenic although this was proved unequivocally by Levine et al who 
showed that EPEC causes diarrhoea in volunteer challenge studies (Levine et al., 1978). 
The EPEC strain used in this study was E2348/69 which has remained a prototypic and 
widely studied strain.  
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In contrast to EPEC, EHEC is more prevalent in industrialized countries and is associated 
with outbreaks from contaminated food sources. The spectrum of disease from EHEC 
infection ranges from watery diarrhoea to haemorrhagic colitis (HC) and haemolytic 
uremic syndrome (HUS), the latter two of which are dependent on Stx (Nataro & Kaper, 
1998). Although initially associated with bovine food products, EHEC transmission has 
since been reported through a wide array of food produce including fruit and vegetables 
(Berger et al., 2010). For example the EHEC 0157:H7 outbreak in Sakai 1996 was 
associated with white radish sprouts (Michino et al., 1999). The O157:H7 serotype of 
Stx-producing E. coli is the most commonly associated with disease in industrialized 
countries although serogroups O26 and O111 are also prevalent (Hiroi et al., 2012; Vally 
et al., 2012). However in other countries, for example Brazil, non-O157 strains 
predominate (Aidar-Ugrinovich et al., 2007).  
 
1.9  EPEC/EHEC pathogenesis 
1.9.1 A/E pathogens and the Locus of enterocyte effacement (LEE) 
EHEC and EPEC are grouped together, along with the mouse pathogen Citrobacter 
rodentium, by the distinctive attaching and effacing (A/E) lesion they form during 
infection. This lesion is characterised by effacement of the normal absorptive microvilli 
structures of intestinal epithelial cells and intimate attachment of the bacteria (Fig. 8) 
(Frankel et al., 1998; Knutton et al., 1987). Infection with these pathogens in vitro also 
leads to the formation of actin pedestals where the bacterial cell is raised on a platform of 
polymerised actin (Knutton et al., 1989))(Fig. 8). 
Formation of the A/E lesions in vivo and localised actin polymerisation in vitro is 
dependent on a pathogenicity island termed the locus of enterocyte effacement (LEE), a 
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region which is highly conserved between A/E pathogens EPEC, EHEC, Rabbit EPEC 
(REPEC) and Citrobacter species (Jarvis et al., 1995). Additionally, the EPEC LEE is 
sufficient to confer actin polymerisation capability on the E. coli commensal K-12 
(McDaniel & Kaper, 1997). In both EPEC and EHEC, the LEE contains 41 ORFs within 
5 polycistronic operons which encode gene regulators, structural components of the 
T3SS, chaperones, the bacterial surface protein intimin and a number of translocated 
proteins including the intimin receptor Tir (Elliott et al., 1998)(Fig. 8C).  
 
Figure 8. The attaching and effacing lesion 
(A) Scanning electron micrograph showing pedestals formed during EPEC infection of cultured 
cells. (B) Transmission electron micrograph showing intimate attachment of bacteria on raised 
structures and microvilli effacement characteristic of A/E lesions on intestinal cells. (C) 
Schematic of the LEE from EPEC E2348/69 showing the genetic organisation of the T3SS 
components, translocators, effector proteins, chaperones and regulators. Images taken from 
(Wong et al., 2011).  
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1.9.2  Adhesion 
EPEC and EHEC rely on a number of fimbrial and afimbrial adhesins for intestinal 
colonisation. These factors facilitate initial adhesion before the bacterial surface protein 
intimin mediates intimate adherence. EPEC strains are divided in to ‘typical’ and 
‘atypical’ strains dependent on the presence on the E. coli adherence factor plasmid EAF 
(Trabulsi et al., 2002). The bundle forming pilus (BFP) is encoded on the EAF plasmid 
and facilitates both adherence to host cells and between bacteria promoting microcolony 
formation (Cleary et al., 2004; Tobe et al., 1999). BFP has been suggested to interact 
with phosphoethanolamine in cellular membranes and N-acetyl-lactosamine containing 
receptors (Hyland et al., 2008; Khursigara et al., 2001). Other EPEC adhesins include 
type I fimbriae, which binds glycoproteins, and Lymphostatin (LifA) which is thought to 
contribute to adhesion and inhibit lymphocyte activation (Badea et al., 2003; Klapproth 
et al., 2000). EHEC also encode proteins homologous to LifA, Efa1 and ToxB that 
mediate adherence (Nicholls et al., 2000; Tatsuno et al., 2001). Additionally, EPEC and 
EHEC flagella have been shown to be required for maximal adherence (Erdem et al., 
2007). Furthermore, the E. coli common pilus (ECP), haemorrhagic coli pilus (HCP), the 
long polar fimbriae (LPF) and the outer membrane protein OmpA are thought to 
contribute EHEC adhesion (Jordan et al., 2004; Rendon et al., 2007; Torres & Kaper, 
2003; Xicohtencatl-Cortes et al., 2007). 
In addition to these factors unrelated to the LEE, the EspA filament of the T3SS and the 
LEE-encoded intimin contribute to adhesion (Cleary et al., 2004). There are multiple 
antigenically distinct intimin (Int) subtypes with over 20 now described (Lacher et al., 
2006). EPEC E2348/69 encodes Intα and EHEC O157:H7 Intγ which contribute to tissue 
tropism colonising small intestine and large intestine respectively (Phillips & Frankel, 
2000; Tzipori et al., 1995). Intα is thought to contribute to adhesion through binding β1 
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integrins whilst Intγ binds to nucleolin (Frankel et al., 1996; Hartland et al., 1999; 
Sinclair & O'Brien, 2002).  
Through the T3SS, A/E pathogens translocate their own receptor, Tir, into host cells to 
mediate intimate attachment (Kenny et al., 1997). Once translocated, Tir integrates into 
the host cell membrane in a hairpin topology with both the amino- and carboxy-terminal 
tails in the cytoplasm (DeVinney et al., 1999; Kenny, 1999). The external loop of Tir 
binds to intimin on the bacterial surface (Hartland et al., 1999; Kenny, 1999). Both 
intimin and Tir have been shown to be essential for colonization and pathogenesis in 
multiple in vivo infection models (Dean-Nystrom et al., 1998; Donnenberg et al., 1993a; 
Donnenberg et al., 1993b; Marches et al., 2000; Schauer & Falkow, 1993).  
 
1.9.3  Non-T3SS virulence factors 
The most important virulence factor of EHEC strains is the prophage-encoded Stx toxin, 
which is also present in some Shigella strains. There are two main subgroups, Stx1 and 
Stx2, although Stx2 is more frequently associated with severe human disease (Johannes 
& Romer, 2010). There is no secretion mechanism for Stx and release occurs through 
lambdoid phage mediated bacterial lysis (Wagner et al., 2002). Stx are AB5 toxins where 
Stx B subunits bind to the membrane glycolipid globotriaosylceramide (Gb3) mediating 
internalisation (Romer et al., 2007). Following internalisation, Stx follows retrograde 
trafficking pathways to the Golgi apparatus and then the ER, where the A subunit is 
cleaved and activated (Warnier et al., 2006). Stx then acts in the cytoplasm and cleaves 
28S ribosomal RNA of the ribosome inhibiting protein synthesis. Stx toxins promote cell 
death both through inhibition of protein synthesis and through enhancing pro-apoptotic 
signalling (Johannes & Romer, 2010). EHEC pathologies of bloody diarrhoea and HUS 
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are explained by the prominence Gb3 on renal epithelial cells and micro-vascular 
endothelial cells. 
The majority of O157 strains also carry the pO157 plasmid which encodes further 
virulence factors including adhesins (eg. ToxB and other fimbriae), haemolysin, and the 
SPATE EspP (Burland et al., 1998; Orth et al., 2010; Schmidt et al., 1994; Tatsuno et 
al., 2001). EspP has been shown to cleave components of the complement cascade (Orth 
et al., 2010). EPEC strains do not encode Stx toxins but some do produce the SPATE 
EspC. Although homologous to Pet from EAEC, EspC requires the T3SS for 
translocation (Vidal & Navarro-Garcia, 2008). Like Pet, it disrupts the cytoskeleton 
cleaving the actin binding protein spectrin (Navarro-Garcia et al., 2004).  
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1.10 EPEC/EHEC subversion of host cell signalling by T3SS effector proteins 
EHEC and EPEC use the T3SS to inject dozens of effector proteins into the eukaryotic 
cell cytoplasm. Once translocated, these effector proteins subvert diverse signalling 
pathways and physiological processes (Fig. 10). In addition to the seven effectors 
encoded in the LEE, there are other effectors encoded within prophages and other 
integrative elements (Tobe et al., 2006). Although EPEC and EHEC show high levels of 
conservation between the LEE encoded effectors, there is significant diversity in their 
non-LEE effector repertoire. Iguchi et al have shown EPEC E2348/69 to have 21 intact 
effector genes whereas the EHEC O157:H7 strain Sakai is estimated to have closer to 50 
T3SS effectors (Iguchi et al., 2009; Tobe et al., 2006). For example EHEC O157:H7 
strain Sakai encodes the effector EspW which is not present in EPEC, as well as multiple 
copies of NleG proteins which act as ubiquitin ligases (Wu et al.). 
 
1.10.1 Mechanisms of diarrhoea  
Diarrhoea caused by EPEC/EHEC seems to be due to the combined actions of a range of 
effector proteins altering cellular morphology, protein secretion, ion transport and barrier 
function. An imbalance in normal ion and water absorption increases liquid in the gut 
lumen resulting in watery diarrhoea. In the case of Stx-producing EHEC, the extensive 
cellular damage caused by the toxin mediates destruction of the enterocytes contributing 
to bloody diarrhoea.  
A single layer of intestinal epithelial cells facilitate the absorption of nutrients, 
electrolytes and water whilst acting as barrier to prevent access of the lumenal contents to 
the underlying lamina propria. In order to promote absorption, the surface area is 
maximized both through finger like structures on the surface of enterocytes and 
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organisation of enterocytes in to villi. The effacement of microvilli is one of the defining 
features of EPEC/EHEC infections and leads to a reduction in the absorptive surface area 
of the cells (Knutton et al., 1987). This activity has been attributed to the actions of Map 
and EspF following Tir:intimin dependent sinking in to the cell surface (Dean et al., 
2006). Microvilli contain a core of crosslinked actin filaments stabilized by myosins and 
other cytoskeletal components. EspB disrupts microvilli structure by preventing the 
interaction between myosins and actin thereby contributing to effacement (Iizumi et al., 
2007). Interestingly, although extensive microvilli debris is apparent around infected 
cells, this does not seem to contain F-actin suggesting actin depolymerisation and/or 
contraction as part of the effacement process (Dean et al., 2006).  
In addition to microvilli effacement, EPEC/EHEC effectors disrupt normal absorptive 
processes by altering the location or activity of ion transporters. For example the 
combined effects of Tir, intimin, Map and EspF have been shown to inhibit the activity 
of the sodium/glucose co-transporter SGLT1 which plays a major role in water 
absorption (Dean et al., 2006; Meinild et al., 1998). EspF also acts to alter activities of 
Na+/H+ exchangers (NHE) disrupting NHE3 activity through an unknown mechanism 
(Hodges et al., 2008). In addition to disruption of Na+ transport, EPEC/EHEC effectors 
target Cl- absorption through reducing the levels of the DRA Cl-/OH- exchanger on the 
apical surface (Gill et al., 2007). This internalisation of DRA is dependent on the 
effectors EspG and EspG2 which are also reported to disrupt microtubules, protein 
secretion and endomembrane trafficking (Clements et al., 2011; Selyunin et al., 2011; 
Tomson et al., 2005). EspG and EspF also contribute to the disruption of absorptive 
processes by altering the localisation of aquaporin (AQP) water channels (Guttman et al., 
2007). The mislocalisation of AQPs from the membrane to the cytoplasm reduces 
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absorption of water from the gut lumen potentiating the effects of disrupted NaCl 
absorption resulting in diarrhoea.  
Contacts between cells, and in particular tight junctions, are critical for maintaining the 
integrity of enterocyte barrier function and controlling paracellular flow. Tight junctions 
are located between cells at the edge of the apical surface and regulate the flow of ions 
and molecules between cells. The main TJ components include occludins, claudins and 
zonula occludens (ZOs) although the composition and regulation of TJs are highly 
dynamic (Gonzalez-Mariscal et al., 2008). EPEC infection results in dephosphorylation 
of occludin and its concurrent dissociation from TJs (Simonovic et al., 2000). Map, EspF 
and intimin were shown to be required for EPEC disruption of TJs and redistribution of 
occludin, although the mechanism remains unclear (Dean & Kenny, 2004). More 
recently, EspM was reported to cause a mislocalisation of TJs and ZO-1 with the cell 
body bulging out above altered TJs (Simovitch et al., 2010). EspI/NleA was also shown 
to disrupt TJs and protein secretion (Kim et al., 2007a; Thanabalasuriar et al., 2010). 
Through binding Sec24, a component of COPII coat, it inhibits fusion of COPII vesicles 
thereby disrupting protein trafficking (Kim et al., 2007a). Disruption of TJs by 
EspI/NleA is thought to occur as a result of altered protein trafficking preventing 
necessary delivery of TJ proteins (Thanabalasuriar et al., 2010). 
This combined assault of EPEC/EHEC effectors on absorptive processes and the barrier 
function of enterocytes, exacerbated by inflammatory responses and transmigration of 
neutrophils, results in a watery diarrhoea (Viswanathan et al., 2009).   
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Figure 9. Modulation of host cell signalling by EPEC/EHEC effector proteins 
Effector proteins targeting diverse cell signalling pathways within host cells are shown. (A) Tir-
dependent actin polymerisation. (B) Manipulation of RhoGTPases. (C) Mechanisms of diarrhoea. 
(D) Disruption of innate immune signalling. (E) Subverting cell death and adhesion. (F) 
Inhibition of phagocytosis. See text for further details. Image taken from (Clements et al., 2012). 
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1.10.2 Modulation of the actin cytoskeleton  
EPEC/EHEC use a number of effector proteins to direct reorganization of the host actin 
cytoskeleton. These effectors function in a variety of ways targeting Rho GTPases, GEFs 
and receptor tyrosine kinase signalling to re-program actin dynamics.  
i. Tir-dependent actin polymerisation 
In addition to mediating intimate attachment, the interaction of Tir and intimin also 
triggers downstream signalling pathways resulting in actin polymerisation underneath 
attached bacteria (Knutton et al., 1987; Knutton et al., 1989). In in vitro cell culture the 
bacteria are raised on actin rich pedestals protruding from the cell surface (Knutton et al., 
1989). Actin pedestals have been shown to be dynamic structures both in terms of 
pedestal length and movement across the cell surface (Sanger et al., 1996). The Tir 
molecule has multiple cell signalling modules in its cytoplasmic tails. The amino-
terminal tail has a PRR suggested to be important for recruitment of kinases through SH3 
domains and also for the recruitment of α-actinin and so linking Tir to the actin 
cytoskeleton (Bommarius et al., 2007; Goosney et al., 2000). However, other studies 
have shown that both the PRR and the entire N terminal tail or TirEPEC are dispensable 
for pedestal formation (Campellone et al., 2004a).  
Both EPEC and EHEC Tir signal via their carboxy-terminal domains to trigger actin 
polymerisation although importantly they utilize different signalling pathways that 
converge on N-WASP (Lommel et al., 2004). Tir from EPEC O127:H6 and EHEC 
O157:H7, which use distinct signalling pathways, are discussed here and referred to as 
TirEPEC and TirEHEC. It has been shown that TirEPEC can from pedestals in an EHECΔtir 
mutant but conversely TirEHEC is not sufficient for pedestal formation when expressed in 
EPECΔtir highlighting key differences in downstream signalling (Kenny, 2001). The 
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predominant pathway for EPEC pedestal formation relies on tyrosine phosphorylation of 
Y474 of the carboxy-terminal tail of Tir (Kenny, 1999). Although in some early papers 
tyrosine phosphorylation of Tir was observed in the absence of intimin, a significant 
body of evidence now suggests that clustering of Tir through intimin binding facilitates 
or greatly enhances the levels of phosphorylation (Campellone et al., 2004a; Campellone 
& Leong, 2005; Hayward et al., 2009; Kenny et al., 1997). Indeed, clustering of Tir 
using αTir antiserum is sufficient to induce tyrosine phosphorylation (Campellone et al., 
2004a). Whilst some studies have shown phosphorylation of Tir Y474 to be specifically 
dependent on the SFK Fyn, others have shown a number of redundant kinase including 
Abl and Tec family kinases to be involved (Bommarius et al., 2007; Phillips et al., 2004; 
Swimm et al., 2004). This phosphorylation event provides a docking site for host adaptor 
proteins Nck1 and Nck2 through their SH2 domains (Gruenheid et al., 2001). Nck 
binding facilitates recruitment of N-WASP and subsequently the actin nucleating Arp2/3 
complex for actin pedestal assembly (Lommel et al., 2001; Rohatgi et al., 2001). A 12 
amino acid peptide, including this tyrosine residue, has been shown to be sufficient for 
actin polymerisation as beads coated with this peptide lead to actin tail formation with 
Xenopus egg extract (Campellone et al., 2004a). Pedestal formation has been shown to 
depend on the WH1 domain of N-WASP whilst evidence for the requirement of the Nck-
binding PRD is conflicting (Lommel et al., 2004; Wong et al., 2012b). Although WIP is 
proposed to bind Nck and recruit N-WASP, dominant negative WIP did not inhibit 
pedestal formation indicating further proteins may be involved (Lommel et al., 2004). 
Wong et al have recently shown that both Tir and the effector EspH promote WIP 
recruitment and that EspH dependent WIP and N-WASP recruitment enhances the Tir-
Nck pathway (Wong et al., 2012b). 
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Although this pathway accounts for the majority of EPEC pedestal formation, 
experimental anomalies suggested the presence of other less efficient pathways. Mutation 
of Y474 significantly inhibits pedestal formation but a residual 5-9% remains as well as 
faint bands by αpTyr immunoblot (Campellone & Leong, 2005). Additionally, 
Campellone et al report 25% bacteria forming pedestals on Nck -/- cells suggesting Nck 
independent pedestal formation pathways exist (Campellone et al., 2004b). Through 
comparison with Vaccinia virus A36R which is phosphorylated on two tyrosine residues 
for downstream actin polymerisation, TirEPEC Y454 was tested to see if it contributed to 
pedestal formation. Mutation of this residue in addition to Y474 abolished residual 
phosphorylation (Campellone & Leong, 2005). Y454 is part of a conserved NPY motif 
thought to lead to inefficient pedestal formation without Nck recruitment (Brady et al., 
2007). However this low level could not account for the level of pedestals formed on 
Nck-/- cells suggesting Y474 is also capable of signalling in an Nck independent manner. 
Interestingly overexpression of Nck SH2 domain inhibits pedestal formation to a greater 
extent than infection of Nck-/- cells suggesting further host proteins are involved 
(Campellone & Leong, 2005). Indeed, a range of cytoskeletal and signalling proteins 
have been reported to localise to pedestals including CrkII, Grb2, p130CAS and 
ADF/cofilin (Goosney et al., 2001). 
EHEC also form actin rich pedestals on cultured cells although several key differences 
were observed many years before the pathway was elucidated. EHEC pedestals are not 
enriched with Tyr phosphorylated proteins nor dependent on Tyr phosphorylation 
(DeVinney et al., 1999; Ismaili et al., 1995). Critically, TirEHEC lacks an equivalent 
residue to the Y474 in the TirEPEC carboxy terminal tail (Kenny, 1999). Additionally 
further experiments revealed the TirEHEC itself was not sufficient for pedestal formation. 
EPECΔtir pTirEHEC could not form pedestals alone but actin polymerisation was restored 
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with coninfection with an EHECΔeaeΔtir strain suggesting other bacterial factors are 
required (DeVinney et al., 2001). This EHEC protein was identified simultaneously 
through transcriptome analysis and putative PI deletions and called TccP and EspFU 
(Campellone et al., 2004b; Garmendia et al., 2004). TccP/EspFU is encoded on a cryptic 
prophage CP-933U and shares 24% identity with the effector EspF. Although 
TccP/EspFU can also mediate some known EspF functions (eg. Disruption of tight 
junctions), EspF is not involved in pedestal formation (McNamara & Donnenberg, 1998; 
Viswanathan et al., 2004). TccP/EspFU was shown to bridge Tir and N-WASP through 
indirect binding to Tir and direct interaction with N-WASP through its C terminal proline 
rich region (Campellone et al., 2004b; Garmendia et al., 2004). TccP/EspFU contains 
multiple polypeptide repeats which act synergistically to increase the efficiency of actin 
polymerisation through oligomerisation of N-WASP (Campellone et al., 2008). These 
repeats act by binding the autoinhibitory region of the N-WASP GBD relieving auto-
inhibition (Cheng et al., 2008; Sallee et al., 2008). Subsequently it was shown that the 
host proteins IRSp53 and IRTKS bind TirEHEC at its NPY motif and recruit TccP/EspFU 
facilitating actin polymerisation (Vingadassalom et al., 2009; Weiss et al., 2009). 
Interestingly this is the same motif at TirEPEC Y454 although EHEC has evolved to 
amplify this pathway with TccP/EspFU. Interestingly, Vingadassalom et al reported that 
EHEC required N-WASP for efficient T3SS translocation but not for pedestal formation 
(Vingadassalom et al., 2010). 
It is important to note that further analysis revealed that the division of signalling 
pathways is not maintained across all EPEC and EHEC strains. A screen for the 
incidence of tccP identified its presence in O26 (EHEC), O119 (typical EPEC), and O55 
(atypical EPEC) strains (Garmendia et al., 2005). Additionally, a tccP homologue tccp2 
was identified and conserved in 95% non-O157 EHEC and all tested lineage 2 EPEC 
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strains, whilst this was absent from EPEC lineage 1 strains (Ogura et al., 2007; Whale et 
al., 2007). Furthermore over 90% non-O157 EHEC tccp2 positive strains also expressed 
a Tir molecule capable of signalling through the Nck pathway (Ogura et al., 2007). As 
such the presence of both pathways now seems to be the norm in contrast to the 
segregation of signalling between EPEC O127:H6 E2348/69 and EHEC O157:H7 
(Frankel & Phillips, 2008).  
 
Figure 10. EPEC O127:H6 and EHEC O157:H7 pedestal formation pathways 
EPEC O127:H6 directs actin polymerisation through SFK dependent phosphorylation of Y474 
leading to subsequent recruitment of Nck and N-WASP, enhanced by WIP. EHEC O157:H7 
lacks this phosphorylation site and recruits N-WASP through IRTKS/IRSp53 and the effector 
protein TccP/EspFU for Arp2/3 complex mediated actin polymerisation.  
 
 
Analysis of the contribution of these actin polymerisation pathways to in vivo 
colonization and pathogenesis led to some surprising results (Frankel & Phillips, 2008). 
Similar results were observed in several in vivo experimental systems revealing that Tir 
actin polymerisation pathways are not required for A/E lesion formation and colonisation 
(Girard et al., 2009; Schuller et al., 2007; Vlisidou et al., 2006). During C. rodentium 
infection, mutation of Tir Y471/451 revealed that although Nck and IRTKS were not 
recruited, N-WASP was recruited and normal A/E lesions were observed (Crepin et al., 
2010). However, C. rodentium strains expressing wild type Tir outcompeted those 
expressing Tir Y471A/451A in a mixed infection suggesting that the ability to 
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polymerise actin gives the pathogen a competitive edge (Crepin et al., 2010). Moreover, 
studies of the effect of TccP in EHEC infection revealed a role in the progression of 
infection establishing sites away from that initially infected (Ritchie et al., 2008). 
The carboxyterminal tail or TirEPEC and TirEHEC also include tandem ITIMs. Mutation of 
these residues (Y483 and Y511) in TirEPEC leads to dysregulation of pedestal morphology 
and length whilst no changes are observed with mutation of equivalent residues of 
TirEHEC (Smith et al., 2010). Smith et al showed these motifs were required for 
recruitment of the inositol phosphatase SHIP2 which converts PI(3,4,5)P3 to PI(4,5)P2 
leading to the recruitment of the cystoskeletal regulator lamellipodin (Smith et al., 2010). 
As described below these ITIM residues also impact upon immune signalling (Yan et al., 
2012).  
In addition to the tyrosine phosphorylation sites within the carboxy-terminal of Tir, 
further phosphorylation sites are present. Serine or threonine phosphorylation have long 
been suggested to be responsible for Tir modification prior to membrane insertion 
(Kenny, 1999). Furthermore, Tir was shown to be serine phosphorylated by protein 
kinase A (PKA) contributing to efficient pedestal formation (Warawa & Kenny, 2001). 
Interestingly, serine phosphorylation of Tir promotes Rac phosphorylation by PKA 
resulting in its inactivation (Brandt et al., 2009). Thus Tir cytoplasmic tails contain 
multiple signalling motifs that impact upon host cell processes.  
 
ii. Modulating Rho GTPases 
EPEC/EHEC translocate members of the WxxxE family of bacterial GEFs to direct actin 
polymerisation. These proteins have been shown to directly activate Rho GTPases and 
the family includes effectors from EPEC/EHEC (EspM, Map, EspT), Shigella (IpgB1 
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and IpgB2) and Salmonella (SifA) (Bulgin et al., 2010). Structural analysis of Map 
revealed a V-shaped fold, similar to that of the Salmonella GEF SopE (Buchwald et al., 
2002; Huang et al., 2009). NMR based modeling of EspM2 indicates a similar V-shaped 
structure (Arbeloa et al., 2010). Additionally, Map and SopE were shown to interact with 
the Switch I and Switch II regions of GTPases enforcing the same conformation 
observed with eukaryotic GEFs (Buchwald et al., 2002). Whilst Map is encoded on the 
LEE and present in all EPEC and EHEC strains, a recent screen of ~1000 isolates 
showed the presence of espM in 50% EPEC and EHEC isolates and espT in 2% EPEC 
and absent from all EHEC strains tested (Arbeloa et al., 2009). Map and EspM variants 
activate Cdc42 and RhoA respectively, leading to filopodia and stress fibre formation 
(Alto et al., 2006; Arbeloa et al., 2008; Kenny et al., 2002). EspT activates Rac and 
Cdc42 leading to formation of lamellipodia and surface ruffles, and subsequent 
‘triggered’ internalisation (Bulgin et al., 2009). Once internalised, Tir-dependent 
signalling leads to actin-rich protrusions which are associated with the bacteria-
containing vacuole (Bulgin et al., 2009). With the exception of EspT-positive invasive 
strains, EPEC/EHEC inhibit their internalisation and focus actin polymerisation 
underneath attached bacteria through Tir-dependent signalling pathways. 
Map-dependent filopodia are apparent around attached bacteria in the initial stages of 
infection peaking at 10 min before retraction dependent on Tir (Berger et al., 2009). 
Filopodia formation is dependent on Cdc42 but not Rac or RhoA (Kenny et al., 2002). In 
addition to the role of Map GEF activity, a PDZ binding domain also contributes to 
filopodia through stabilising and prolonging filopodia. This occurs through interaction 
with Nherf-1 thought to provide a signalling platform allowing ezrin and RhoA/ROCK 
dependent filopodia stabilisation (Berger et al., 2009). Filopodia withdrawal is dependent 
on Tir and the initation of Tir-Nck signalling although a putative GAP-like GLXR motif 
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in the carboxy-terminal tail of Tir has also been proposed to mediate this function 
(Berger et al., 2009; Kenny et al., 2002). EspH is also involved in promoting the 
transition from filopodia to Tir-dependent actin polymerisation as EPECΔespH exhibits 
prolonged filopodia formation (Tu et al., 2003). EspH has been shown to inactivate host 
DH-PH GEFs by binding to the DH-PH domain and thereby preventing their interaction 
and activation of Rho GTPases (Dong et al., 2010). In addition EspH has recently been 
shown to promote recruitment of WIP to Tir thereby enhancing pedestal formation 
(Wong et al., 2012b). The effector EspV has also recently been shown to impact upon the 
actin cytoskeleton. It has only been detected in two EPEC strains, E110019 and E22, and 
causes nuclear condensation, cell rounding and dentrite-like projections through an 
unknown mechanism (Arbeloa et al., 2011). 
 
1.10.3 Modulating innate immune signalling 
EPEC/EHEC use the concerted actions of a number of effector proteins to disrupt host 
innate immune signalling. Bacteria can be detected through recognition pathogen-
associated molecular patterns (PAMPs) by pattern recognition receptors (PRRs). For 
example LPS and flagellin are recognised by Toll-like receptor (TLR)-4 and TLR5 
respectively. This leads to the activation of nuclear factor-κB (NF-κB) and mitogen-
activated protein kinase (MAPK) signalling pathways, and the consequent expression of 
pro-inflammatory cytokines. EPEC infection is associated with an initial activation of 
inflammatory signalling and IL-8 production, largely through recognition of flagellin 
(Schuller et al., 2009). Cytokine production is subsequently dampened through the 
actions of T3SS effectors which inhibit pro-inflammatory signalling (Ruchaud-
Sparagano et al., 2007).  
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One of the central pro-inflammatory pathways extensively targeted by EPEC is the NF-
κB pathway. NF-κB family proteins (p65, p50, p52, c-Rel and RelB) homo- and/or 
hetero dimerise (p50/p65 is most common) and following activation, translocate to the 
nucleus where they activate expression of pro-inflammatory cytokines. Without 
stimulation, NF-κB is held in the cytoplasm through its interaction with the inhibitor of 
NF-κB (IκB). Phosphorylation of IκB by IKK promotes its ubiquitination and 
degradation releasing NF-κB. EPEC inhibits this pathway in a number of ways. NleB and 
NleE both modulate innate immune responses by preventing IκB degradation (Nadler et 
al., 2010; Newton et al., 2010). NleE was recently shown to act as a S-adenosyl-L-
methionine-dependent methyltransferase (SAM) and to disrupt the ubiquitin binding 
properties of TAK-binding proteins 2 and 3 (TAB2/3) (Zhang et al., 2011). TAB2/3 are 
part of the transforming-growth-factor-β-activated kinase 1 (TAK1) complex. Following 
TLR stimulation, the TNF receptor-associated factor 6 (TRAF6) is ubiquitinated 
facilitating TAK1 recruitment via TAB2/3. Once recruited, TAK1 phosphorylates and 
activates IKK (Kanayama et al., 2004). Thus through methylating key cysteines within 
the ubiquitin binding domain of TAB2/3, NleE inhibits IKK activation and IκB 
degradation. NleB was then shown to function as an N-acetyl-D-glucosamine (O-
GlcNAc) transferase modifying glyceraldehyde 3-phosphate dehydrogenase (GADPH) 
disrupting its interaction with TRAF2 and TRAF2 ubiquitination (Gao et al., 2013). 
Disruption of NF-κB signalling is further promoted by the effector NleC as shown by the 
enhanced IL-8 secretion following infection with an EPEC ΔnleBEC triple mutant as 
compared to EPEC ΔnleBE (Baruch et al., 2011; Pearson et al., 2011). NleC contains a 
zinc-dependent metalloprotease motif required for its activity, and has been shown to 
localise to the nucleus where it cleaves and inactivates the NF-κB proteins p65, p59 and 
c-Rel. NleD also has a zinc-dependent metalloprotease motif and cleaves the MAPKs 
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JNK and p38 (Baruch et al., 2011). This prevents the phosphorylation and activation of 
AP-1 transcription factors which regulate a range of cellular processes including 
proliferation, apoptosis and inflammation (Baruch et al., 2011). 
The NleH effectors are also implicated in the manipulation of immune signalling. NleH1 
and NleH2 have been shown to abrogate NF-κB signalling by disrupting ubiquitination 
and degradation of phosphorylated IκB following TNFα stimulation (Royan et al., 2010). 
Additionally, both NleH1 and NleH2 interact with the non-Rel NF-κB protein RPS3 
(Gao et al., 2009). Interestingly, although NleH1 was shown to reduce RPS3 
phosphorylation and nuclear abundance NleH2 seemed to increase RPS3 dependent 
transcription (Gao et al., 2009; Wan et al., 2011).  
Tir is also involved in dampening immune signalling through SHP-1 binding to its 
carboxy-terminal ITIM motif. Tir was shown to promote SHP-1 interaction with TRAF6 
and prevent its ubiquitination, a key signal in pro-inflammatory responses (Yan et al., 
2012). Through the concerted actions of NleB, NleC, NleD, NleE, NleH and Tir 
EPEC/EHEC effectively dampen host immune response and pro-inflammatory 
signalling. It is interesting to note that in contrast to this anti-inflammatory strategy, 
EspT induces expression of pro-inflammatory cytokines through Erk/Jnk and NF-κB 
pathways perhaps highlighting different requirements for invasive strains (Raymond et 
al., 2011).  
 
1.10.4 Modulating cell death and adhesion 
Programmed cell death, apoptosis, and the normal exfoliation and regeneration of cells 
are innate protection strategies promoting the removal of infected cells. EPEC and EHEC 
use a number of effector proteins to manipulate host cell death and adhesion to subvert 
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these protection mechanisms. Interestingly, both pro-apoptotic and anti-apoptotic 
effectors are translocated in to host cells mediating a careful balance between cell death 
and survival signalling. EPEC/EHEC infection results in increased cell death with the 
induction of apoptosis through both non-T3SS mechanisms (e.g. binding via the pilus 
BFP induces cell death (Abul-Milh et al., 2001)) and effector proteins (e.g. Map, EspF 
and Cif). Map localises to the mitochondria and disrupts membrane potential and 
respiration thereby initiating cell death (Kenny & Jepson, 2000; Ma et al., 2006). EspF is 
also targeted to the mitochondria and disrupts membrane potential leading to cytochrome 
c release and cleavage of caspases 3 and 9, indicative of apoptotic signalling (Crane et 
al., 2001; Nougayrede & Donnenberg, 2004). Additionally, the cycle inhibiting factor Cif 
prevents cell cycle progression and induces apoptosis by inhibiting the ubiquitination and 
degradation of the cell cycle inhibitory proteins p21waf1 and p27kip1(Samba-Louaka et 
al., 2008; Samba-Louaka et al., 2009). It has been hypothesised that EPEC/EHEC 
promote apoptotic signalling to enhance their adhesion as apoptosis increases levels of 
phosphatidylethanolamine in the outer leaflet, a phospholipid with which EPEC/EHEC 
have been shown to interact (Barnett Foster et al., 2000). 
Interestingly, analysis of infected cells has revealed the presence of early signs of 
apoptosis (e.g. changes in membrane composition) but not late stage events including cell 
blebbing and nuclear condensation, indicating the presence of other factors inhibiting 
apoptotic signalling (Crane et al., 1999; Hemrajani et al., 2010). As discussed above 
NleD inactivates JNK which prevents activation of AP1-dependent transcription (Baruch 
et al., 2011). This activity inhibits expression of pro-apoptotic proteins following JNK 
activation. NleH1 and NleH2 are key players in the inhibition of apoptosis by 
EPEC/EHEC and have been shown to protect cells from death following treatment with 
apoptosis inducers C. difficile Toxin B and the kinase inhibitor staurosporine (Hemrajani 
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et al., 2010; Robinson et al., 2010). NleH proteins bind to the anti-apoptotic protein Bax-
inhibitor 1 (BI-1) at the ER membrane and have been shown to prevent cleavage of 
caspase-3 (Hemrajani et al., 2010). 
Like EPECΔnleH, infection with strains lacking espZ leads to enhanced cell death 
(Hemrajani et al., 2010; Shames et al., 2010). EspZ interacts with the plasma membrane 
protein CD98 to promote adhesion and survival signalling through integrin and FAK 
pathways (Shames et al., 2010). Recently EspZ was shown to regulate translocation 
through the T3SS with the hypothesis that a ΔespZ mutant can no longer control the 
amount of translocation leading to increased levels of pro-apoptotic effectors (Berger et 
al., 2012).  
EPEC infection has also been shown to modulate FAs with both a reduction in both the 
size and numbers of FAs of infected cells, correlating with reduced FAK phosphorylation 
(Shifrin et al., 2002). EspH induces FA disassembly promoting cell rounding and 
detachment in contrast to the FA stabilisation and FAK phosphorylation mediated by 
EspZ (Shames et al., 2010; Tu et al., 2003; Wong et al., 2012a). EspO has been 
identified as another key effector protein in promoting adherence of infected cells. EspO 
interacts with integrin linked kinase (ILK) and promotes the stabilisation of FAs to 
prevent cellular exfoliation (Kim et al., 2009). The identification of effector proteins both 
inhibiting and promoting cell death and adhesion highlights the careful balance between 
these pathways required for efficient colonisation and survival.  
 
1.10.5 Inhibiting phagocytosis 
EPEC/EHEC inhibit both transcytosis through M cells and internalisation by phagocytes 
through the actions of several effector proteins (Goosney et al., 1999; Martinez-Argudo 
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et al., 2007). This allows them to remain extracellular in the gut lumen, intimately 
attached to the apical surface of enterocytes. EspH inactivates endogenous DH-PH GEFs, 
preventing Rho GTPase activation and so inhibiting phagocytosis (Dong et al., 2010). 
EspB, which also functions in the translocation pore, interacts with myosin family 
proteins. The binding site within myosin-1c was localised to its actin-binding region. 
EspB binds this site with 20-fold higher affinity than actin thereby inhibiting the 
interaction between myosins and actin (Iizumi et al., 2007). This disruption of the acto-
myosin system results in inhibition of phagocytosis and disruption of intestinal 
microvilli. The EPEC/EHEC effector EspF is also central in inhibiting internalisation of 
non-opsonised bacteria and in preventing transcytosis through M cells (Marches et al., 
2008; Martinez-Argudo et al., 2007; Quitard et al., 2006). Although EspF has been 
shown to inhibit PI3K dependent internalisation dependent on its N-terminal 101 
residues, it does not inhibit opsono-phagocytosis (Marches et al., 2008; Quitard et al., 
2006). A number of binding partners for EspF have been identified including actin, 
profilin and sorting nexin 9 (SNX-9) but the mechanism of action required to inhibit 
internalisation remains unclear (Alto et al., 2007; Peralta-Ramirez et al., 2008). 
Additionally, EspJ is implicated in the inhibition of opsono-phagocytosis pathways, 
inhibiting both FcγR and CR3-mediated internalisation. However, it does not prevent 
internalisation of uncoated bacteria (Marches et al., 2008). As yet, the intricacies of these 
effectors’ functions in targeting subsets of phagocytic pathways are not established. 
 
1.11 EspJ 
The non-LEE encoded EPEC/EHEC effector EspJ is a protein of 217 residues which was 
identified by transcriptome analysis and subsequently shown to be translocated during 
infection (Dahan et al., 2004; Dahan et al., 2005). espJ has been shown to be present in 
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the majority of EHEC and EPEC strains and was detected in all EHEC strains tested (n = 
407) in a screen of clinical isolates (Garmendia et al., 2005). In another study espJ was 
detected in ~95 % of 152 EHEC strains and ~99% of 87 EPEC strains tested whilst 
absent in avirulent E. coli strains (Bugarel et al., 2011). In EHEC O157:H7 strains espJ 
is encoded on prophage CP933U in an operon with tccP whilst in EPEC E2348/69 espJ 
is within prophage 2 downstream of Cif and NleH (Garmendia & Frankel, 2005; Iguchi 
et al., 2009). EspJ has been suggested to modulate colonisation dynamics as prolonged 
infection was observed with a C. rodentium ΔespJ mutant (Dahan et al., 2005). 
Additionally, EspJ has been shown to inhibit opsono-phagocytosis and despite key 
differences between FcγR and CR3 mediated phagocytosis, is capable of preventing 
opsono-phagocytosis through both pathways (Marches et al., 2008). Further investigation 
of EspJ suggested a mitochondrial localisation during ectopic expression and highlighted 
the unstable nature of the protein (Kurushima et al., 2010). Additionally, a role in 
protection against apoptosis has been suggested (S. Dahan, unpublished). However, the 
mechanism of action of EspJ in inhibiting these pathways remains entirely undetermined. 
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1.12 Aims and Objectives 
The aim of this study is to determine the mechanism of action of the EPEC/EHEC 
effector protein EspJ in its subversion of host cell signalling. Previous work has shown 
that EspJ inhibits opsono-phagocytosis (Marches et al., 2008) and a protection against 
apoptosis has also been suggested (S. Dahan, unpublished) although the mechanism of 
action of either phenotype is unknown.  
Specific objectives are to: 
• Further characterise the effects and localisation of EspJ in eukaryotic cells during 
EPEC infection and ectopic expression  
• Determine host cell binding partners or signalling pathways affected by EspJ 
• Use bioinformatic and structural analysis to determine which regions of EspJ are 
required and the effects of targeted point mutations on EspJ-mediated inhibition 
of opsono-phagocytosis  
• Analyse host cell factors involved in opsono-phagocytosis to determine at which 
stage of the signalling pathway EspJ is acting 
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Chapter 2 - Materials and methods 
2.1 Cells and strains 
2.1.1 Mammalian cell culture 
HeLa cells were obtained from ATCC and maintained in 1000 mg/l glucose DMEM 
(Sigma) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 2mM 
Glutamax (Invitrogen) at 37°C and 5% CO2. Cos-7, J774.A1 and Swiss 3T3 cell lines, 
obtained from ATCC, and Nck -/- fibroblasts (Bladt et al., 2003) were maintained in 
4500 mg/l DMEM (Sigma) supplemented as above. Cell lines were routinely passaged 
every 2-3 days and seeded at a 1:6 -1:8 dilution following trypsinisation (PBS, 1mM 
EDTA, 2 mM trypsin) (Sigma) for all cell lines except J774.A1 which were detached 
using a cell scraper. 
 
2.1.2 Strains and growth conditions 
The bacterial strains used in this study are listed in Table 1. Bacteria were routinely 
cultured in Luria-Bertani (LB) broth at 37°C shaking at 200 RPM, with ampicillin (Amp) 
(100 µg/ml), chloramphenicol (Cm) (34 µg/ml), kanamycin (Kan) (50 µg/ml) or 
tetracycline (Tet) (6 µg/ml) as appropriate. Saccharomyces cerevisiae strain AH109 
(Clontech) was cultured at 30°C in YPD (1% yeast extract, 2% peptone, 2% glucose, 20 
mg/L adenine hemisulfate) or synthetic dropout medium (SD) for plasmid selection (6.7 
g/L Yeast nitrogen base (Difco), 2% glucose, supplemented with required amino acids as 
per Clontech yeast protocols handbook).  
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Table 1. Bacterial and yeast strains 
Strain Name Description Source 
E. coli Top10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 nupG recA1 araD139 Δ(ara-leu)7697 rpsL(StrR) endA1 λ- Invitrogen  
E. coli BL21 (DE3) E. coli F– ompT hsdSB(rB–, mB–) gal dcm (DE3)  Invitrogen 
E. coli  E2348/69 EPEC O127:H6  (Levine et al., 1978) 
E. coli E2348/69 ΔescN E2348/69 escN deletion mutant (Garmendia et al., 2004) 
E. coli  E2348/69 ptccP E2348/69 carrying pSA10-tccP (Garmendia et al., 2004) 
E. coli JPN15  Plasmid (EAF) cured derivative O127:H6 E2348/69  (Jerse et al., 1990) 
E. coli JPN15 ΔespJ  JPN15 espJ deletion mutant S. Dahan 
E. coli  85-170 EHEC O157:H7 spontaneous stx1- stx2-, NalR (Tzipori et al., 1987) 
Saccharomyces 
cerevisiae AH109 
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4D, 
gal80D, LYS2::GAL1UAS-GAL1TATA-HIS3, GAL2UAS-
GAL2TATA-ADE2, 
URA3 : : MEL1UAS-MEL1 TATA-lacZ 
Clontech 
 
2.1.3 Plasmids 
Constructs used in this study are shown in Table 2. pCB6-GFP, pCB6-Abl-GFP, pCB6-
Fyn-GFP, pCB6-Src-GFP and pCB6-Yes-GFP were a kind gift from Prof. Michael Way  
(Newsome et al., 2006) and the pEGFP-FcγRIIa plasmids were kindly provided by Anna 
Dart (Tollis et al., 2010). For pcDNA-NTAP constructs, genes optimized for 
mammalian expression encoding EspJEHEC, EspJEPEC and EspJEPEC R79A/D187A were 
synthesized by GeneArt and subcloned in to pcDNA-NTAP. MYL6 isoform 1 and 
Rab1A cDNA were obtained from Open Biosystems while YWHAZ_C15 DNA 
fragment was excised from pGADT7RecAB using EcoRI and SacI. For all other constructs 
bacterial sequences were amplified from EPEC O127:H6 E2348/69, EHEC O157:H7 
Sakai or S. salamae 3588/07 genomic DNA. Oligonucleotides used for gene 
amplification and site directed mutagenesis (SDM) are shown in Table 3. R79A and 
D187A mutations were introduced in to pcDNA-NTAP-espJEHEC and pSA10-espJEPEC. 
 92 
Mutated espJEPEC sequences were then subcloned in to pET28a and pRK5 vectors. All 
constructs were verified by DNA sequencing.  
Table 2. Plasmids used in this study 
 
Plasmid Description Selection Source 
pET28a Bacterial expression vector with N-terminal 6xHis tag Kan Invitrogen 
pET28a-espJ pET28a derivative encoding EspJEPEC Kan This study 
pET28a-espJ28-217 pET28a derivative encoding EspJ28-217 EPEC Kan This study 
pET28a- espJ28-217 R79A pET28a derivative encoding EspJ28-217 EPEC R79A Kan This study 
pET28a-espJ28-217 D187A pET28a derivative encoding EspJ28-217 EPEC D187A Kan This study 
pET28a-espJ28-217 R/79AD187A pET28a derivative encoding EspJ28-217 EPEC R79A/D187A Kan This study 
pET28a-espJ53-217 pET28a derivative encoding EspJ53-217 EPEC Kan This study 
pET28a-espJ73-217 pET28a derivative encoding EspJ73-217 EPEC Kan This study 
pMALc2x Bacterial expression vector as fusion protein with 
maltose binding protein 
Amp NEB 
pMALc2x-espJ pMALc2x derivative encoding EspJEPEC Amp This study 
pMALc2x-espJ28-217 pMALc2x derivative encoding EspJ28-217 EPEC Amp This study 
pMALc2x-espJ53-217 pMALc2x derivative encoding EspJ53-217 EPEC Amp This study 
pMALc2x-espJ73-217 pMALc2x derivative encoding EspJ73-217 EPEC Amp This study 
pACYC-GFP pACYC184 derivative encoding GFP Cm O. Marches 
pSA10 pKK17.1 containing lacI gene Amp (Levine et al., 1978) 
pSA10-espJ pSA10 derivative encoding EspJEPEC Amp This study 
pSA10-espJ1-72 pSA10 derivative encoding EspJ1-72 EPEC  Amp This study 
pSA10-espJ C7A pSA10 derivative encoding EspJEPEC C7A Amp This study 
pSA10-espJ R79A pSA10 derivative encoding EspJEPEC R79A Amp This study 
pSA10-espJ D187A pSA10 derivative encoding EspJEPEC D187A Amp This study 
pSA10-espJART pSA10 derivative encoding EspJEPEC R79A D187A Amp This study 
pSA10-tccP pSA10 derivative encoding TccP Amp (Garmendia et al., 
2004) 
pCX340 Bacterial expression as a TEM fusion protein Tet Charpentier et al.,  
2004) 
pCX340-espJ pCX340 derivative encoding EspJEPEC  Tet This study 
pCX340-espJ R79A pCX340 derivative encoding EspJEPEC R79A Tet This study 
pCX340-espJ D187A pCX340 derivative encoding EspJEPEC D187A Tet This study 
pCX340-espJ R79A/D187A pCX340 derivative encoding EspJEPEC R79A D187A Tet This study 
pCX340-nleD pCX340 derivative encoding NleD Tet (Marches et al., 
2005) 
pCX-4xHA pCX340 derivative for bacterial expression with 4xHA 
tag 
Tet G. Schroeder 
pCX-4xHA-espJ pCX-4xHAderivative encoding EspJEPEC Tet This study 
pGBT9 Yeast expression as a fusion protein with the Gal4 DBD Amp/-Leu Clontech 
pGBT9-espJEHEC pGBT9 derivative encoding EspJEHEC Amp/-Leu This study 
pGBT9-espJEPEC pGBT9 derivative encoding EspJEPEC Amp/-Leu This study 
pGADT7 Yeast expression as a fusion protein with the Gal4 AD Amp/-Trp Clontech 
pGADT7-MYL6 pGADT7 derivative encoding MYL6 isoform 1 Amp/-Trp This study 
pGADT7-rab1A pGADT7 derivative encoding Rab1A Amp/-Trp This study 
pGADT7-YWHAZ pGADT7 derivative encoding YWHAZ carboxy-
terminal 15 residues as pulled out of yeast-two-hybrid 
screen 
Amp/-Trp This study 
pEGFP-FcγRIIa GFP-tagged FcRIIa for expression in mammalian cells Kan (Tollis et al., 2010) 
pEGFP-FcγRIIa Y282F/Y298F pEGFP-FcγRIIa derivative with Y282F/Y298F 
mutations 
Kan (Tollis et al., 2010) 
pRK5 N-terminal myc-tag mammalian expression vector Amp Clontecth 
pRK5-espJ pRK5 derivative encoding myc tagged EspJEHEC Amp This study 
pRK5-espJ1-72 pRK5 derivative encoding myc tagged EspJ1-72EHEC Amp This study 
pRK5-espJ73-217 pRK5 derivative encoding myc tagged EspJ73-217EHEC Amp This study 
pRK5-espJ C7A pRK5 derivative encoding myc tagged EspJEHEC C7A Amp This study 
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2.2 DNA manipulations 
2.2.1 Polymerase chain reaction (PCR) 
For plasmid construction DNA sequences were amplified by PCR using KOD 
polymerase (Merck) with 50 ng DNA template, 0.2 mM dNTPs and 0.3 µM primers 
(Thermohybrid) in a 50 µl reaction volume. Colony screening PCR was performed with 
RedTaq ReadyMix (Sigma) in a 20 µl reaction volume and 0.5 µM primers.  Typical 
PCR settings were 95 °C for 5 min followed by 30 cycles of 95 °C for 30 sec, 55 °C for 
30 sec and 70 °C for 1 min, and a final extension step at 70 °C for 10 min.  
 
 
 
Plasmid Description Selection  Source 
pRK5-espJEPEC pRK5 derivative encoding myc tagged EspJEPEC  Amp This study 
pRK5-espJ R79A/D187A pRK5 derivative encoding myc tagged EspJEPEC R79A 
D187A  
Amp This study 
pRK5-espJ28-217 pRK5 derivative encoding myc tagged EspJ28-217EPEC  Amp This study 
pRK5-GFP pRK5 derivative encoding myc tagged GFPC Amp This study 
pRK5-seoC pRK5 derivative encoding myc tagged SeoC  Amp This study 
pcDNA-NTAP pcDNA3.1 derivative for expression in mammalian cells 
with TAP tag (3xFLAG tag - TEV cleavage site – 
calmodulin binding peptide).  
Amp A. Clements 
pcDNA-NTAP-GFP pcDNA-NTAP derivative encoding TAP-tagged eGFP in 
pcDNA3.1(+) 
Amp (Clements et al., 
2011) 
pcDNA-NTAP-espJEPEC pcDNA-NTAP derivative encoding codon optimised 
EspJEPEC 
Amp This study 
pcDNA-NTAP-espJEPEC 
R79A/D187A 
pcDNA-NTAP derivative encoding codon optimised 
EspJEPEC R79A D187A 
Amp This study 
pcDNA-NTAP-espJEHEC pcDNA-NTAP derivative encoding codon optimised 
EspJEHEC  
Amp This study 
pcDNA-NTAP-espJEHEC 
R79A/D187A 
pcDNA-NTAP derivative encoding codon optimised 
EspJEHEC R79A D187A 
Amp This study 
pCB6-GFP Mammalian expression of GFP Amp (Newsome et al., 
2006) 
pCB6-Abl-GFP GFP tagged Abl for expression in mammalian cells Amp (Newsome et al., 
2006) 
pCB6-Fyn-GFP GFP tagged Fyn for expression in mammalian cells Amp (Newsome et al., 
2006) 
pCB6-Src-GFP GFP tagged Src for expression in mammalian cells Amp {(Newsome et al., 
2006) 
pCB6-Yes-GFP GFP tagged Fyn for expression in mammalian cells Amp (Newsome et al., 
2006) 
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Table 3. Oligonucleotides used in this study 
Restriction sites shown in bold and mutated bases underlined. 
 
 
 
 
Name Oligonucleotide sequence 5’-3’ 
pET28a  
NdeI espJEPEC F gctcagccatatgccaatcataaagaactgcttatc 
NdeI espJ28-217EPEC F gatcatccatatggagcaaacaggaaaactgttaaac  
NdeI espJ53-217EPEC F gctcagccatatggcagatttaataaaagaaaactac 
NdeI espJ73-217EPEC F gatcatccatatgcgggatttcgttgctgtaagaatc 
espJEPEC HindIII R  aataagctttcattttttgagtgggtggatattaac 
pMALc2x  
EcoRI espJEPEC F cagaattcatgccaatcataaagaactgcttat 
EcoRI espJ28-217 EPEC F gcgaattcgagcaaacaggaaaactgttaaac 
EcoRI espJ53-217 EPEC F gcgaattcgcagatttaataaaagaaaactac 
EcoRI espJ73-217 EPEC F gcgaattccgggatttcgttgctgtaagaatc 
espJEPEC HindIII R  aataagctttcattttttgagtgggtggatattaac 
pSA10  
EcoRI espJEPEC F cagaattcatgccaatcataaagaactgcttat 
EcoRI espJEPEC C7A F cggaattcatgccaatcataaagaacgccttatcatc 
espJ1-72 EPEC HA PstI R ttgtcgaagcttggctgcagctaagcgtagtctgggacgtcatatgggtatgctccttttatattgaaaatagataaaac 
espJEPEC HA PstI R ttgtcgaagcttggctgcagctaagcgtagtctgggacgtcatatgggtatgctccttttttgagtgggtggatattaac 
pCX340  
NdeI espJEPEC F gctcagccatatgccaatcataaagaactgcttatc 
espJEPEC EcoRI R gcgaattctcttttttgagtgggtggatattaac 
pRK5  
BamHI espJEPEC F ctgggatccatgccaatcataaagaactgcttatc 
BamHI espJ28-217 EPEC F ctgggatccgagcaaacaggaaaactgttaaac 
espJEPEC PstI R tggcggccaagcttctgcagtcattttttgagtgggtggatattaac 
BamHI espJEHEC F ctgggatccatgtcaattataaaaaactgcttatc 
BamHI espJEHEC  C7A F ctgggatccatgtcaattataaaaaacgccttatcatta 
BamHI espJ73-217 EHEC F ctgggatcccgagattttgttgctgtaagaatcc 
espJ1-72 EHEC PstI R tggcggccaagcttctgcagttattttattttaaatatggataaaactc 
espJEHEC PstI R tggcggccaagcttctgcagttattttttgagaggatatatgtcaac 
BamHI GFP F gcggatccgtgtccaagggcgaggaactg 
GFP EcoRI R Gcgaattctcatttgtatagttcgtccatgcc 
BamHI seoC F ctgggatccatgaatgttataaagaactgtttttc 
seoC PstI R tggcggccaagcttctgcagctattttttacttacaggataaatatc 
pGBT9  
EcoRI espJEHEC F cggaattcatgtcaattataaaaaactgcttat 
espJEHEC PstI R tggcggccaagcttctgcagttattttttgagaggatatatgtcaac 
EcoRI espJEPEC F cagaattcatgccaatcataaagaactgcttat 
espJEPEC PstI R Tggcggccaagcttctgcagtcattttttgagtgggtggatattaac 
pGADT7  
NdeI rab1a F ttacgctcatatgtccagcatgaatcccgaatatg 
rab1a BamHI R atggatccttagcagcaacctccacctgac 
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For SDM QuickChange II Site-Directed Mutagenesis kit (Stratagene) was used as per 
manufacturer’s instructions with 10 ng template and 1.25 ng primers in a 50 µl reaction 
volume. PCR conditions were 95 °C for 30 sec followed by 18 cycles of 95 °C for 30 s, 
55 °C for 1 min then 68 °C for 5 min. Following template digestion with DpnI (NEB) at 
37 °C for 3 h, SDM PCR products were transformed into competent E coli as described 
below. 
 
2.2.2 Agarose gel electrophoresis 
PCR products were analysed on agarose gels made from 1-1.5% w/v agarose dissolved 
in TAE buffer (40 mM Tris-acetate, 1 mM EDTA) with 1:10000 dilution of SYBRSafe 
DNA stain (Invitrogen). DNA samples were mixed with 6 x loading buffer (NEB) and 
separated at 120 V. Bands were visualised using a SafeImage blue light trans-illuminator 
(Invitrogen). 
 
2.2.3 Restriction digestion and ligation  
Following verification on agarose gel, PCR products were purified using Qiaquick PCR 
purification kit (Qiagen) as per manufacturer’s instructions. Vectors and PCR products 
were digested at 37 °C for 2 h using the appropriate restriction enzymes (NEB) in a 50 
Name Oligonucleotide sequence 5’-3’ 
Site Directed Mutagenesis  
SDM_espJEPEC R79A F  cgggatttcgttgctgtagcaatccaaagtaatcag 
SDM_espJEPEC D187A F ggagccaaagtatatccagctatatcatgctctctgaga 
SDM_espJEHEC opt R79A F ggacttcgtggccgtggccatccagaacaatcagttcacc 
SDM_espJEHEC opt D187A F gccaaggtgtaccccgccaccagctgctccctg 
Yeast two hybrid screening  
AD-LD F ctattcgatgatgaagataccccaccaaaccc 
AD-LD R aatcgtagatactgaaaaaccccgcaagttcact 
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µl reaction volume with 1 unit of enzyme/µg DNA. Digestion products were separated 
on 1% agarose gel and purified using Qiaquick Gel Extraction kit (Qiagen). 50 ng vector 
was ligated with insert at a ratio of 1:3 with T4 DNA ligase (NEB) at RT for 2 h in a 20 
µl reaction volume. 
 
2.2.4 Preparation of competent cells  
Bacterial cultures were grown overnight at 37 °C and 200 RPM then diluted 1:100 and 
grown until an OD600 of 0.4-.0.6. For electrocompetent cells, cells were washed in 1/2 
volume H2O, then 1/4 and 1/20th volume 10% glycerol and a final resuspension in 
1/200th volume 10% glycerol. For chemically competent cells, pelleted cells were 
resuspended in 1/2 volume 100mM RbCl, 50 mM MgCl2, 30 mM CH3COOK, 10 mM 
CaCl2, 15% glycerol then pelleted and resuspended in 1/20th volume 10 mM MOPS, 10 
mM RbCl, 75 mM CaCl2, 15% glycerol (L. Ensell and L. Bukowski). All solutions were 
kept on ice and cells incubated on ice between each step. 
 
2.2.5 Bacterial transformation 
2 µl of ligation reaction was mixed with 50 µl chemically competent Top10 cells, 
incubated on ice for 20 min, heatshocked at 42 °C for 45 sec and returned to ice for 2 
min. 1 ml of LB was added and cells were allowed to recover at 37 °C for 1 hr before 
plating on LB agar with the appropriate selection antibiotic. Presence of the insert was 
checked by colony PCR and positive colonies were grown in LB with the appropriate 
antibiotic for plasmid extraction and sequence verification (GATC).  
For the pCX340 and pSA10 constructs 1 µl of plasmid miniprep was mixed with 50 µl 
electrocompetent E2348/69, E2348/69ΔescN, E2348/69ΔespJ, JPN15 or JPN15 ΔespJ 
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and shocked with a 2.5 V electric pulse. pET28a and pMALc2x constructs were 
transformed by heatshock in to chemically competent BL21 (DE3) for protein 
expression. 
 
2.2.6 Plasmid extraction 
For small scale plasmid extraction, plasmid DNA was extracted from 5 ml overnight 
cultures using Peqlab miniprep kits (Peqlab) according to manufacturer’s instructions. 
Where DNA was to be used for transfections, plasmid DNA was extracted from 150 ml 
overnight cultures using Nucleobond Extra Maxi kit (Macherey-Nagel). Plasmids were 
eluted in sterile dH2O and concentration determined using a NanoDrop NS-1000 
(Thermo Scientific). 
 
2.3 Protein analysis 
2.3.1 SDS-PAGE 
For protein analysis samples were denatured at 98 °C for 5 min in Laemmli buffer (60 
mM Tris-HCl pH6.8, 1% SDS, 5% glycerol, 5% β-mercaptoethanol, 0.01% bromophenol 
blue) and separated by polyacrylamide gel electrophoresis (SDS-PAGE) at 140V in Tris-
Glycine-SDS buffer (GeneFlow). 10-15% polyacrylamide gels were composed of 0.375 
M Tris-HCL pH 8.8, 0.1% SDS with a 4% polyacrylamide stacking layer (4% 
polyacrylamide, 125 mM Tris-HCL pH 6.8, 0.1% SDS) and 0.1% (w/v) ammonium 
persulfate /0.1% (v/v) TEMED for induction of acrylamide polymerisation. Gels were 
either Coomassie stained (50% methanol, 10% acetic acid, 1 g/l Coomassie Brilliant blue 
R250) or transferred to Polyvinylidene fluoride (PVDF) membrane (GE Healthcare) for 
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Western blotting. Coomassie stained gels were destained in 50% methanol, 10% acetic 
acid to visualise bands. 
 
2.3.2 Western blotting 
PVDF membranes were activated in methanol for 1 min before gel transfer in Tris-
Glycine buffer (GeneFlow) at 15 V for 30 min for semi-dry or at 400 mA for 90 min for 
wet transfers. Membranes were blocked overnight in phosphate buffered saline (PBS) 
(VWR) with 0.1% Tween-20 (PBS-T) and 3% skimmed milk (Merck). Membranes were 
probed with appropriate antibodies (see Table 4 for dilutions) for 1 h at room temperature 
or overnight at 4 °C before washing 3 X with PBS-T and incubation with a HRP-
conjugated secondary antibody. Following 3 further washes, ECL plus reagent (GE 
Healthcare) was used as per manufacturer’s instructions and chemiluminescence detected 
using a LAS-3000 Fuji Imager. 
 
2.3.3 Protein expression and purification 
BL21 (DE3) carrying pET28a-espJ or pMALc2x-espJ derivatives were grown in LB 
overnight at 37 °C and then diluted 1:100 in LB and grown until an OD600 of ~0.6. When 
protein was to be used for 2D HSQC NMR analysis overnight cultures were diluted in 
minimal media containing 0.07% 15NH4Cl (J. Garnett). Expression was induced with 0.1 
mM isopropyl-β-D-thiogalactopyranoside (IPTG) and cultures grown for a further 3 h at 
30 °C and 37 °C or 18 h at 18 °C where soluble protein was being assessed or 18 h at 37 
°C for denaturing purification. For solubility tests, whole cell lysates were generated by 
resuspending bacterial pellets from 1ml culture in 200 µl Laemmli buffer. The soluble 
and insoluble fractions were generated by resuspending a 1 ml culture pellet in 400 µl 50 
mM Tris, 150 mM NaCl, 10 mM imidazole, 10 mM β-mercaptoethanol, with cOmplete 
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EDTA-free protease inhibitors (Roche) and lysing cells by sonication (2 X 10 sec pulse). 
Following centrifugation at 16 000 g for 20 min 130 µl 4X Laemlii buffer was added to 
the supernatant and the pellet was resuspended in 200 µl Laemlii buffer. 
For protein purification 1L cultures were centrifuged at 4000 RPM for 20 min and the 
pellet resuspended in 25 ml protein buffer (50 mM NaPO4 pH 7.4, 200 mM NaCl, 5 mM 
β-mercaptoethanol and cOmplete EDTA-free protease inhibitors (Roche)) with 10 mM 
imidazole and lysed with three passes through an Emulsiflex B-15 (Avestin). Samples 
were clarified at 12 000 RPM for 20 min and the supernatant loaded onto His-bind resin 
(Novagen) pre-equilibrated in protein buffer with 10 mM imidazole. Resin was washed 
with protein buffer with 10 mM imidazole, protein buffer containing 30 mM imidazole 
and the sample eluted with protein buffer containing 200 mM imidazole. Eluents were 
then dialyzed against protein buffer to remove the imidazole. For denaturing purification, 
8 M urea was included in all buffers and eluents were dialyzed against protein buffer 
with 1 M urea followed by protein buffer. Where protein was used for NMR the His-tag 
was cleaved with thrombin (GE Healthcare) at 1 unit /100 µg protein passed through His-
bind resin and finally gel filtered using a Superdex-75 gel filtration column (GE 
healthcare). Protein samples were concentrated using Amicon Ultra centrifugal filters as 
per manufacturer’s instructions. 
 
2.3.4 NMR analysis 
NMR experiments were conducted with J Garnett, Imperial College. For 1H NMR 
experiments spectra were recorded on a Bruker AvanceIII 600 (1H frequency 600.05 
MHz) using 100-200 µM protein in 50 mM NaPO4 pH 7.4, 200 mM NaCl, 5 mM β-
mercaptoethanol, 10% D2O at a temperature of 298K. NMR 1H15N Heteronuclear Single 
Quantum Coherence (HSQC) experiments were performed on a Bruker Avance II 800 
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MHz spectrometer equipped with a TXI cryoprobe at 295 K using 0.25 mM 15N-labelled 
EspJ in 50 mM NaPO4 pH 7.4, 200 mM NaCl, 5 mM β-mercaptoethanol, 10% D2O in 
the presence and absence of NAD (Sigma) prepared in the same buffer. Data were 
processed with NMRpipe (Delaglio et al., 1995) and analyzed with NMRview (Johnson 
& Blevins, 1994).  
 
2.3.5 Differential scanning fluorimetry (DSF) 
Proteins were analysed in a 20 µl reaction volume with Sypro Orange dye (Sigma, 
supplied at 5000X) in twin.tec real-time PCR Plates (Eppendorf). During optimisation of 
protein and dye concentrations the buffer used was 50 mM NaPO4 pH 7.4, 200 mM 
NaCl, 5 mM β-mercaptoethanol. For buffer screening 2.5 µM protein with 1X dye was 
used. Measurements were taken over a temperature gradient (12-95 °C) using Eppendorf 
Realplex qPCR machine with excitation at 492 nm. 
 
2.3.6 In vitro ADP-ribosylation assay 
To generate cell lysate 6 x 107 J774A.1 cells were pelleted, washed in PBS and 
resuspended in 1 ml 20 mM Hepes pH7.4, 1 mM EDTA, 250 mM sucrose with cOmplete 
EDTA-free protease inhibitors (Roche). Cells were lysed on ice with a 25-gauge needle 
and unbroken cells removed by centrifugation at 400 x g for 5 min. The lysate was 
enriched for membranes by centrifugation at 16 000 x g and resuspending the pellet in 20 
mM Hepes pH7.4 1mM EDTA with protease inhibitors. 15 µg J774A.1 cell lysate was 
added to reaction buffer (50 mM Hepes, 1 mM EDTA, 2.5 mM MgCl2, pH 7.4) to give a 
final volume of 20 µl. 1 µM 32P labeled NAD (Perkin Elmer) was added per sample (0.1 
µCi per tube, (3.7 kBq)) followed by 0.1 µg C2I (kindly proved by A. Lang, Albert 
Ludwigs University of Freiburg) or 1 µg EspJ28-217 or EspJ28-217 R79A/D187A. For the 
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denaturing experiment EspJ28-217 was heated at 95°C for 5 min or SDS was added to the 
reaction buffer at a final concentration of 0.01 or 0.1%. Samples were incubated at rt for 
1 h then the reaction terminated with Laemmli buffer. Where stability in NH2OH was 
assessed, the reaction was as above but samples were subsequently incubated with 0.5 M 
NH2OH and 1% SDS for 2 h before the addition of Laemmli buffer. Samples were 
separated by SDS-PAGE and subsequent phosphorimaging (Molecular Dynamics).  
 
2.3.7 In vitro Fyn activity assay 
Kinase activity was assessed using the ProFluor Src-Family Kinase assay kit (Promega) 
with recombinant Fyn (Upstate) at a concentration of 25 mU/well (96-well plate) 
following manufacturer’s instructions. Before the assay Fyn was incubated with 5X 
excess of (30 nM) EspJ28-217 or EspJ28-217 R79A/D187A for 1 h in assay buffer in the 
presence or absence 30 nM NAD (Sigma). Fluorescence emission at 520 nm was 
measured using a Fluostar Optima plate reader (excitation wavelength 480 nm). 
 
2.4 Yeast two-hybrid analysis 
2.4.1 Yeast transformation 
Plasmids were transformed in to yeast using the LiAc method. Briefly, a 10 ml overnight 
culture was diluted 1:10 and grown in 50 ml YPD media for 4 h at 30 °C at 200 RPM. 
Cells were centrifuged for 5 min at 4000 RPM, washed in 10 ml H2O, and resuspended in 
500 µl 100 mM LiAc. 50 µl aliquots were used for each transformation: 240 µl PEG, 25 
µl SS-DNA, 25 µl 1M LiAc, 50 µl H2O and 5 µl of each plasmid were added to the yeast 
and incubated at 30 °C for 30 min then heat shocked at 42 °C for 20 min before plating 
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on selective SD media (double drop out (DDO) - Leu, -Tryp; triple DO (TDO) - Leu, - 
Tryp, - Ade; quadruple (DO) QDO -Leu , -Tryp, -Ade, -His). 
 
2.4.2 Yeast-two hybrid screen 
A Y2H screen was conducted using S. cerevisiae AH109 expressing EspJEPEC as the bait 
protein with the Matchmaker HeLa cDNA library (Clontech). pGBT9-espJEPEC was 
transformed in to AH109 and transformants mated with the library following Clontech 
protocols guide. Mated culture was plated onto high stringency media (QDO) to select 
for the presence of both plasmids and for an interaction. Colonies were re-streaked on 
QDO and the library insert amplified by colony PCR using AD-LD primers (Table 3). 
PCR products were purified using Qiaquick PCR purification kit and sent for sequence 
analysis. In order to confirm protein interactions, full length Rab1A or the YWHAZ 
fragment isolated in the screen were inserted into pGADT7. pGADT7-rab1a, pGADT7-
myl6 and pGADT7-YWHAZ_C15 were directly transformed into AH109 with pGBT9-
espJEPEC or pGBT9-espJEHEC and transformants plated on DDO, TDO and QDO for 
growth analysis.  
 
2.5 Mammalian cell techniques 
2.5.1 Transfection of Cos-7 and Swiss 3T3 cells  
Cos-7 cells and Swiss 3T3 cells were seeded onto glass coverslips in 24-well plates at a 
density of 5 X 104 cells per well 24 h prior to transfection with FuGene 6 (Roche) or 
Lipofectamine 2000 (Invitrogen) respectively according to manufacturer’s instructions. 
Briefly, 3 µl GeneJuice was incubated with 1 µg plasmid DNA in 100 µl Optimem 
(Invitrogen) for 15 min and 50 µl added to each well. For Swiss 3T3 cell transfections 
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1.5 µl Lipofectamine 2000 was diluted in 50 µl Optimem, incubated for 5 min and mixed 
with 0.8µg DNA previously diluted in 50 µl Optimem. The transfection mix was 
incubated for 20 min and 100 µl added per well. Cells were incubated at 37 °C with 5% 
CO2 and assayed 15 h post transfection. 
 
2.5.2 Infection of mammalian cells  
J774.A1 cells were seeded on glass coverslips in a 24 well plate at a density of 1.5x105 
cells per well 18 h before infection while HeLa and Swiss 3T3 cells were seeded at 5x104 
cells per well 40 h prior to infection. All cells were starved in serum free (SF) DMEM for 
at least 1 h before infections. For EPEC infections overnight cultures were diluted 1:100 
in SF-DMEM and incubated statically for 3 h in 5% CO2 before infection. EHEC strains 
were grown for 8 h in LB then diluted 1:500 in SF-DMEM and grown statically in 5% 
CO2 for 16 h. Bacterial cultures were induced with 0.05 mM IPTG 30 min before 
infection if required. J774.A1 cells were infected with 200 µl JPN15 cultures and the 
plates centrifuged at 1000 RPM for 4 min and incubated for 1 h at 37°C in 5% CO2. 
Infected cells were washed three times with PBS, to remove unbound bacteria and 
challenged with opsonised red blood cells to assay phagocytosis as described below. 
Swiss 3T3 cells were infected with 100 µl EPEC cultures and incubated for 1 h or 3 h 
where EPEC (pSA10-TccP) was used. For EHEC 85-170 infection 25 µl culture was 
added and plates centrifuged at 1000 RPM for 4 min, incubated at 37 °C in 5% CO2 for 
2.5 h washed 3 times and incubated for a further 2.5 h. For immunofluorescence analysis 
cells were washed 3 times in PBS and fixed with 4% paraformadlehyde (PFA) (Agar 
Scientific) for 20 min at RT. 
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2.5.3 Cell viability assay 
HeLa cells were infected wild type (WT) EPEC 2348/69, ΔespJ, or ΔespJ (pSA10-
espJEPEC) for 1 h, then washed and treated with 200 µg/ml gentamicin in DMEM for a 
further 3 h. Cells were trypsinised, mixed 1:1 with trypan blue solution and were counted 
using a haemocytometer. Percentage of cells lost was calculated as compared to 
uninfected cells. For apoptotic signalling analysis were treated with 66 µM Zvad-fmk 
(Promega) for 2 h prior to infection. For Staurosporine (Sts) control cells were treated 
with 1 µM Sts (Sigma) for 4 h. 
 
2.5.4 Translocation assay  
The β-lactamase (TEM1)-translocation assay was performed as previously described 
(Charpentier & Oswald, 2004). Briefly, 4.0 x 104 HeLa cells were seeded per well of a 96 
well plate (BD Falcon, cat. 353948) and cultured overnight. EPEC E2348/69 and the 
ΔescN mutant carrying the pCX340 plasmids were grown as above and 200 µl culture 
added per well and incubated for 1 h. The cell monolayers were washed with 100 µl 
Hanks' Buffered Salt Solution (Gibco), supplemented with 20 mM HEPES and 3 mM 
Probenecid (Sigma) pH7.4, and developed as described previously. Fluorescence 
emission at 450 nm and 520 nm was measured using a Fluostar Optima plate reader 
(excitation wavelength 410 nm). The translocation rate was calculated as recommended 
in the LiveBLAzer™ FRET-B/G Loading Kit manual.  
 
2.5.5 Red blood cell (RBC) opsonisation and phagocytosis assay 
0.3 µl or 0.1 µl of sheep RBC per well (J774.A1 or Cos-7 respectively) were opsonised 
with an equal volume of α-sRBC IgG (Sigma) previously diluted 1:50 in gelatin veronal 
buffer (GVB, Sigma) and rotated in a total volume of 500 µl GVB for 30 min at RT. 
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Opsonised RBC were pelleted at 4000 RPM for 2 min and resuspended in 500 µl DMEM 
per well. Prior to challenge, cells were serum-starved for at least 1 h. To assay for % 
internalization, infected cells were challenged with opsonised RBC for 30 min and 
transfected Cos-7 cells were challenged for 90 min. Where actin accumulation or 
phosphotyrosine staining were assessed infected macrophages were incubated at 4 °C for 
15 min then 37 °C for 8 min after the addition of IgG-RBC. Cells were washed and fixed 
in PFA or where differential staining of RBC was required cells were chilled on ice, 
washed with PBS and external RBC were stained with Alexa647 conjugated α-rabbit 
antibody (1:500, Invitrogen) before fixing. Alternatively cells were washed and fixed 
with 2.5 % glutaraldehyde for SEM analysis.  
 
2.5.6 Immunofluorescence staining 
Fixed cells were permeabilised with 0.1% Triton X-100 for 2 min and incubated in 2% 
BSA/PBS at RT to block non-specific interactions. For phagocytosis assays total RBC 
were stained with Alexa555 conjugated α-rabbit antibody (Invitrogen). In general cells 
were incubated for 45 min at RT with the appropriate primary antibody mix (See Table 4 
for antibody details and the dilutions used). Cells were then washed 3X with PBS, 
incubated with appropriate secondary antibodies and Phalloidin to visualize F-actin and 
DAPI to visualize cellular and bacterial nuclei where needed. Coverslips were mounted 
in ProLong Gold antifade reagent (Invitrogen) and analysed using a ZEISS Axio Imager 
fluorescence microscope. The percentage of phagocytosis was defined as % bound RBC 
internalised by macrophages/transfected Cos-7 cells. In total, 50 transfected Cos-7 or 100 
J774.A1 cells were counted for each experiment. For pedestal analysis, actin or Nck or 
Src pY418 staining was scored for bacteria attached to 50 transfected Swiss cells. Three 
repeats were performed for each experiment. GraphPad Prism v6.0 (GraphPad Software, 
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California, USA) was used to statistically analyse data sets using one-way ANOVA 
where appropriate. A significant result is defined as p< 0.05 as compared to uninfected or 
GFP control. * indicates p< 0.05  , ** p< 0.01 as  , *** p< 0.001 and **** p< 0.0001.  
 
Table 4. Antibodies and fluorescent reagents 
Antibody Origin Dilution (IF) Dilution (WB)  Source 
Primary antibodies 
EPEC O127  Rabbit 200 - VLA 
Flag M2 Mouse 500 - Sigma 
GFP Rabbit - 2000 Abcam 
Haemagglutination (HA) Mouse 500 - Covance 
Myc tag clone 4A6 Mouse 500 - Millipore 
Nck Rabbit 200 - Millipore 
Phosphotyrosine Mouse 500 2500 Sigma 
Poly-His-HRP Mouse - 3000 Sigma 
Src pY418 (active) Rabbit 500 - Sigma 
Tir Rabbit 500  G. Frankel 
Secondary antibodies 
Anti-mouse RRX Donkey 200 - Jackson ImmunoResearch  
Anti-mouse 488 Donkey 200 - Jackson ImmunoResearch  
Anti-rabbit Alexa555 Donkey 500 - Invitrogen 
Anti-rabbit Alexa647 Donkey 500 - Invitrogen 
Anti-rabbit RRX Donkey 200 - Jackson ImmunoResearch  
Anti-rabbit 488 Donkey 200 - Jackson ImmunoResearch  
Anti-mouse-HRP Goat - 10000 Jackson ImmunoResearch  
Anti-rabbit-HRP Goat - 10000 Jackson ImmunoResearch  
Other fluorescent reagents 
MitoTracker Red CMXRos  10000 - Invitrogen 
Phalloidin Alexa350  100 - Invitrogen 
Phalloidin Alexa647  100 - Invitrogen 
Phalloidin Oregan Green488  100 - Invitrogen 
Phalloidin TRITC  500 - Sigma 
DAPI   1000 - Sigma 
 
2.5.7 Processing for SEM analysis 
Samples were washed 3X 5 min in 0.2 M phosphate buffer pH7.4 and fixed in 1% 
osmium tetroxide for 30 min. Samples were washed 3X 5min in 0.1M phosphate buffer 
pH7.4 then 3X 5min in H2O. Samples were dehydrated with 10 min incubations in 50%, 
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75%, 85%, 95% and 100% ethanol before drying in a K850 Critical Point Dryer 
(Quorumtech), mounting and sputter coating using a Polaron SC7620 Mini Sputter 
Coater (Quorumtech).  
 
2.5.8 Immunoprecipitation 
8x105 Cos-7 cells were seeded in 10cm dishes 24 h before transfection with pEGFP-
FcγRIIa or pEGFP-FcγRIIa Y282F/Y298F along with pcDNA-NTAP, pcDNA-NTAP-
espJEPEC or pcDNA-NTAP-espJEPEC R79A/D187A. Cells were washed and incubated 
with serum free media for 1 h before incubation with 0.5 µg/ml mouse anti-FcγRIIa 
(IV.3) (Stemcell Technologies) at 4°C. Cells were washed three times and treated with 2 
µg/ml goat anti-mouse antibody (Merck) for crosslinked or media alone for non-
crosslinked samples. Samples were washed three times and lysed on ice in 1 ml RIPA 
buffer (1% Triton X-100, 0.5% Nonidet P-40, 100 mM NaCl, 2 mM EGTA, 2 mM 
EDTA, 30 mM HEPES pH7.4) with cOmplete EDTA-free protease inhibitors (Roche) 
and phosSTOP phosphatase inhibitors (Roche). Lysed cells were clarified by 
centrifugation at 510 x g for 10 min and the supernatant was mixed with 20 µl protein G 
Dynabeads (Invitrogen) for 2.5 h at 4°C and 30 min at RT. For non-crosslinked samples 
beads were pre-coated with anti-mouse IgG. Beads were washed with RIPA buffer, 0.2% 
Triton X-100/TBS and TBS then boiled in 2 x Laemmli sample buffer for 5 min. Proteins 
were separated by SDS-PAGE and transferred to Hybond PVDF membrane (GE 
Healthcare) before blocking in 10 mM Tris pH 7.4, 150 mM NaCl, 0.1% Tween-20, 1 
mM EDTA, 3% BSA, 0.5% gelatin. The membrane was probed mouse anti-pTyr 
antibody then HRP-conjugate anti-mouse and visualized with EZ-ECL (GeneFlow) as 
per manufacturer’s instructions. Membranes were stripped with RestorePLUS stripping 
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buffer (Thermo Scientific) and probed with rabbit anti-GFP then HRP-conjugated anti-
rabbit antibody both diluted in 3% milk PBS-T. 
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Chapter 3 - Bioinformatic and structure-function analysis of 
EspJ 
3.1 Bioinformatic analysis of EspJ 
3.1.1 Homologues  
EspJ is a T3SS effector protein conserved between the A/E pathogens EHEC, EPEC and 
C. rodentium. EspJ from EPEC E2348/69 and C. rodentium ICC168 share 79.3% and 
75.8% amino acid identity respectively, with the EHEC O157:H7 Sakai sequence. 
Bioinformatic sequence analysis (Basic Local Alignment Search Tool (BLAST), NCBI) 
revealed homologous proteins present in a range of Gram negative pathogens including 
Escherichia albertii, Salmonella bongori, Salmonella enterica subsp. arizonae and 
salamae, Yersinia enterolitica subsp. enterolitica and Pseudomonas syringae pathovars 
tomato, morsprunorum, and delphini (Fig. 11). The Salmonella and Yersinia homologues 
are more closely related to the E. coli proteins sharing ~50% amino acid identity. 
However sequence identity is concentrated in the carboxy terminal region of the protein. 
The Pseudomonas syringae AvrPphF-ORF-2 /HopF2 proteins are more divergent sharing 
~15% identity with the EHEC EspJ sequence, although several sequence stretches are 
conserved in the carboxy terminus.  
 
3.1.2 ADP-ribosylation domain 
EspJ is predicted to be a member of the ADP-ribosylation superfamily (SSF56399) of 
proteins and the AvrPphF-ORF-2 family (pfam09143, E value 9.46e-05) also called the 
Type III effector HopF2 family (IPR015226) by Conserved Domain Database analysis 
(NCBI, (Marchler-Bauer et al., 2011)) and InterProScan (EBI) respectively. The HopF2 
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family currently includes 74 Escherichia protein sequences, 14 Pseudomonas, 4 
Ralstonia and one Acidovorax. The founding member AvrPphF-ORF2 is a T3SS effector 
protein of the plant pathogen Pseudomonas syringae pv. phaseolicola which is both 
required for full virulence on susceptible hosts and for avirulence in genetically resistant 
plants (Tsiamis et al., 2000). 
 
 
 
S. salamae MNVIKNCFSSLNNILGMSCRSYAVSEGHAASKFGDKILAAKNTPVELLTYRSADLSKERA 60 
S. arizonae MNIIKNCFSFLNSMLGMSGRSYAVSEGHIASKLGSKIVNVKNGSAELLTYRSADLSKERV 60 
Y. enterolitica MNFIKSGFSSLSNILGMSCRSYAVSKGHAASKFAGNILSTKSSPIELLTYRCADLSKEHF 60 
S. bongori MNVIKNCLSSLNNLLGISCRSYAVSEGHVASKFLGGVLAVKNSPVELLTHRNADLSKERF 60 
EPEC  MPIIKNCLSSISNILRNEKTSYSLIKTEQTGKLLNRKITTTPTPAKLLSYRNADLIKENY 60 
C. rodentium MPIIRSCLSSVNNILKNEKTSYSLIKTEQTGKLLNRNISPANTPAKLLSFRNADLTKEKY 60 
EHEC  MSIIKNCLSLINNALNIQKTSYSLTKMEQAGKLLNRKITPENTPPMLLSYRNADLTQEKN 60 
* .*:. :* :.. *  .  **:: : . :.*: .  :     .  **:.* *** :*.  
 
S. salamae ITQEILSRFNITEKFVAVRIQEDKFTDLKSKTIQGHKDTVARVRDWYNPYQNYLGISMGK 120 
S. arizonae ITQEILSRLDIRENFVAVRIQEDKFTDLKNKTIQGHKETVAKVRDWYNPYQNYLGISMGR 120 
Y. enterolitica ITQNILSIFDISENFVAIRVQGDKFTDLKNKTIQGHKNTVAKVRDWYNPYQNNFGISMGK 120 
S. bongori ITQSVLSNFGIRKDFVAVRVQEDKFTDFKNKEIQGHKETVAKVRDWYNPYENYLGIPMGR 120 
EPEC  ITEKVLSIFNIKRDFVAVRIQSNQFTDLKNKTIQGHKDTVAKVIDWYNPQKNAFGIMMGT 120 
C. rodentium ITDKVLSIFNIKRNFVAVRVQDNQFTDLKNKTIQGHKGTVAQVIDWYNSRQNAFGITTGI 120 
EHEC  ITERVLSIFKIKRDFVAVRIQNNQFTDLKNKKIQGHQNTVASVMDWYNPQKNALGITMGT 120 
**: :** : * ..***:*:* ::***:*.* ****: *** * ****. :* :**  *  
 
S. salamae LELSSDVTKKEYRNAMNVMLMEKDDFNKKILNFD-NLQKHYGGNGNKSWVVAPLKDLLDK 179 
S. arizonae VELSSDIAKKECRNAMNVMLMERNDFNNKILNSD-NLQKQYGGNGDKSWVVAPLKELLDK 179 
Y. enterolitica LKPSSDIAKKECRNAINVMLMEKNDFKNKILNHD-NLQSQYGGDGNKSLVVASLKDFLDI 179 
S. bongori LESSSDVAKKECRNAMNVMLMEKNVFDEKVLNAD-NLQKQYGGNVNKSWVVAPLTELLEK 179 
EPEC  PRRSADIAKEESRNALNFMIMEKDTFNEKILNSNANLQKKYGTTENSSWVSASVGSLLDK 180 
C. rodentium PRRSADIAKEESRNALNFMIMEKDTFNEKILNSDANLQKKYSKTENSSWVVTSIGELLDK 180 
EHEC  PRKSADIAKEEHRNALNFMIMEKNTFHEKILNSNDNLQKSYSKTEDSSWVAASVGSLLDK 180 
. *:*::*:* ***:*.*:**:: *.:*:** : ***. *.   :.* * :.: .:*:  
 
S. salamae GAKLYPDESCSLRLGQPFIITLPETTKVNVDIYPVSKK 217 
S. arizonae GAKVYPDETCSLRLGQPFIITLPETTKVNVDIYPVNKK 217 
Y. enterolitica GAKVYPDESSALRLGQPFIITFPETTKINVDIYPVSNK 217 
S. bongori GAKVYPDESCALRLGEPFIITLPETAKVNVDIYPVNKK 217 
EPEC  GAKVYPDISCSLRLGEPFIITLPETVRLDVNIHPLKK- 217 
C. rodentium GAKVYPDISCSLRLGEPFIITLPESVRLDVDIYPFKK- 217 
EHEC  GAKVYPDTSCSLRLGEPFIFTLPESVRVDVDIYPLKK- 217 
***:*** :.:****:***:*:**:.:::*:*:*..:  
 
Figure 11. EspJ homologues  
EspJ amino acid sequence from EPEC 0127:H6 E2348/69 and EHEC O157:H7 Sakai aligned 
with homologues from C. rodentium ICC168, S. bongori 12419, S. enterica subsp. arizonae 
62:z4,z23:-- (ABX20206.1), S. enterica subsp. salamae 3588/07 and Yersinia enterocolitica 
subsp. enterocolitica WA-314. C7, R79 and D187 are shown in bold and black. Sequences 
conserved in Pseudomonas syringae pathovars delphini, tomato, morsprunorum, and 
phaseolicola homologues are underlined in the EHEC sequence. Amino acid color code: Red: 
small, hydrophobic, aromatic, not Y; Blue: acidic; Magenta: basic; Green: hydroxyl, amine, 
amide, basic; "*": identical; ":": conserved substitutions (same colour group); ".": semi-conserved 
substitution (similar shapes).  
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The AvrPphF2-ORF2 crystal structure reveals a novel ‘mushroom like’ fold with an 
elongated ‘stalk’ and more compact ‘head’ subdomains (pdb1s21) (Singer et al., 2004). 
The head subdomain shares limited structural homology with known ADP-
ribosyltransferases (Singer et al., 2004), which are characterised by a structurally 
conserved beta sheet core. Comparison of AvrPphF-ORF2 and the canonical ART 
diphtheria toxin (DT) (pdb 1tox)(Bell & Eisenberg, 1996) structures allowed the 
prediction of key catalytic residues of AvrPphF-ORF2. The DT residues H21 and E148 
are required for hydrogen bonding to ADP-ribose moiety of NAD and catalysis through 
stabilisation of the transition state, respectively (Takada et al., 1995). AvrPphF-ORF2 
residues R72 and D174 showed equivalent positions and were essential for AvrPphF-
ORF2 phenotypes (Singer et al., 2004). 
Using the Phyre protein fold recognition server (Kelley & Sternberg, 2009), EspJ was 
predicted to share significant structural similarity (E value 1.3x10-8) with AvrPphF-
ORF2 (pdb 1s21)(Singer et al., 2004) generating a model structure which shared 
‘mushroom like’ fold of AvrPphF-ORF2 and the characteristic beta sheet core of ART 
domains (Fig. 12). Comparison of this structural model with AvrPphF-ORF2 and DT 
was used to design point mutations within the putative NAD binding region targeting 
predicted key residues in EspJ. Overlay of the EspJ model with DT showed 
superimposition of the beta-sheet core and NAD binding cleft (Fig. 13A). The EspJ 
residues R79 and D187, identified by sequence identity with AvrPphF-ORF2, projected 
in to the NAD binding site and are predicted to correspond with the DT residues H21 and 
E148 respectively (Fig. 13B). 
These predicted key ART residues are conserved in all EspJ homologues. In addition, 
EspJ has a conserved predicted palmitoylation site, a lipid modification involved in 
membrane localisation (CSS-Palm (Ren et al., 2008)). This cysteine (C7) is conserved 
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amongst Escherichia and Salmonella homologues but not in Pseudomonas or Yersinia 
proteins. 
 
Figure 12. EspJ model  
Phyre (Kelley & Sternberg, 2009) prediction based on AvrPphF-ORF2 pdb 1s21 (Singer et al., 
2004). Model coloured from amino-terminal (blue) to carboxy-terminal (red). A53 and R73 
highlighted in black with dashed lines indicating the position of the truncations EspJ53-217 and 
EspJ73-217 as discussed in Section 3.2.1. Side chains of R79 and D187 are shown as sticks. 
 
 
 
 
 
 
EspJ73-217
!"#
EspJ53-217
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Figure 13. EspJ ADP-ribosyltransferase domain 
(A) Overlay of EspJ model (Phyre (Kelley & Sternberg, 2009) prediction based on AvrPphF 
ORF2 (pdb 1s21) (Singer et al., 2004)) and Diphtheria toxin (pdb 1tox (Bell & Eisenberg, 1996)) 
generated using the Dali server (Holm & Rosenstrom, 2010). EspJ is shown in cyan and DT in 
orange. The NAD binding region is highlighted by a black box. (B) Magnification of the NAD 
binding region with NAD drawn as sticks (C shown in green, O in red, N in blue and P in 
orange). The side chains of R79, D187A (EspJ) and H21, E148 (DT) are shown (with O in red 
and N in blue). 
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3.2 Structural analysis of EspJ 
3.2.1 Construct design and testing  
In order to further study EspJ, constructs were designed for recombinant protein 
expression to allow structural and functional analysis. espJ sequences were cloned in to 
pET28a and pMALc2x for expression with an amino-terminal 6xHis tag and as fusion 
protein with maltose binding protein (MBP), respectively. His-tagged EspJ proved 
unstable, and so truncations were designed based on the model structure and secondary 
structure predictions (Jpred 3 (Cole et al., 2008)). As the N terminal ~20 residues of 
T3SS effectors function as a secretion signal and are generally unstructured (Munera et 
al., 2010), constructs lacking the first 27 residues were designed (EspJ28-217). In addition, 
the EspJ model predicted the N terminal region to be less structured and so the 
truncations EspJ53-217 and EspJ73-217 were designed to test whether this more flexible 
region affected protein stability (Fig. 12). Test expression of His-tagged EspJ28-217, 
EspJ53-217 and EspJ73-217 revealed that EspJ28-217 was the most stable with the highest 
proportion of protein in the soluble fraction (Fig. 14A). A small proportion of EspJ53-217 
was observed in the soluble fraction while EspJ and EspJ73-217 were undetectable in this 
fraction by Commassie staining or α-His immunoblot. Full length EspJ and the EspJ 
truncations were also tested for stability as MBP fusion proteins. As predicted, 
expression as a fusion protein improved the proportion of EspJ53-217 and EspJ73-217 present 
in the soluble fraction (Fig. 14B). However, the stability of EspJ28-217 was not improved 
significantly enough to outweigh the increase in tag size. Therefore, His-tagged EspJ28-
217, rather than the MBP fusion, was chosen for further investigation.  
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Figure 14. Analysis of expression and solubility of EspJ derivatives 
Cultures of BLB21 carrying pET28a-espJ or pMALc2x-espJ derivatives were induced with 0.1 
mM IPTG and grown at 30 °C for 3 h. Induction and solubility of recombinant His-tagged EspJ, 
EspJ28-217, EspJ53-217 and EspJ73-217. shown on Coomassie stained polyacrylamide gel (A) and α-
His Western blot (B).  (C) Expression and solubility of MBP-EspJ, MBP-EspJ28-217, MBP-EspJ53-
217 and MBP-EspJ73-217. shown on Coomassie stained polyacrylamide gel. U uninduced, I 
induced, S soluble, P insoluble pellet. 
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To improve the yield of recombinant protein, EspJ28-217 was purified under denaturing 
conditions and subsequently refolded (Fig. 15A). This strategy increased the protein 
yield by approximately three fold (Fig. 15B). To ensure that the product of denaturing 
purification had refolded in the correct way, the 1D NMR spectra of native and refolded 
EspJ28-217 were compared. The regions of the spectra with chemical shifts of < 0 ppm and 
8-10 ppm are particularly indicative of a folded structure arising from aromatic shifted 
methyls and hydrogen bonded amide groups respectively. Overlay of the spectra showed 
equivalent peaks in both the methyl and amide regions of the spectra indicating correct 
folding of the protein (Fig. 15C). The improved yields of correctly folded protein through 
denaturing purification coupled with smaller proteins being more applicable to NMR 
analysis, meant that both EspJ28-217 and EspJ53-217 were tested for use in structural 
analysis. 
Heteronuclear Single Quantum Correlation (HSQC) NMR analysis gives more detailed 
information in two dimensions (1H and 15N) arising from the correlation between 
nitrogen and the hydrogen in an amide bond. Each peak in the spectra represents either 
an amide bond in the protein backbone or an amide group in an amino acid side chain 
and the spectra therefore gives a protein fingerprint. Initial 2D NMR HSQC analysis of 
15N labeled EspJ28-217 and EspJ53-217 showed well dispersed peaks in the spectra 
suggesting EspJ would be amenable to structural analysis. Comparison of the two spectra 
revealed that EspJ53-217 had fewer overlapping peaks in the central unstructured region of 
the spectra, indicating that the shorter construct would be most suitable for structural 
determination (Fig. 16). However, protein precipitation was observed over 72 h and so 
optimisation of the construct and buffer were conducted. 
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Figure 15. Analysis of EspJ28-217 purified under denaturing conditions  
(A) His-tagged EspJ28-217 was purified by affinity chromatography under denaturing conditions 
(8M urea), refolded and the His-tag removed with thrombin cleavage shown on Coomassie 
stained polyacrylamide gel. WCL whole cell lysate, S soluble, P insoluble pellet, W wash, E 
eluent, cleaved FT flow through post thrombin cleavage, cleaved E eluent post thrombin 
cleavage. (B) Example 280 nm absorbance gel filtration trace of the yield of soluble expressed 
EspJ28-217 (native) or EspJ28-217 purified under denaturing conditions and refolded. (C) 1D NMR 
spectra of native (cyan) or refolded (purple) EspJ28-217. 
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Figure 16, Comparison of the 1H15N HSQC NMR EspJ28-217 and EspJ53-217 
2D 1H15N HSQC NMR spectra of recombinant 15N labeled EspJ28-217 (black) superimposed with 
the spectra of recombinant 15N labeled EspJ53-217 (green). The red ellipse highlights the region of 
the spectra associated with amides in unstructured amino acids 
 
3.2.2 Construct optimisation 
To test whether limited proteolysis of EspJ53-217 led to a more stable product, EspJ53-217 
was incubated with trypsin, chymotrypsin and proteinase K and analysed by SDS-PAGE. 
While proteinase K digestion lead to an initial smear and complete degradation (Fig. 
17A), more distinct bands were apparent with trypsin and chymotrypsin digestion (Fig. 
17B,C). With both trypsin and chymotrypsin digestion a strong lower MW band 
appeared which was subsequently completely digested. However, an additional more 
consistent band was apparent which persisted up to 6 h. Mapping of trypsin (Arg, Lys) 
and chymotrypsin (Tyr, Trp, Phe) digestion sites on to the predicted structure allowed a 
digestion products to be hypothesised in which part of the extended stalk portion of the 
structure were removed (Fig. 17D). Constructs to test this hypothesis were made (J 
Garnett, Imperial College) but as it was not possible to refold these proteins and 
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extensive protein aggregation was observed, these constructs were not investigated 
further.  
 
 
Figure 17. Optimisation of pET28a-espJ53-217 construct  
Recombinant EspJ53-217 was incubated with trypsin (A), chymotrypsin (B) or protease K (C) at a 
1000:1 ratio and the digestion patterns analysed by SDS-PAGE at time intervals shown. t time, E 
enzyme. Arrow heads highlight positions of unstable cleavage products and arrow highlights 
more stable products. (D) Trypsin (cyan; K,R) and chymotrypsin (orange; F,W,Y) cleavage sites 
highlighted on EspJ model. Arrows highlight and side chains are shown for cleavage sites 
hypothesised to produce the stable products indicated on (A) and (B).  
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3.2.3 Buffer optimisation 
To assess the best conditions for further NMR analysis the stability of EspJ53-217 in 
different buffers was tested using 1D NMR and differential scanning fluorimetry (DSF). 
In order to test a variety of buffers (Phosphate, HEPES), pH and reducing agents DSF 
was used to allow analysis in a 96 well plate. This assay allows the temperature at which 
a protein unfolds (Tm) to be measured using a fluorescent dye (Niesen et al., 2007). The 
dye used fluoresces when it binds to hydrophobic regions and is quenched in aqueous 
solution. Therefore, binding of the dye to the hydrophobic core exposed during 
unfolding, leads to an increase in fluorescence. This fluorescence then decreases as the 
unfolded protein begins to aggregate. The Tm for each protein can be determined by 
calculating the maximum of the first derivative, dF/dT, of each melting curve. 
Initial assay optimization tested varying protein (2.5 µM to 50 µM) and dye (0.1X to 
50X) concentrations for optimal curve shape. With non-optimal protein:dye ratios the 
melting curve was insufficient or undetectable maxima were observed (Fig. 18A). Curve 
analysis indicated that 2.5 µM EspJ and 1X dye were the best conditions for the buffer 
screen. Given previously observed precipitation in Tris based buffers, phosphate and 
Hepes were chosen for testing at pH 5, 6, 7 and 8 with the reducing agents tris(2-
carboxyethyl)phosphine (TCEP), Dithiothreitol DTT or β-mercaptoethanol (β-ME) and 
the additive Arg/Glu. The addition of Arg/Glu has been shown to reduce protein 
aggregation and precipitation and so improve stability (Golovanov et al., 2004). 
Preliminary analysis showed several anomalous Tms but did indicate a consistent drop in 
Tm when TCEP was included as the reducing agent (data not shown). As such TCEP was 
excluded from further analysis. Further screens showed increased stability at higher pH 
with increased Tms at pH7 and 8 than pH5 or 6 (Fig. 18B). This pattern was observed 
with both phosphate and Hepes buffers although results with phosphate buffer were more 
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consistent. No significant changes were observed between DTT and β-ME so β-ME was 
selected, as it is more stable over time. The results suggested that higher salt 
concentrations were preferable but inconsistencies meant no conclusions could be drawn 
as regards to salt concentration in this assay. Analysis was therefore extended to NMR to 
test salt concentrations with a phosphate pH7, 5mM β-ME buffer.  
EspJ was incubated under differing salt concentrations (50 mM, 100 mM, 200 mM and 
400 mM NaCl) and temperatures (295 K and 303 K (21.85 °C and 29.85 °C 
respectively)) and the ID NMR spectra before and after incubation compared. Through 
comparison of peaks in the methyl region the amount of signal loss, which is directly 
proportional to protein loss, was estimated following incubation. 100% signal loss was 
observed with 50 mM NaCl buffer, ~65% 100 mM or 200 mM NaCl and ~40% loss with 
400 mM NaCl indicating that stability increased with higher salt concentrations (Fig. 
19A). Additionally, incubation at 303 K resulted in more signal loss than incubation at 
295 K indicating that lower temperatures are required to avoid loss of signal over time 
(Fig. 19B). Although higher temperature and low pH and salt concentrations are 
preferential for NMR analysis, spectra can be obtained at low (~15°C) temperatures. 
However, NMR tests with low temperature incubations revealed that EspJ53-217 was not 
sufficiently stable to allow structural determination by NMR. Nevertheless, well 
dispersed peaks did mean further NMR based experiments were possible over short 
timescales (ie. NAD binding). 
In addition to NMR analysis, EspJ28-217 and EspJ53-217 were entered into crystallization 
trials for structural determination (J. Garnett, Imperial College). However, no crystals 
were formed under the screening conditions.  
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Figure 18. Optimisation of buffer conditions for EspJ53-217  
Analysis of EspJ53-217 by differential scanning fluorimetry. EspJ53-217 was mixed with 
SyproOrange dye and fluorescence, resulting from protein denaturation, was recorded over a 
temperature gradient. (A) Example melting curves with varying protein and dye concentrations 
from assay optimisation. Melting curves from 0.1 X dye with 2.5 uM EspJ53-217, 1 X dye with 2.5 
uM EspJ53-217 and 1 X dye with 7.5 uM EspJ53-217 shown. (B) DSF results from screen of 50mM 
phosphate buffers with 125 mM, 250 mM or 500 mM NaCl with 5 mM β-ME, 5 mM DTT or 50 
mM Arg/Glu as buffer additives. Average Tm of duplicate samples shown as a heatmap generated 
by Excel conditional colour formatting. (C) DSF results from screen of 50 mM HEPES buffers 
with 125 mM, 250 mM or 500 mM NaCl with 5 mM β-ME, 5 mM DTT or 50 mM Arg/Glu as 
buffer additives. Average Tm of duplicate samples shown as a heatmap generated by Excel 
conditional colour formatting. 
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Figure 19. Impact of NaCl concentration and temperature on EspJ53-217 stability  
(A) 1H NMR spectra of EspJ53-217  in 50 mM NaPO4 pH7.4, 5 mM β-ME buffer with 50 mM, 100 
mM, 200 mM or 400 mM NaCl prior to (purple) and following (cyan) 72 h incubation. (B) 1H 
NMR spectra of EspJ53-217 in 50mM NaPO4 pH7.4, 400 mM NaCl, 5 mM β-ME buffer prior to 
(purple) and following (cyan) 72 h incubation at 295 K or 303 K. Arrows highlight peaks 
assessed to estimate amount of signal loss. 
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3.3 Functional analysis of the ADP-ribosyltransferase domain 
3.3.1 ART domain mutations do not disrupt EspJ28-217 structure 
In order to analyse the predicted ADP-ribosyltransferase domain of EspJ in vitro, the 
R79A, D187A and R79A/D187A mutations designed to target the ART domain, were 
introduced in to pET28a-espJ28-217 for expression of ART mutant proteins. Wild type and 
mutant EspJ28-217 were purified by affinity chromatography and gel filtration for 
structural and functional analysis (Fig. 20). In order to determine whether the R79A, 
D187A and R79A/D187A mutations affected the overall protein structure, wild type and 
mutant EspJ28-217 were analysed by NMR. Initial analysis by 1D NMR revealed peaks in 
the methyl and amide regions of the spectra, indicative of folded protein, for each EspJ 
derivative (not shown). Further 1H15N HSQC NMR analysis of 15N labeled proteins 
showed well dispersed peaks were apparent for all mutants again suggesting that the 
mutations had not disrupted the overall protein structure (Fig. 21). Whilst the positions of 
some peaks had moved in relation to the wild type spectra this could be due to 
electrostatic changes from the substitution of charged residues and more drastic 
perturbations would be expected if there were significant secondary structure disruption. 
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Figure 20. Purification of ART mutants of EspJ28-217  
His-tagged EspJ28-217, EspJ28-217 R79A, EspJ28-217 D187A and EspJ28-217 R79A/D187A were 
purified by affinity chromatography under denaturing conditions. Coomassie stained 
polyacrylamide gels of initial purification (A) and purified samples post refolding and gel 
filtration (B) shown. WCL whole cell lysate, S soluble, W wash, E eluent. 
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Figure 21. R79A and D187A mutations do not disrupt EspJ28-217 structure.  
2D 1H15N HSQC NMR spectra of recombinant 15N labeled EspJ28-217 (black) superimposed with 
the spectra of recombinant 15N labeled EspJ28-217 R79A, EspJ28-217 D187A or EspJ28-217 
R79A/D187A (red). Arrow heads highlight regions where some chemical shift perturbations are 
apparent. 
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3.3.2 ART domain mutations do not disrupt EspJ translocation 
To address whether the EspJ ART domain mutations affected protein translocation 
through the T3SS, wild type EspJ and the ART mutant proteins were analysed in a 
translocation assay. In this assay effector proteins are expressed as β-lactamase (TEM) 
fusion proteins and translocation by EPEC is detected by cleavage of a fluorescent TEM 
substrate within eukaryotic cells (Charpentier & Oswald, 2004). EspJ-TEM, EspJ R79A-
TEM, EspJ D187A-TEM and EspJ R79A/D187A-TEM were expressed in EPEC and 
EPECΔescN, which lacks a functional T3SS, and their translocation assessed following 
infection of HeLa cells. NleD-TEM was used as a positive control. As expected, no 
cleavage of the TEM substrate was detected when the TEM-fusion proteins were 
expressed in EPECΔescN but changes in fluorescent signal were observed following 
expression in EPEC indicating translocation of the effectors. Importantly, EspJ and the 
ART mutant proteins were translocated in to infected cells at comparable levels 
indicating these targeted mutations do not disrupt T3SS-dependent translocation (Fig. 
22).  
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Figure 22. R79A and D187A mutations do not disrupt EspJ translocation during EPEC 
infection  
HeLa cell monolayers were infected with EPEC E2348/69 wild type (black bars) and the T3SS 
deficient EPECΔescN (grey bars) carrying pCX340 TEM-effector gene constructs as indicated. 
The T3SS effector NleD was used as a positive control. Results are averages of triplicate samples 
from a single experiment. Similar results were obtained in three individual experiments. The 
error bars represent standard deviations (SD). 
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3.3.3 EspJ binds NAD dependent on an intact ART domain 
In order to gain insight into whether the ART domain of EspJ was functional, EspJ was 
tested for its ability to interact NAD. Recombinant 15N labeled EspJ28-217 was purified 
and analysed by 1H15N HSQC NMR in the presence and absence of NAD. The addition 
of NAD caused significant chemical shift changes in the 2D spectra indicating an 
interaction with EspJ (Fig. 23). Spectral shifts were observed at a NAD:EspJ molar ratio 
of 0.25:1 (data not shown) suggesting tight binding, which was saturated at a ratio of 1:1. 
In order to determine whether the predicted ART residues were required for this 
interaction EspJ28-217 R79A, EspJ28-217 D187A and EspJ28-217 R79A/D187A were analysed 
in the same manner. When R79 was substituted for alanine no chemical shift 
perturbations were observed with the addition of NAD at a 1:1 ratio or even at a 10:1 
molar excess indicating that this residue is essential for binding NAD (Fig. 23). 
Interestingly, when D187 was mutated to alanine, NAD binding was disrupted but 
spectral changes were observed with a 10 fold excess of NAD consistent with D187 
being in the NAD binding pocket but not essential for its recognition (Fig. 23). As 
expected, EspJ28-217 R79A/D187A showed no spectral perturbations with the addition of 
ten fold excess of NAD (Fig. 23). These NAD binding results for wild type and ART 
mutant EspJ support the structural model and the hypothesis that EspJ has an ADP 
ribosyltransferase domain with R79 essential for binding to NAD.  
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Figure 23. EspJ28-217 binds NAD dependent on an intact ART domain 
2D 1H15N HSQC NMR spectra of recombinant 15N labeled EspJ28-217, EspJ28-217 R79A, EspJ28-217 
D187A or EspJ28-217 R79A/D187A (black) superimposed with spectra in the presence of 1:1 NAD 
(red) or 10:1 NAD (cyan). Arrow heads highlight examples of spectral changes upon addition of 
NAD. 
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3.3.4 In vitro ADP ribosylation assay 
In order to determine whether EspJ could function as an ADP-ribosyltransferase, EspJ28-
217 was tested in an in vitro ADP-ribosylation assay. Recombinant EspJ28-217 and EspJ28-
217 R79A/D187A were incubated with 32P labeled NAD and cell lysates followed by 
analysis of modified proteins. The ART domain of the Clostridium botulinum toxin C2, 
which ADP-ribosylates actin, was used as a positive control. Intriguingly, a band 
corresponding to EspJ28-217, labeled with 32P-NAD, was apparent in the presence and 
absence of cell lysates. However, no cell lysate proteins bands were consistently labeled 
with the addition of EspJ (Fig. 24A). Self-labeling was also observed with EspJ28-217 
R79A/D187A which contrasts with the NAD binding observed with NMR. It has 
previously been reported that ADP-ribose can react non-enzymatically with cysteine 
residues (McDonald et al., 1992; McDonald & Moss, 1994). To determine whether this 
observed labeling of EspJ was reliant on folded protein, heat and SDS-denatured EspJ28-
217 were tested (In collaboration with Dr Alex Lang). This analysis showed that native 
EspJ28-217 was required for labeling with 32P-NAD and so even if non-enzymatic ADP-
ribosylation was occurring it required folded EspJ (Fig. 24B). To further analyse this 
labeling, its resistance or sensitivity to hydroxylamine was assessed as different ADP-
ribose-residue linkages display differing sensitivities to hydroxylamine treatment. 
Enzymatic modification of cysteine gives a thioglycoside bond which is resistant to 
hydroxylamine whereas non-enzymatic modification of cysteine is sensitive to 
hydroxylamine treatment. As observed, the C2 modification of actin on Arg is sensitive 
to and therefore removed by hydoxylamine treatment. In contrast, labeling of EspJ28-217 
was resistant to hydroxylamine treatment indicating that it is unlikely to be as a result of 
non-enzymatic cysteine labeling (Fig. 24C). 
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Figure 24. Analysis of in vitro ADP ribosylation  
(A) Recombinant EspJ28-217, EspJ28-217 R79A/D187A (1 µg) or C2I (0.1 µg) were incubated with 
32P NAD for 60 min at 23 °C in the presence or absence of 15 µg cell lysate. Samples were 
separated by SDS-PAGE and imaged by phosphorimaging. (B) Untreated EspJ28-217 or EspJ28-217 
heated to 95°C for 5 min was incubated with 32P NAD in the presence or absence of 15 µg cell 
lysate and 0.01 or 0.1% SDS before SDS-PAGE separation and analysis. (C) ADP-ribosylation 
assay samples (as in (A)) were left untreated or treated with 0.5 M NH2OH for 1 h before SDS-
PAGE separation and analysis. Arrows indicate 32P NAD labeled proteins modified by EspJ28-217, 
EspJ28-217 R79A/D187A or C2I.  
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3.4 Binding partner identification - Yeast-two-hybrid analysis 
Identifying substrates and/or binding partners of EspJ would give vital information about 
its mechanism of action and so a yeast-two-hybrid (Y2H) screen was used to determine 
interacting proteins. This system uses the activation of reporter gene expression to 
identify protein:protein interactions and relies on the modular nature of the transcription 
factor Gal4. Gal4 is capable of activating transcription when its DNA binding (DBD) and 
activation domains (AD) are brought in to proximity indirectly by interacting proteins. 
espJEPEC was cloned into pGBT9 for expression as a fusion protein with the Gal4-DBD 
for use in the Y2H screen against a library of HeLa cell transcripts expressed as Gal4-AD 
fusion proteins. Following mating of AH109 (Mata) carrying pGBT9-espJ with the yeast 
library pre-transformed in Y187 (Matα), clones expressing interacting proteins were 
selected on quadruple dropout media (QDO) which selects for the presence of each 
plasmid and for reporter gene activation.  
Analysis of the number of diploids able to grow on double drop out media (DDO), which 
selects only for the presence of the plasmids, revealed a mating efficiency of 4.2% and an 
estimated 1x107 clones screened indicating a successful mating. Three colonies grew on 
QDO media and which were subsequently restreaked and the library insert amplified and 
sent for DNA sequencing. Two of the sequences were identified by BLAST analysis and 
the translated products corresponded to residues 62 -205 of the small GTPase Rab1A and 
the carboxy-terminal 15 residues of the phosphoserine-binding protein YWHAZ. To 
confirm these interactions sequences were subcloned into pGADT7, for expression as 
Gal4-AD fusion proteins, and co-transformed with pGBT9-espJEPEC and pGBT9-
espJEHEC in to AH109. Additionally, each vector was co-transformed with the 
complementary empty vector as negative controls. Transformants were selected for on 
DDO, and interactions on low stringency triple dropout (TDO) and high stringency QDO 
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media. Although the positive control, pGBT9-p53 and pGADT7-Tantigen, grew on all 
medias equivalently, growth was only observed on DDO medium for EspJ test 
interactions (Fig. 25). Limited growth was observed on TDO medium but at a 
comparable level to that of the negative controls suggesting it is due to background 
activation rather than indicative of an interaction. As such, further investigation is 
required to determine whether the proteins identified by the screen are in fact EspJ 
binding partners. 
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A 
Number pGBT9 pGADT7 DDO TDO QDO 
1 p53 TAg +++ +++ +++ 
2 EspJEPEC YWHAZ_C15 +++ - - 
3 EspJEHEC YWHAZ_C15 +++ - - 
4 EspJEPEC Rab1A +++ + - 
5 EspJEHEC Rab1A +++ + - 
6 EspJEPEC empty +++ + - 
7 EspJEHEC empty +++ + - 
8 empty YWHAZ_C15 +++ + - 
9 empty Rab1A +++ + - 
10 empty empty +++ + - 
 
Figure 25. Yeast-two hybrid analysis  
S. cereviseae AH109 was co-transformed with pGBT9 and pGADT7 vectors either encoding test 
proteins or as empty vector controls and growth on double (DDO), triple (TDO) or quadruple 
(QDO) drop out minimal media assessed. (A) Table summarising growth on each media. (B) 
Images of yeast transformants streaked on DDO, TDO and QDO media.  
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3.5 Discussion 
The T3SS effector protein EspJ is an anti-phagocytic protein conserved amongst EHEC, 
EPEC and C. rodentium strains although its host cell targets and mechanism of action 
have remained undefined (Marches et al., 2008). Further bioinformatic and structural 
analysis of EspJ was therefore conducted to gain insight into its activity within host cells. 
Bioinformatic analysis of EspJ revealed the presence of similar proteins in a range of 
Gram negative pathogens with increased sequence conservation in the carboxy-terminal 
region of the protein. Importantly, sequence homology and structural prediction 
identified EspJ as a member of the AvrPphF-ORF2/HopF2 family of proteins with a 
putative ADP-ribosyltransferase domain. A structural model of EspJ, based on AvrPphF-
ORF2, allowed comparison with the canonical ART diphtheria toxin showing overlap of 
the beta-sheet core conserved amongst ARTs. 
Structural analysis of EspJ was initiated in order to confirm the ART domain-like fold of 
the model structure and to allow further biochemical investigation of the protein. 
Extensive testing of EspJ truncations, purification methods, buffer components and 
temperatures was carried out to determine the optimal conditions to improve the yield 
and stability of recombinant EspJ. Despite this analysis the inherent instability of EspJ 
could not be entirely overcome, meaning it was not amenable to structural determination 
by NMR. Although structural determination by NMR requires the protein to be stable for 
prolonged periods of time, valuable information can also be acquired during short time-
scale NMR experiments. Indeed, optimisation experiments did establish conditions for 
short-term experiments with recombinant EspJ.  
The combination of the model structure and NMR analysis allowed significant insight in 
to EspJ to be gained. Through comparison with AvrPphF-ORF2 and DT, mutations were 
designed to target key residues within the ART domain. R79 was predicted to be 
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important in NAD binding while D187 was predicted to function in catalysis of the ADP-
ribosylation reaction. These residues were substituted to alanine and the impact assessed. 
1H15N HSQC NMR NMR analysis revealed that these mutations had not significantly 
disrupted the structure of the protein. Although chemical shift perturbations were 
observed, this is not unexpected following substitution of a large charged or acidic 
residue for a small residue.  
NMR analysis of recombinant EspJ also allowed investigation of the NAD-binding 
capabilities of wild type and ART mutant protein. Importantly, perturbations in the 1H15N 
HSQC NMR spectra upon addition of NAD revealed that EspJ binds NAD, a 
requirement for ADP-ribosylation. Analysis of EspJ R79A, D187A and R79A/D187A 
confirmed the hypothesis that these residues are involved in NAD binding. As predicted, 
R79 was essential for NAD binding and indeed even with a ten fold molar excess of 
NAD, no spectral perturbations were observed when this residue was mutated. EspJ 
D187A showed substantially reduced NAD binding ability, although some alterations in 
the spectra were observed with an excess of NAD. It is interesting to note that the EspJ 
spectral perturbations observed with the addition of NAD were in the same regions as 
those apparent when comparing wild type to the ART mutant spectra. This observation 
further supports the hypothesis that R79 and D187A are located within the NAD binding 
pocket.  
Although the NAD binding data strongly supports the prediction that EspJ is an ADP-
ribosyltransferase, in vitro ADP ribosylation assays did not reveal any consistent labeling 
of host cell proteins. However, these assays did show that both wild type EspJ and EspJ 
R79A/D187A are modified by, or associate with 32P labeled NAD. Auto-ADP-
ribosylation is not an unusual phenomenon and has been reported for several other 
bacterial ARTs. For example, Streptococcus pyogenes SpyA has been shown to auto-
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ADP-ribosylate and to ADP-ribosylate cytoskeletal proteins. Intriguingly, although 
mutation of the catalytic glutamic acid disrupted modification of target proteins, both 
wild type and mutant SpyA were capable of auto-ADP-ribosylation (Coye & Collins, 
2004). Interestingly, auto-ADP ribosylation of Pseudomonas aeruginosa ExoS has been 
shown to function in regulation of the protein. ExoS is a multi-domain protein with an 
amino-terminal GAP domain and auto-ADP-riboslyation by the carboxy-terminal ART 
domain has been shown to inhibit GAP activity (Riese et al., 2002). 
In the absence of their target protein, ARTs can catalyse the hydrolysis of NAD where 
water molecules function as the nucleophile although the efficiency of this activity varies 
considerably. From analysis of the predicted EspJ structure, a cysteine residue projects in 
to the NAD binding pocket adjacent to the nicotinamide-ribose raising the interesting 
possibility that it could act as the attacking nucleophile. Although both non-enzymatic 
and enzymatic modification of cysteines has been reported (McDonald & Moss, 1994), 
the requirement for folded EspJ and resistance to hydroxylamine treatment, strongly 
suggests this modification is enzymatic. However, to confirm this, further tests should be 
carried out including determining whether the same modification is observed with ADP-
ribose or whether it is blocked by free cysteine. However, this potential modification site 
does not solve the discrepancy between results observed with NMR binding and analysis 
of 32P-NAD whereby NAD binding was only observed with WT EspJ by NMR but both 
WT and EspJ R79A D187A were labeled following incubation with 32P NAD. A possible 
explanation is that the NMR spectra will show the average chemical shift and so perhaps 
NAD can weakly bind residual structure in the pocket which is not detected by NMR but 
the sensitivity of radiography allows the minority of modified EspJ to be detected. As 
such, it would be interesting to use more sensitive detection methods, for example 
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isothermal titration calorimetry, to determine the binding affinities of wild type and ART 
mutant EspJ for NAD. 
It is important to note that in some cases auto-ADP ribosylation has been suggested to be 
non-physiological. Sirtuins were originally identified as ARTs and shown both to bind 
NAD and auto-ADP-ribosylate (Sauve et al., 2006). More recent work has shown that 
these enzymes function as NAD-dependent deacetylases and suggests that auto-ADP-
ribosylation occurs as a result of an inefficient side-reaction (Du et al., 2009; Sauve et 
al., 2006). Furthermore, recent work on PTMs is increasingly using elegant co-factor 
analogues, rather than radiolabeling techniques, which rely on the Copper-Catalyzed 
Azide-Alkyne Cycloaddition reaction (Du et al., 2009; Grammel et al., 2011). 
Modifications using alkyne-tagged co-factors are detected using azide-tagged capture 
reagents, which contain the functionality of choice, for example a fluorophore for 
visualisation or biotin for protein isolation. Du et al suggest that the use of alkyne-tagged 
NAD molecules is advantageous as weak non-physiological ADP-ribosylation is not 
detected (Du et al., 2009). Additionally, these azide-tagged capture reagents can be 
exploited to allow pull down and identification of modified targets following PTM 
reactions within the cell. As such, it would be interesting to use such elegant probes for 
further analysis EspJ.  
Recent work on modifications by bacterial effector proteins has revealed that conserved 
domains do not always modify proteins in the same manner. The Legionella 
pneumophila effector AnkX contains a Fic domain, which normally functions in 
AMPylation of target proteins (Roy & Mukherjee, 2009). However, AnkX was recently 
shown to modify host proteins by adding a phosphocholine group thus highlighting that 
conserved domains can catalyse diverse reactions (Mukherjee et al., 2011). 
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Although NMR analysis has shown NAD binding by EspJ, it is not yet clear whether 
EspJ is an active enzyme or whether it uses NAD as a cofactor for protein-protein 
interactions. Importantly, it has been reported for some ARTs that NAD binding is 
required for substrate recognition. Indeed in the case of DT, NAD bound within the 
binding pocket both induces conformational changes required for substrate binding and 
provides part of the substrate-binding interface (Bell & Eisenberg, 1996). As such, NAD 
binding is a pre-requisite for DT substrate binding. It therefore seems possible that even 
if EspJ is not a functional ADP-ribosyltransferase, NAD binding ability could be 
required to allow interactions with target proteins. 
As an alternative method to identify host cell binding partners/substrates, a yeast-two-
hybrid screen was conducted using EspJ as the bait. Two proteins were identified, 
namely Rab1A and YWHAZ, which both appeared to be interesting targets for EspJ. 
Rabs are small GTPases associated with endomembranes are required for membrane 
fusion events, including phagocytic processes (Agola et al., 2011). YWHAZ is a member 
of the 14-3-3 family of proteins which bind to phosho-serine or phospho-theronine 
residues and act as adaptor proteins in diverse signalling networks including survival and 
adhesion (Matta et al., 2012). Intriguingly, binding to 14-3-3 proteins is required for the 
ADP-ribosylation activity of ExoS (Fu et al., 1993). This requirement for an activating 
host protein is not unique as the intrinsically low activity of CT is stimulated upon 
binding to ADP-ribosylation factor (ARF) GTPases (Kahn & Gilman, 1986). The 
carboxy-terminal loop of 14-3-3 proteins binds within the pSer binding site and needs 
displaced to allow further interactions, suggesting a regulatory mechanism (Truong et al., 
2002). Interestingly it was this carboxy-terminal region that was identified in the Y2H 
screen with EspJ. However, the lack of confirmation of this interaction through co-
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transformation raises questions as to the validity of the result meaning further work is 
required to confirm the putative interacting partners. 
Bioinformatic and structural analysis of EspJ conducted in this study has revealed EspJ 
to be conserved across many pathogens and suggested that it functions as an ADP-
ribosyltransferase. NMR analysis supported this hypothesis as EspJ was shown to bind to 
NAD and the conserved residues R79 and D187 were shown to be required for this 
interaction. There are currently only two ARTs, Arr and HopF2, known to depend on an 
aspartic acid for catalysis (Baysarowich et al., 2008; Wang et al., 2010). Further work is 
required to determine whether EspJ effector proteins have enzymatic activity and can be 
included in this family of aspartic acid dependent ARTs. 
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Chapter 4 - Mechanisms of EspJ-mediated inhibition of 
opsono-phagocytosis 
4.1 Inhibition of opsono-phagocytosis by EspJ 
4.1.1 Full length EspJ is required for inhibition of FcγR- mediated phagocytosis  
EspJ has previously been shown to inhibit opsono-phagocytosis through the FcγR and 
CR3 pathways (Marches et al., 2008). To gain further insight in to the mechanism of 
action of EspJ, and which regions of the protein were required for this phenotype, 
constructs for the expression of EspJ derivatives were generated and tested for their 
ability to inhibit opsono-phagocytosis through the FcγR pathway. The amino-terminal 
and carboxy-terminal regions were assessed with EspJ1-72 and EspJ73-217 respectively, and 
the role of the predicted palmitoylation site was assessed with EspJ C7A. Additionally, 
the role of the ART domain was assessed using EspJ R79A, D187A and R79A/D187A 
mutants. 
J774A.1 macrophages were infected with GFP expressing EPEC strains and challenged 
with IgG opsonised red blood cells (IgG-RBC). Following differential 
immunofluorescent staining to distinguish internal and external IgG-RBC, the percentage 
of internalisation was quantified. To aid counting the EPEC JPN15 strain was used, 
which lacks the plasmid encoding BFP and therefore does not form large microcolonies 
on the macrophage cell surface. As the amino-terminal of effector proteins is required for 
translocation through the T3SS, EspJ73-217 was not tested in this system. Uninfected cells 
internalised ~ 40% of attached IgG-RBC which was inhibited to ~ 2% internalisation 
with wildtype JPN15 infection. Infection with JPN15ΔespJ showed ~23% RBC 
internalisation; expression of EspJ or EspJ C7A in trans restored inhibition of 
phagocytosis indicating that the putative palmitoylation site is not required for inhibition 
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of phagocytosis by EspJ (Fig. 26). In contrast, when EpsJ1-72 was provided in trans 
inhibition was not restored and internalisation was comparable to that of JPN15ΔespJ 
infection (Fig. 26).  
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Figure 26. Full length EspJ is required to FcγRIIa-mediated phagocytosis during infection  
J774A.1 macrophages were infected with GFP expressing JPN15 strains for 1 h and challenged 
with IgG-RBC for 30 min before fixing and staining for immunofluorescent analysis. RBC were 
differentially stained to reveal external (cyan) and total (red) RBC. DNA was stained with DAPI 
(shown in blue). Representative images of macrophages are shown (A). White arrowheads show 
examples of internalised RBC in the merge image, red arrowheads show the internalised RBC in 
the total RBC image and cyan arrowheads indicate the absence of staining in the external RBC 
image.. Internal and external RBC were analysed to determine the percentage of phagocytosis of 
RBC attached to 100 cells (B). Results are the mean ± SD of three independent experiments. 
 
 
To analyse the activity of EspJ in isolation rather than in the complex context of the 
entire T3SS effector repertoire, EspJ derivatives and the FcγRIIa were ectopically 
expressed in Cos-7 cells and IgG-RBC phagocytosis assessed. Control cells transfected 
with the pFcγRIIa and empty vector internalised ~42% IgG-RBC. This internalisation 
was inhibited when cells were expressing a mutated FcγRIIa lacking the ITAM 
phosphorylation sites (Y282F/Y298F). When EspJ or EspJC7A were expressed in 
conjunction with the FcγRIIa, internalisation was inhibited to ~ 2% confirming that this 
residue is not required for EspJ activity (Fig. 27). Expression of either EspJ1-72 or EspJ73-
217  did not inhibit internalisation further indicating that the full length protein is required 
for inhibition of phagocytosis. 
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Figure 27. EspJ inhibits FcγRIIa mediated phagocytosis in Cos-7 cells  
Cos-7 cells were transfected with pEGFP-FcγRIIa or pEGFP-FcγRIIaY282F/Y298F in 
conjunction with pRK5, pRK5-espJ, pRK5-espJ1-72, pRK5-espJ73-217 or pRK5-espJ C7A for 15 h 
then challenged with IgG-RBC for 90 min. RBC were differentially stained to reveal external 
(cyan) and total (red) RBC. Representative images shown with arrowheads indicating 
internalised RBC. RBC were analysed to determine the percentage of phagocytosis of RBC 
attached to 50 transfected cells. Results are the mean ± SD of three independent experiments. 
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4.1.2 ART domain is required for inhibition of FcγR phagocytosis by EspJ 
To address whether the ART domain was required for EspJ activity during infection, 
EspJ R79A, EspJ D187A and EspJ R79A/D187A were tested for their ability to inhibit 
opsono-phagocytosis. As previously, J774A.1 macrophages were infected with GFP 
expressing EPEC JPN15 strains, challenged with IgG-RBC and the percentage 
internalisation quantified. As previously shown infection with wild type JPN15 inhibited 
phagocytosis to < 2% compared to ~ 40% phagocytosis in uninfected cells and ~23% 
internalisation with JPN15ΔespJ. Inhibition of internalisation was restored when wild 
type EspJ was provided on a plasmid but not when EspJ R79A, D187A or R79A/D187A 
were expressed (Fig. 28A). As translocation levels and correct folding of the ART 
mutants had been verified, these results indicate that a functional ART domain is 
necessary for inhibition of opsono-phagocytosis by EspJ. As the same phenotype was 
observed with both R79A and D187A mutations, only the double mutant was used in 
subsequent experiments. 
To further clarify the requirement of EspJ ART domain for inhibition of phagocytosis, 
EspJ and EspJ R79A/D187A were ectopically expressed with the FcγRIIa in Cos7 cells 
and IgG-RBC phagocytosis assessed. Whereas EspJ inhibited RBC internalisation from 
~32% to ~5%, expression of EspJ R79A/D187A did not significantly alter the level of 
phagocytosis from that of the FcγRIIa control (Fig. 28B), further highlighting the 
importance of a wild type ART domain for EspJ-mediated inhibition of phagocytosis. 
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Figure 28. EspJ ART domain is required for inhibition of FcγRIIa-mediated phagocytosis  
(A) J774A.1 macrophages were infected with GFP expressing JPN15 strains for 1 h and 
challenged with IgG-RBC for 30 min. RBC were differentially stained to reveal external (cyan) 
and total (red) RBC. Actin was stained with Phalloidin (shown in blue). (B) Cos-7 cells were co-
transfected with plasmids encoding FcγRIIa and Myc-tagged EspJ, EspJ R79A/D187A or an 
empty vector. After at least 15 hours of expression, cells were challenged with IgG-RBC for 
90min. Cells were stained with anti-myc antibody (blue) and RBC were differentially stained to 
reveal external (cyan) and total (red) RBC. For both (A) and (B) internal and external RBC were 
analysed to determine the percentage of phagocytosis of RBC attached to 100 infected cells or 50 
transfected cells. Representative images and the quantification of three independent experiments 
are shown. White arrowheads show examples of internalised RBC stained only red. Results are 
the mean ± SD.   
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4.1.3 EspJ inhibits actin accumulation at sites of IgG-RBC attachment 
As actin polymerisation is essential to form the phagocytic cup during phagocytosis, the 
effect of EspJ on actin enrichment at the site of RBC attachment was analysed by 
immunofluorescence. J774A.1 cells were infected with GFP expressing JPN15 strains 
and challenged with IgG-RBC as above. The presence of wild type EspJ coincided with a 
significant reduction in actin accumulation at RBCs compared to uninfected cells 
although actin polymerisation associated with bacteria was still observed (Fig. 29A). 
Actin accumulation at RBCs was observed during infection with JPN15ΔespJ and 
inhibition of actin accumulation was restored when the mutant was complemented with 
wild type espJ. Importantly, inhibition of actin accumulation could not be complemented 
when espJ R79A/D187A was supplied on a plasmid (Fig. 29A). This indicates that EspJ 
acts at the initial stages of phagocytic signalling preventing actin polymerisation. 
The impact of EPEC and EPECΔespJ infection on FcγR-mediated phagocytosis was also 
assessed by scanning electron microscopy (SEM). IgG-RBCs attached to uninfected 
J774A.1 cells were frequently associated with pseudopodia whereby the cell appeared to 
be engulfing the RBC (Fig. 29B). In contrast, cells infected with EPEC showed no such 
extensions and attached IgG-RBCs were only associated with minor protrusions. This 
inhibition was not observed following infection with EPECΔespJ and attached IgG-RBC 
were again surrounded by cellular extensions. 
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Figure 29. EspJ disrupts actin accumulation at sites of RBC attachment dependent on its 
ART domain  
J774A.1 macrophages were infected with GFP expressing JPN15 strains for 1 h and challenged 
with IgG-RBC for 15 min at 4 °C and 8 min at 37 °C before fixing and staining for 
immunofluorescent analysis (A) or SEM analysis (B). (A) Actin stained with Phalloidin is shown 
in red, RBC are shown in cyan. Representative images of macrophages and the quantification of 
actin accumulation at attached RBC for 50 cells are shown. White arrow heads show examples of 
actin accumulation. Results are the mean ± SD of three independent experiments. (B) SEM 
images of IgG-RBC associated pseudopodia. Black arrows show examples of membrane 
protrusions.  
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4.2  EspJ-mediated disruption of actin polymerisation 
4.2.1 EspJ colocalises with actin-rich structures  
i. Localisation during infection 
In order to determine the localisation of EspJ during infection, EPEC expressing EspJ 
with 4x HA tags was analysed. Infection of eukaryotic cells followed by anti-HA 
immunofluorescent staining revealed EspJ to be enriched around bacterial attachment 
sites, frequently surrounding actin pedestals (Fig. 30). However, EspJ did not appear to 
be restricted to this site as spreading throughout the cell was observed. 
 
Figure 30. EspJ localisation during infection  
Swiss 3T3 cells were infected with EPEC carrying pCX-4xHA (Control) or pCX-4xHA-espJ for 
90 min. Cells were stained with anti-HA antibody (red), Phalloidin for actin visualisation (green) 
and DAPI to visualize cellular and bacterial nuclei (blue). 
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ii. Localisation during ectopic expression in eukaryotic cells 
To further assess the effect of EspJ on eukaryotic cells the localisation of EspJ 
derivatives was analysed during ectopic expression. Expression of EspJ in Cos-7 cells 
showed co-localisation with actin structures, frequently in surface ruffles (Fig. 31). This 
localisation was apparent with EspJ, EspJ C7A and EspJ1-72 but EspJ73-217 showed 
cytoplasmic localisation suggesting that the amino-terminal region contains the signal or 
protein interaction region for determining localisation (Fig. 31). Additionally, EspJ C7A 
showed more variable localisation with some cells exhibiting colocalisation with actin 
and others cytoplasmic staining. 
 
 
Figure 31. EspJ colocalises with actin in Cos-7 cells  
Cos-7 cells were transfected with empty pRK5 (Control) or pRK5 encoding EspJ, EspJ1-72, 
EspJ73-217 or EspJ C7A. After 15 h cells were fixed and stained with α-Myc antibody (red), 
Phalloidin (green) and DAPI (blue) for immunofluorescent analysis. Enlarged images of the 
merge are shown for each construct.  
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In order to determine whether mutation of the ART domain affected the localisation of 
EspJ, constructs for the expression of wild type EspJ and EspJ R79A/D187A were 
transfected in to Swiss cells. As mitochondrial localisation has been previously reported 
for EspJ (Kurushima et al., 2010), and colocalisation with actin was observed, 
mitochondrial and actin fluorescent stains were used and the colocalisation of EspJ 
quantified. To ensure that this localisation was specific to EspJ, Flag-tagged GFP was 
expressed as a control and the proportion of cells showing colocalisation with actin 
quantified. GFP showed a predominantly cytoplasmic localisation with only ~11 % cells 
showing Flag staining colocalising with actin. In contrast, > 95% of cells expressing 
EspJEHEC, EspJEPEC or EspJEPEC R79A/D187A showed a characteristic staining 
colocalising with actin in naturally occurring membrane structures while only a small 
proportion of cells showed cytoplasmic staining or mitochondrial localisation (Fig. 32). 
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Figure 32. EspJ and EspJ R79A/D187A colocalise with actin rich structures in Swiss 3T3 
cells 
Swiss 3T3 cells were transfected with plasmids for the expression of Flag tagged GFP, EspJEHEC, 
EspJEHEC R79A/D187A, EspJEPEC, and EspJEPEC R79A/D187A. Cells were stained with anti-Flag 
anitobodies (green) as well as Mitotracker (red) and Phalloidin (purple) to visualize the 
mitochondria and actin respectively. Representative images are shown. The localisation of Flag-
tagged GFP, EspJEHEC, EspJEPEC, and EspJEPEC R79A/D187A was quantified for 50 transfected 
cells. Results are the mean ± SD of three independent experiments. 
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4.2.2 Ectopically expressed EspJ inhibits EPEC pedestal formation but not filopodia 
formation 
Given the similarities between the signalling pathways leading to FcγRIIa-mediated 
phagocytosis and Tir-mediated EPEC pedestal formation, overexpression of EspJ was 
tested for effects on actin polymerisation during EPEC infection. To address this 
question Swiss cells ectopically expressing EspJ were infected with EPEC and actin 
pedestal formation was analysed. Swiss 3T3 cells were transfected with pRK5 constructs 
for the expression of wild type EspJ, EspJ1-72, EspJ73-217 or EspJ C7A. Infection of Swiss 
3T3 cells transfected with empty pRK5 showed normal actin accumulation and pedestal 
formation. In contrast, cells transfected with pRK5-espJ and infected with EPEC lacked 
pedestals and showed less distinct actin accumulation (Fig. 33). This effect was also 
observed with the EspJ C7A mutant, however transfection of the amino-terminal or 
carboxy-terminal regions of EspJ did not affect pedestal formation during infection. 
These results show that the presence of EspJ in the cell is sufficient to affect actin 
accumulation and pedestal formation but full length EspJ is required. 
To further analyse the effect of EspJ on EPEC mediated actin polymerisation, different 
infection timepoints were assessed. At early timepoints EPEC induces filopodia 
formation preceding pedestal formation and so 15 min EPEC infection was analysed. 
Control cells showed filopodia formation with some cells progressing to small pedestals 
at 15 min post infection. In contrast, cells expressing EspJ showed enhanced filopodia 
but no pedestals were observed (Fig. 34A). Additionally, a longer infection was tested to 
determine whether EspJ was inhibiting or delaying pedestal formation. Control cells 
showed robust pedestal formation at 2.5 h post infection while cells expressing EspJ 
showed only minimal actin recruitment to the sites of bacterial attachment (Fig. 34B). 
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These results indicate that EspJ specifically inhibits actin polymerisation involved in 
pedestal formation but that not all actin polymerisation pathways are affected. 
 
Figure 33. Ectopic expression of full length EspJ disrupts pedestal formation upon EPEC 
infection  
Swiss 3T3 cells were transfected with empty pRK5 (Control) or pRK5 encoding EspJ, EspJ1-72, 
EspJ73-217 or EspJ C7A for 15 h and infected with EPEC E2348/69 for 1h. Cells were stained with 
mouse anti-Myc (red) and anti-EPEC (purple) antibodies and Phalloidin (green) and DAPI (blue) 
for immunofluorescent analysis. 
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Figure 34. EspJ does not inhibit filopodia formation  
Swiss 3T3 cells were transfected with plasmids for the expression of Flag tagged GFP or 
EspJEHEC 15 h before infection with EPEC E2348/69 for 15 min (A) or 2.5 h (B). Cells were 
stained with anti-Flag antibodies (green), anti-EPEC antibodies (purple) to detect EPEC and 
Phalloidin for actin visualization (red).  
 
 
4.2.3 EspJ ART domain is required for inhibition of pedestal formation 
In order to determine whether the ART domain of EspJ was required for inhibition of 
pedestal formation, Swiss 3T3 cells expressing GFP, EspJ or EspJ R79A/D87A were 
infected and pedestals quantified. This analysis included wild type and ART mutant EspJ 
from EPEC and EHEC. Whereas cells expressing GFP showed actin polymerisation 
under 67% of attached bacteria during EPEC infection, actin polymerisation was reduced 
to 18% on cells expressing EspJEPEC and to only 2% on cells expressing EspJEHEC (Fig. 
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35). For both EspJEHEC and EspJEPEC inhibition of pedestal formation required an intact 
ART domain, as expression of EspJ R79A/D187A did not affect pedestal formation.  
 
Figure 35. EspJ inhibits EPEC pedestal formation dependent on its ART domain  
Swiss 3T3 cells were transfected with plasmids for the expression of Flag tagged GFP, EspJEHEC, 
EspJEHEC R79A/D187A, EspJEPEC or EspJEPEC R79A/D187A 15 h before infection with EPEC 
E2348/69 for 1h and immunofluorescent analysis. Cells were stained with anti-Flag antibodies 
(green), Phalloidin for actin visualization (red) and DAPI to detect bacteria (blue). Pedestal 
formation was quantified for bacteria attached to 50 transfected cells. Representative images and 
quantification results are shown. Results are the mean ± SD of three independent experiments 
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4.2.4 EspJ does not affect EspFU/TccP dependent pedestal formation 
To further analyse the effect of EspJ on pedestal formation, actin accumulation during 
EHEC infection was assessed. Whereas actin polymerisation by EPEC relies on 
phosphorylation of Tir to recruit N-WASP, EHEC recruit N-WASP via the effector 
protein TccP/EspFU (Campellone et al., 2004b; Garmendia et al., 2004). In contrast to 
EPEC infection, when cells ectopically expressing EspJ were infected with EHEC no 
inhibition of pedestal formation was observed (Fig. 36A). In order to verify that EPEC 
pedestals were inhibited due to their reliance on Tir phosphorylation, EPEC with 
TccP/EspFU provided in trans was analysed. Importantly, when cells ectopically 
expressing EspJ were infected with EPEC pTccP, circumventing the requirement for 
tyrosine phosphorylation, pedestal formation was restored (Fig. 36B). 
 
4.2.5 EspJ does not affect pedestal formation during EPEC infection 
The previous experiments provided EspJ ectopically in the cell prior to infection. To 
determine if EspJ delivered during infection could also inhibit pedestals Swiss 3T3 cells 
were infected with EPEC, EPECΔespJ, and EPECΔespJ with EspJ or EspJ R79A/D187A 
provided in trans and the polymerised actin visualised. No clear differences in pedestal 
formation between strains was observed suggesting that EspJ needs to be present in the 
cell prior to initiation of pedestal signalling for inhibition to be observed (Fig. 37).  
 
 161 
 
 
Figure 36. EspJ does not affect EspFU/TccP dependent pedestal formation  
Swiss 3T3 cells were transfected with plasmids for the expression of Flag tagged GFP or 
EspJEPEC for 15 h before infection for 5 h with EHEC 85-170 (A) or for 3 h with EPEC E2348/69 
expressing TccP from a plasmid (B). Cells were stained with anti-Flag antibodies (green), 
Phalloidin for actin visualisation (red) and DAPI to detect bacteria (blue). Representative images 
are shown. 
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Figure 37. EspJ delivered during EPEC infection does not alter pedestal formation  
Swiss 3T3 cells were infected with EPEC, EPECΔespJ or EPECΔespJ carrying pSA10-espJ or 
pSA10-espJ R79A/D187A for 1h. Cells were stained with anti-EPEC antibodies (red), Phalloidin 
for actin visualisation (green) and DAPI to detect cell nuclei (blue). 
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4.3  Mechanisms of action of EspJ 
4.3.1 EspJ inhibits Tyr phosphorylation of Tir and Nck recruitment but not Tir 
translocation 
As the differential inhibition of actin polymerisation by EPEC but not EHEC suggested 
an alteration in the Tir receptor phosphorylation, the impact of EspJ on the initial stages 
of Tir signalling was assessed by immunofluorescence. The presence of Tir, 
phosphotyrosine and Nck underneath attached bacteria were evaluated. Whereas Tir 
staining was present at the site of bacterial attachment in GFP, EspJ and EspJ 
R79A/D187A expressing cells (Fig 38), a marked reduction in phosphotyrosine staining 
was observed specifically in the presence of EspJ (Fig. 39). This reduction was observed 
with EspJEHEC and EspJEPEC but not with the R79A/D187A mutants. Consistently, ectopic 
expression of EspJEHEC or EspJEPEC led to a reduction in Nck recruitment to the site of 
bacterial attachment. Quantification of Nck recruitment revealed a reduction from 76 % 
upon GFP expression to ~16% or ~24% with EspJEHEC or EspJEPEC expression 
respectively (Fig. 40). In contrast, the expression of EspJ R79A/D187A did not affect 
Nck recruitment, further indicating the requirement for a native ART domain for EspJ 
activity. This data suggests that EspJ inhibits phosphorylation of Tir preventing 
recruitment of Nck through its SH2 domain. 
 
 
 164 
 
Figure 38. EspJ does not disrupt the localisation of Tir at EPEC attachment sites  
Swiss 3T3 cells were transfected with plasmids for the expression of Flag tagged GFP, EspJEHEC, 
EspJEHEC R79A/D187A, EspJEPEC or EspJEPEC R79A/D187A 15 h before infection with EPEC 
E2348/69 for 1h and immunofluorescent analysis. Cells were stained with anti-Flag (green) and 
anti-Tir (red) and DAPI to visualize bacteria (blue). Representative images are shown.  
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Figure 39. EspJ inhibits tyrosine phosphorylation at EPEC attachment sites dependent on 
its ART domain  
Swiss 3T3 cells were transfected with plasmids for the expression of Flag tagged GFP, EspJEHEC, 
EspJEHEC R79A/D187A, EspJEPEC or EspJEPEC R79A/D187A 15 h before infection with EPEC 
E2348/69 for 1h and immunofluorescent analysis. Cells were stained with anti-Flag (green) and 
anti-pTyr (red) antibodies and DAPI to visualize bacteria (blue). Representative images are 
shown.  
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Figure 40. EspJ inhibits Nck recruitment to EPEC attachment sites dependent on its ART 
domain  
Swiss 3T3 cells were transfected with plasmids for the expression of Flag tagged GFP, EspJEHEC, 
EspJEHEC R79A/D187A, EspJEPEC or EspJEPEC R79A/D187A 15 h before infection with EPEC 
E2348/69 for 1h and immunofluorescent analysis. Cells were stained with anti-Flag (green) and 
anti-Nck (red) and DAPI to visualize bacteria (blue). Representative images are shown. (B) Nck 
recruitment was quantified for bacteria attached to 50 transfected cells. Results are the mean ± 
SD of three independent experiments. 
 
 
 
Nck
DAPI
Merge
GFP EspJEPEC
!!!!
EspJEPEC
R79A/D187AEspJEHEC
EspJEHEC
R79A/D187A
Flag
GFP EspJEHEC EspJEPEC EspJEPEC
R79A/D187A
EspJEHEC
R79A/D187A
!!!!
!!!!
20
80
60
40
100
%
 b
ac
te
ria
 w
ith
 N
ck
 re
cr
ui
tm
en
t
 167 
4.3.2 EspJ inhibits tyrosine phosphorylation during FcγR phagocytosis 
To determine whether phosphorylation was also affected during EPEC-mediated 
inhibition of phagocytosis the enrichment of phosphotyrosine staining at the site of IgG-
RBC attachment to infected macrophages was analysed. Macrophages were infected with 
JPN15 strains and challenged with IgG-RBC as previously described. Infection with wild 
type JPN15 showed a reduction in pTyr staining at RBC attachment sites, which was not 
observed with JPN15ΔespJ (Fig. 41A). Trans complementation with EspJ reduced the 
pTyr staining while complementation with EspJ R79A/D187A did not, indicating the 
ART domain of EspJ is important for the reduced tyrosine phosphorylation observed. 
 
4.3.3 EspJ inhibits phosphorylation of the FcγRIIa 
As tyrosine phosphorylation is further amplified downstream of the FcγR, the 
phosphorylation state of the FcγRIIa was analysed to clarify whether EspJ inhibits the 
initial receptor phosphorylation. EspJ derivatives and the FcγRIIa were ectopically 
expressed in Cos-7 cells and receptor signalling initiated by crosslinking antibodies 
bound to the FcγRIIa with a secondary antibody. The FcγRIIa was then 
immunoprecipitated and the level of phosphorylation determined. As expected, tyrosine 
phosphorylation of the receptor was detected upon crosslinking in the absence of EspJ 
(Fig. 41B). Phosphorylation was not observed in the control FcγRIIa Y282F/Y298F 
mutant which lacks the ITAM tyrosine phosphorylation sites. When wild type EspJ was 
expressed in conjunction with FcγRIIa, receptor phosphorylation was not observed 
supporting the hypothesis that EspJ acts through inhibition of the initial signalling 
preventing phosphorylation of the receptor. In contrast, expression of EspJ R79A/D187A 
did not inhibit receptor phosphorylation highlighting the dependency on the ART domain 
for this activity. 
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Figure 41. EspJ inhibits tyrosine phosphorylation during FcγR-dependent phagocytosis  
(A) J774A.1 macrophages were infected with GFP expressing JPN15 strains for 1 h and 
challenged with IgG-opsonised RBC for 15 min at 4 °C and 8 min at 37 °C before fixing and 
staining for immunofluorescent analysis. Anti-pTyr staining is shown in red and RBC are shown 
in cyan. Representative images of macrophages and the quantification of enriched pTyr staining 
at attached RBC for 50 cells are shown. White arrow heads show examples of enriched pTyr. 
Results are the mean ± SD of three independent experiments. (B) Cos-7 cells were co-transfected 
with plasmids encoding GFP-tagged wild type or Y282F/Y298F FcγRIIa along with EspJ, EspJ 
R79A/D187A or an empty vector for 15 h before treatment with anti-FcγR IV.3 antibody alone 
or followed by crosslinking with an anti-mouse secondary antibody. After FcγRIIa 
immunoprecipitation, samples were separated by SDS-PAGE and immunoblotted with anti-pTyr 
and anti-GFP antibodies. Arrow indicates position of pTyr FcγRIIa on the blot. 
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4.3.4 EspJ inhibits recruitment of active SFKs to pedestals 
As Src family kinases (SFKs) have been implicated in both FcγR-mediated phagocytosis 
and EPEC pedestal formation we analysed whether active SFKs were recruited in the 
presence of EspJ. Full activation of SFKs requires auto-phosphorylation at Y418 so we 
looked for the presence of pY418 staining at the site of bacterial attachment. As this 
phosphorylation site is highly conserved between SFKs, antibodies against this site detect 
phosphorylation of all family members. In control GFP expressing cells pY418 staining 
was localised at ~ 58 % of bacteria (Fig. 42). When cells were ectopically expressing 
EspJ this was reduced to 5 % and 20 % for the EHEC and EPEC proteins respectively. 
This reduction was not observed when the ART mutant forms of EspJ were expressed 
with 55 % and 52 % attached bacteria with associated pY418 staining with EspJ 
R79A/D187A of EHEC and EPEC respectively. 
 
4.3.5 Src family kinases and Abl localisation to EPEC pedestals is inhibited by EspJ 
To further analyse this phenotype we evaluated whether SFKs were present but inactive 
or not recruited to the bacterial attachment site. To do this the recruitment of individual 
SFKs and the effect of EspJ on this localisation was assessed. Abl family kinases have 
also been implicated in pedestal formation and phagocytosis and so Abl was included in 
this analysis. Swiss cells expressing GFP alone or GFP tagged Src, Fyn, Yes and Abl 
were infected with EPEC and kinase recruitment to pedestals was assessed. Control cells 
expressing GFP showed no specific recruitment of GFP to the site of bacterial 
attachment. However, when GFP-tagged Src Fyn and Yes were expressed recruitment to 
attached bacteria was observed, localising to the tip of pedestals (Fig. 43A). Abl-GFP 
was also recruited to bacterial attachment sites but was observed throughout the length of 
the pedestal rather than localised at the tip (Fig 43A).  
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Figure 42. EspJ inhibits recruitment of Src family kinases to sites of bacterial attachment 
(A) Swiss 3T3 cells were transfected with plasmids for the expression of Flag tagged GFP, 
EspJEHEC, EspJEHEC R79A/D187A, EspJEPEC or EspJEPEC R79A/D187A 15 h before infection with 
EPEC E2348/69 for 1h and immunofluorescent analysis. Cells were stained with anti-Flag 
(green), anti-pY418 (red) to detect active SFKs and DAPI (blue) to detect bacteria. Enriched 
pY418 staining was quantified for bacteria attached to 50 transfected cells. Representative 
images and quantification results are shown. Results are the mean ± SD of three independent 
experiments. 
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Interestingly, when the GFP tagged kinases were expressed in conjunction with 
EspJEHEC, these localisation patterns were disrupted. In the case of Fyn, Src, or Yes, no 
distinct localisation at the site of attached bacteria was observed but the SFKs colocalised 
with EspJEHEC in actin-rich membrane structures (Fig. 43B). In contrast, when co-
expressed with EspJEHEC, Abl-GFP showed a more cytoplasmic localisation and did not 
appear to be associated with attached bacteria (Fig. 43B). 
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Figure 43. Fyn, Yes, Src and Abl localise to sites of bacterial attachment in the absence of 
EspJ 
Swiss 3T3 cells were transfected with plasmids for the expression of GFP or GFP tagged Fyn, 
Src, Yes or Abl in conjunction with empty pcDNA (A) or pcDNA-espJEHEC (B) 15 h before 
infection with EPEC E2348/69 for 1h. Cells were stained with anti-Flag antibody (red) Phalloidin 
for actin visualisation (purple) and DAPI to detect bacteria (blue). Representative images are 
shown. 
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localisation of GFP-tagged Fyn was observed at the site of bacterial attachment despite 
the lack of robust pedestal formation (Fig. 44). In contrast, Abl-GFP was not observed at 
bacterial attachment sites in these cells suggesting that the previously observed pedestal 
recruitment is dependent on actin polymerisation, via the Abl F-actin binding domain, 
and therefore not relevant to EspJ inhibition of pedestal formation (Fig. 44). 
 
 
Figure 44. Fyn localises to the site of bacterial attachment in Nck -/- cells  
Nck-/- fibroblasts were transfected with plasmids for the expression of GFP or GFP tagged Fyn or 
Abl 15 h before infection with EPEC E2348/69 for 1h and immunofluorescent analysis. Cells 
were stained with Phalloidin for actin visualization (red) and DAPI to detect bacteria (blue).  
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4.3.6 An intact ART domain is required for disruption of Fyn-GFP localisation by 
EspJEHEC 
To determine whether the ART domain of EspJ affected recruitment of the tyrosine 
kinases, wild type and ART mutant EspJ were co-expressed with GFP-Fyn and 
localisation assessed. Interestingly, EspJEPEC and EspJEHEC showed different phenotypes 
with this analysis. When EspJEPEC was co-expressed with Fyn, pedestal formation was 
not consistently inhibited suggesting increased expression of SFKs can overcome 
EspJEPEC-mediated inhibition (Fig. 45). However, when EspJEHEC was co-expressed with 
GFP-Fyn, actin polymerisation was still inhibited. As above, the GFP-Fyn recruitment 
pattern was disrupted and showed a more general membrane localisation pattern 
frequently co-localising with EspJEHEC (Fig. 45). When EspJEHEC R79A/D187A was co-
expressed with GFP-Fyn, Fyn was again localised to the site of bacterial attachment and 
pedestal formation although colocalisation with EspJEHEC R79A/D187A was also 
apparent (Fig. 45). Cells co-expressing EspJEHEC and Fyn were analysed with anti-pY418 
immunofluorescent staining to determine the impact of EspJ. Although high expression 
of Fyn-GFP was observed, this was not active in the presence of EspJ. (Fig. 46). These 
data suggest that EspJ disrupts receptor phosphorylation and downstream signalling by 
preventing recruitment and activation of SFKs, dependent on its ART domain. 
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Figure 45. EspJEHEC disrupts Fyn recruitment dependent on its ART domain  
Swiss 3T3 cells were co-transfected with a plasmid for the expression of GFP-Fyn along with 
empty pcDNA (Control) or pcDNA encoding EspJEHEC, EspJEHEC R79A/D187A, EspJEPEC or 
EspJEPEC R79A/D187A 15 h before infection with EPEC E2348/69 for 1h and 
immunofluorescent analysis. Cells were stained with an anti-Flag antibody (red), DAPI to detect 
bacteria (blue) and Phalloidin to visualize actin (purple). 
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Figure 46. EspJEHEC prevents activation of Fyn-GFP  
Swiss 3T3 cells were transfected with a plasmid for the expression of GFP-tagged Fyn in 
conjunction with empty pcDNA (Control) or pcDNA-espJEHEC 15h before infection with EPEC 
E2348/69 for 1h and immunofluorescent analysis. Cells were stained with anti-pY418 antibody 
(red) to stain active SFKs, anti-Flag antibody (purple), and DAPI to detect bacteria (blue). 
 
 
4.3.7 EspJ28-217 does not inhibit Fyn activity in vitro 
To assess whether EspJ could affect the activity of SFKs, an in vitro kinase assay was 
employed with recombinant Fyn and EspJ28-217. In order to ensure that the truncated EspJ 
used in structural analysis could still function within the cell, EspJ28-217 was tested for its 
ability to inhibit phagocytosis. Constructs for the expression of EspJ or EspJ28-217 were 
co-transfected into Cos7 cells with a construct encoding FcγRIIa and the internalisation 
of IgG-RBCs was analysed. Control cells internalised ~40% of bound IgG-RBCs but 
internalisation was inhibited when cells were expressing EspJ, as previously reported 
(Fig. 47). Internalisation was comparably inhibited when EspJ28-217 was expressed 
indicating that deleting the amino-terminal region does not disrupt EspJ activity and 
EspJ28-217 could be used in functional assays. 
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Figure 47. EspJ28-217 inhibits FcγRIIa mediated phagocytosis in Cos7 cells  
Cos7 cells were transfected with pEGFP-FcγRIIa in conjunction with pRK5, pRK5-espJ, pRK5-
espJ28-217 for 25 h then challenged with IgG opsonised RBC for 90 min. RBC were differentially 
stained to reveal external (cyan) and total (red) RBC. Internal and external RBC were analysed to 
determine the percentage of phagocytosis of RBC attached to 50 transfected cells. Results are the 
mean ± SD of three independent experiments. 
 
The SFK assay relies on the differential cleavage of a substrate peptide generating a 
fluorescent product if the peptide is non-phosphorylated and a non-fluorescent product if 
the peptide is phosphorylated. As expected, analysis of Fyn showed a decrease in 
fluorescence, indicating phosphorylation, with the addition of ATP which could be 
inhibited with the SFK inhibitor PP2 (Fig. 48). To test the impact of EspJ, Fyn was 
incubated with EspJ28-217 or EspJ28-217 R79A/D187A and the activity of Fyn assessed. To 
determine whether NAD was required for any effect of EspJ, the assay was carried out in 
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the presence and absence of NAD. The addition of increasing amounts of EspJ28-217  
(molar ratio of EspJ28-217:Fyn from 0.25:1 to 25:1) did not alter Fyn activity in the 
presence or absence of NAD (not shown and Fig. 48). This indicates that EspJ28-217 does 
not inhibit the activity of Fyn in vitro, although an inhibitory activity that requires further 
cellular components cannot be ruled out.  
 
Figure 48. EspJ28-217 does not inhibit Fyn activity in vitro 
Recombinant Fyn was incubated with EspJ28-217 or EspJ28-217 R79A/D187A at a ratio of 1:5 for 1 
h in the presence or absence of NAD then assayed for kinase activity (indicated by a reduction in 
fluorescence from no ATP control). Result observed three times. Single experiment shown as 
mean± SD of triplicate samples. 
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4.4  EspJ homologues 
As shown in Fig. 11, EspJ homologues are present in a range of bacterial pathogens. To 
determine whether these homologues were also capable of exerting the same effects on 
host cells, the Salmonella enterica subsp. salamae orthologue, SeoC, was analysed. 
 
4.4.1 SeoC inhibits phagocytosis 
In order to determine if SeoC can inhibit phagocytosis, the gene was cloned in the 
mammalian expression vector pRK5. This construct, together with the plasmid encoding 
FcγRIIa, was transfected into Cos-7 cells. Transfected cells were challenged with IgG- 
RBC and the percentage internalised IgG-RBC quantified. Ectopic expression of SeoC 
resulted in significant inhibition of IgG-RBC internalisation into FcγRIIa-expressing 
Cos-7 cells showing this EspJ homologue is sufficient to inhibit opsono-phagocytosis 
(Fig. 49A). 
 
4.4.2 SeoC inhibits pedestal formation 
To determine whether SeoC could also inhibit actin polymerisation signalling during 
EPEC infection, Swiss cells ectopically expressing SeoC were infected with EPEC and 
pedestal formation assessed. Pedestals were not observed on cells expressing SeoC 
whereas control cells expressing GFP exhibited normal pedestal formation underneath 
attached bacteria (Fig. 49B). This indicates that the S. salamae protein SeoC inhibits 
actin polymerisation pathways in a manner analogous to EspJ.   
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Figure 49. SeoC inhibits SFK-dependent actin polymerisation  
(A) Cos-7 cells were co-transfected with plasmids encoding FcγRIIa and Myc-tagged SeoC or an 
empty vector. After at least 15 hours of expression, cells were challenged with IgG-RBC for 
90min. Cells were stained with anti-myc antibody (blue) and RBC were differentially stained to 
reveal external (cyan) and total (red) RBC. Internal and external RBC were analysed to determine 
the percentage of phagocytosis of RBC attached to 50 transfected cells. Representative images 
and the quantification of three independent experiments are shown. (B) Swiss 3T3 cells were 
transfected with plasmids for the expression of Myc-tagged GFP or SeoC. After 15 h expression 
and infected with EPEC E2348/69 for 1 h. Cells were stained with anti-Myc antibody (green) and 
Phalloidin (red) and DAPI (blue) for immunofluorescent analysis. 
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4.5  Additional EspJ phenotype 
4.5.1 EspJ protects against detachment during infection 
Previous work by S. Dahan suggested that in addition to its anti-phagocytic phenotype, 
EspJ is also anti-apoptotic (unpublished). To investigate this, we tested the effect of an 
EPEC EspJ deletion mutant on the viability of HeLa cells. Cell monolayers were infected 
with wildtype EPEC E2348/69, EPECΔespJ and EPECΔespJ complemented with a 
plasmid encoding EspJEPEC. Infection with EPEC ΔespJ induced greater cell detachment 
(~66%) compared to wild type E2348/69 infection (~8%) indicating that EspJ confers 
some protection against cell detachment induced by EPEC (Fig. 50). When ΔespJ was 
complemented with a plasmid encoding EspJEPEC, protection was restored.  
To determine whether apoptotic signalling was required for the EPECΔespJ induced 
detachment during the cell viability assay cells were pretreated with Zvad-fmk, an 
inhibitor of apoptosis. Addition of Zvad-fmk inhibits caspase cleavage and activation 
required for apoptosis. HeLa cells treated with Staurosporine (Sts), a kinase inhibitor that 
induces apoptosis, showed nearly 50 % cell loss which was then markedly reduced by the 
addition of Zvad-fmk (Fig. 50). The addition of Zvad-fmk led to a partial reduction in 
EPECΔespJ detachment, decreasing cell loss from 66 % to 43 %. This suggests that the 
EPECΔespJ induced cell loss is partially dependent on apoptotic signalling but 
predominantly apoptosis-independent. 
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Figure 50. EPECΔespJ induces detachment which is predominantly independent of 
apoptotic signalling  
HeLa cells were infected for 1 h with wild type EPEC 2348/69, ΔespJ or ΔespJ with EspJ 
supplied on pSA10, washed to remove bacteria and treated with 200 µg/ml gentamicin in DMEM 
for 3 h. Alternatively cells were treated with 1 µM Staurosporine. Samples were left untreated or 
treated with 66 µM Zvad-fmk for 2 h before infection. % of cells lost was calculated as compared 
to uninfected cells. Average of two independent experiments shown 
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4.6 Results summary 
Table 5. Phenotypes observed during ectopic expression 
 
EspJ EspJ1-72 EspJ73-217 EspJ C7A 
EspJ 
R79A/D187A 
Inhibition of 
FcγR-
phagocytosis 
Y N N Y N 
Inhibition of 
EPEC 
pedestals 
Y N N Y N 
Colocalisation 
with actin Y Y N p Y 
 
Table 6. Phenotypes observed during infection 
 
EPEC EPECΔespJ 
EPECΔespJ 
pespJ 
EPECΔespJ 
pespJ73-217 
EPECΔespJ 
pespJ C7A 
EPECΔespJ 
pespJ 
R79A/D187A 
Inhibition of 
FcγR-
phagocytosis 
Y N Y N Y N 
Inhibition of 
EPEC 
pedestals 
N N N N N N 
Extensive 
detachment 
(HeLa) 
N Y N nt nt nt 
Y yes, N no, p partial, nt not tested. 
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4.7  Discussion 
EspJ has previously been shown to inhibit opsono-phagocytosis although the mechanism 
of action was entirely unknown (Marches et al., 2008). This study aimed to determine the 
mechanism by which it inhibited opsono-phagocytosis and to further investigate the 
effects of EspJ on eukaryotic cells. Through analysis of FcγRIIa-mediated phagocytosis 
and TirEPEC-dependent actin polymerisation pathways, EspJ has been shown to disrupt 
SFK recruitment, receptor phosphorylation and downstream actin polymerisation. 
Furthermore, analysis of the S. enterica subsp. salamae homologue, SeoC, revealed that 
it could also inhibit opsono-phagocytosis and EPEC pedestal formation indicating that 
EspJ homologues do indeed share conserved functions. 
Investigation of FcγRIIa-mediated phagocytosis revealed that EspJ inhibited actin 
accumulation and enrichment of phosphotyrosine at the site IgG-RBC attachment. 
Importantly, EspJ was shown to inhibit phosphorylation of the FcγRIIa itself following 
receptor crosslinking. During ectopic expression EspJ colocalised with actin and was 
shown to block actin polymerisation during EPEC, but not EHEC, infection. EPEC and 
EHEC pedestal pathways converge on N-WASP to direct Arp2/3-mediated actin 
polymerisation with EHEC circumventing upstream kinase requirements by translocating 
TccP/EspFU.(Campellone et al., 2004b; Garmendia et al., 2004; Lommel et al., 2004). 
The differential inhibition, and restoration of EPEC pedestal formation upon TccP/EspFU 
expression, indicates that EspJ acts upstream of N-WASP and the Arp2/3 complex. 
Indeed disruption of the initial stages of TirEPEC signalling, specifically tyrosine 
phosphorylation and Nck recruitment, was observed. This is consistent with EspJ 
disrupting receptor phosphorylation as observed for the FcγRIIa. 
The Src family kinases (SFKs) have long been established as essential for phagocytosis 
and responsible for the phosphorylation of the FcγRIIa ITAM motifs (Fitzer-Attas et al., 
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2000; Huang et al., 1992) although their role in pedestal formation is somewhat 
contentious. Through ‘priming and challenge’ infections where Tir translocation and 
clustering are separated, the SFK Fyn was shown to be specifically necessary and 
sufficient for pedestal formation (Phillips et al., 2004). Swimm et al have shown a more 
relaxed specificity with redundant kinases including Abl and Arg present at and 
sufficient for pedestal assembly (Swimm et al., 2004). In this study Fyn-GFP, Src-GFP 
and Yes-GFP were found to localise to the tip of EPEC pedestals. Abl-GFP was also 
observed at the pedestals although this localisation was not observed in cells lacking Nck 
suggesting actin polymerisation is required for Abl recruitment. The inhibition of TirEPEC 
dependent actin polymerization by EspJ correlated with a decrease in the recruitment of 
GFP-tagged SFKs and active SFKs to bacterial attachment sites. Additionally, during 
ectopic expression EspJ and SFKs were shown to colocalise suggesting EspJ may target 
receptor phosphorylation by disrupting SFK activity. Inhibition of Fyn activity was not 
observed in an in vitro assay with EspJ28-217, although an effect requiring further host 
factors cannot be excluded. 
In addition to gaining further insight in to the affects of EspJ on host cells, this study 
aimed to determine which regions of EspJ were required for its activity. To do this the 
amino-terminal and carboxy-terminal regions were analysed with EspJ1-72, and EspJ73-217 
as well as mutations targeting a predicted palmitoylation site (C7A) and the ART domain 
(R79A, D187A). Neither truncation was capable of inhibiting opsono-phagocytosis or 
EPEC pedestals although EspJ1-72 did show the same localisation pattern as the full-
length protein. EspJ C7A was still able to inhibit both opsono-phagocytosis and pedestal 
formation suggesting this site is not important for the function of EspJ. Importantly, 
mutations targeting the ART domain abolished the ability of EspJ to inhibit actin 
polymerisation, Nck recruitment, tyrosine phosphorylation and SFK recruitment at the 
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site of attached bacteria. These ART domain residues were also required for inhibition of 
opsono-phagocytosis during infection indicating this domain is central to the activity of 
EspJ. EspJ R79A/D187A showed the same localisation pattern as the wild type protein 
indicating that these mutations disrupt EspJ activity or target-binding rather than cellular 
localisation. These results indicate that the amino-terminal region of EspJ facilitates its 
localisation with actin-rich structures while the ART domain is required for its function. 
Interestingly, pedestals were unaffected when EspJ was translocated through the T3SS 
during EPEC infection, although in this context inhibition of phagocytosis is observed. 
This highlights the importance of spatio-temporal control of effector proteins in concert 
with the reported hierarchy of EPEC effector protein translocation (Mills et al., 2008). 
Indeed, Tir has been shown to be translocated prior to EspJ (Mills et al., 2008). These 
results suggest a requirement for EspJ to be present within the cell before the initiation of 
Tyr kinase-dependent signalling for inhibition to be observed. This observation raises the 
possibility that EspJ may act to prevent activation and recruitment of SFKs but be unable 
to affect previously activated SFKs. 
SFKs are tightly controlled and exist in an auto-inhibited state through intra-molecular 
interactions between the SH2 domain and phosphorylated Y527 and the SH3 domain 
with the SH2-SH1 linker region (Boggon & Eck, 2004). Activation involves 
dephosphorylation of Y527, binding of SH2 and SH3 ligands and phosphorylation at 
Y418; activation and recruitment via SH2/SH3 ligands are therefore intimately coupled 
(Bradshaw, 2010). It would be interesting to further determine what effect EspJ has on 
SFKs with the possibility that EspJ could stabilize the inactive conformation preventing 
both activation and recruitment.  
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It is interesting to note that in these analyses, a stronger phenotype was frequently 
observed with EspJEHEC than EspJEPEC. Additionally, upon ectopic of Fyn-GFP, EspJEHEC 
remained capable of inhibiting pedestal formation whereas EspJEPEC-mediated inhibition 
appeared to be overcome. It has previously been suggested that EHEC has a strong 
dephosphorylation activity as although pedestals were observed when TirEPEC was 
expressed in EHEC, tyrosine phosphorylation was not readily detected by immunoblot 
(Kenny, 2001). Perhaps EHEC can translocate a more potent inhibitor of tyrosine kinase 
signalling as it has evolved a pedestal formation pathway not reliant on phosphorylation. 
Analysis of the impact of EspJ during infection of HeLa cells revealed that EPEC lacking 
espJ caused increased cell detachment compared to the wild type strain. This suggests 
EspJ plays a protective role during infection, consistent with the anti-apoptotic properties 
previously suggested (S. Dahan, unpublished). Inhibition of apoptosis has also been 
shown for the EspJ homologue HopF which can prevent Bax-induced apoptosis in yeast 
(Jamir et al., 2004). However in the presence of the caspase inhibitor Zvad-fmk, 
EPECΔespJ-induced detachment was only partially reduced, suggesting the detachment 
is independent of apoptotic signalling. SFKs are implicated in adhesion and key targets 
of Src include the focal adhesion components focal adhesion kinase (FAK), paxillin and 
p130CAS (Glenney & Zokas, 1989; Kanner et al., 1990; Parsons & Parsons, 2004). Src 
and FAK are thought to function together in integrin signalling and the impaired 
spreading and motility phenotypes are mirrored in FAK-/- cells (Ilic et al., 1995; Webb et 
al., 2004). FAK-Src signalling promotes adhesion, leads to actin polymerisation required 
for extension at the leading edge of the cell and promotes focal adhesion turnover 
required for motility (Playford & Schaller, 2004). As SFKs are required for 
adhesion/spreading on integrin ligands and inhibition of SFKs abrogates adhesion (Jones 
et al., 2002; Kaplan et al., 1995) it would be expected that EspJ would have a negative 
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effect on adhesion and spread area. This seems to be the case during ectopic expression 
as reduced spread area and cell loss were frequently observed in this context. However, 
this contrasts with the reduced cell loss in the presence of EspJ during infection. The 
discrepancy between these observations could be explained by increased expression 
levels or more widespread localisation during transfection. Alternatively, antagonistic 
actions of effectors is a common theme during T3SS pathogenesis whereby a careful 
balance is achieved by a combination of effector proteins. This phenomena is already 
well described for the manipulation of cell death and adhesion by EPEC effector proteins 
where a combination of effector proteins promote (Map, EspF, Cif) and inhibit (NleH, 
EspZ) apoptosis (Wong et al., 2011). Furthermore, EspZ and EspO promote adhesion 
whilst EspH disrupts focal adhesions and leads to enhanced detachment (Kim et al., 
2009; Shames et al., 2010; Wong et al., 2012a). As such the different phenotypes during 
transfection and infection could result from EspJ acting in isolation in contrast to the 
complex interplay of effector proteins although further work is required to dissect the 
mechanism by which EspJ prevents cell detachment.  
This analysis of EspJ has provided valuable insight in to the mechanism of action of EspJ 
in its inhibition of opsono-phagocytosis as well as uncovering novel observations as to its 
association with actin, inhibition of actin polymerisation and prevention of cell 
detachment. The discovery that EspJ inhibits SFK recruitment and activation, and the 
dependence of this phenotype on an intact ART domain, raises the exciting possibility 
that EspJ acts to modify these ubiquitous kinases. Furthermore, investigation of the 
activity of this bacterial effector has revealed that the SFKs Src, Yes and Fyn localise to 
EPEC pedestals. As such dissection of the mechanism of action of EspJ has also 
provided insight in to the host factors involved in EPEC infection. 
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Chapter 5 - General Discussion and future prospects 
A combination of bioinformatic and in vitro protein analysis with infection and ectopic 
expression based techniques has provided key insights into the mechanism of action of 
EspJ. The prediction of an ART domain and model structure allowed the rational design 
of mutations to test this region of the protein. Further recombinant protein analysis 
revealed that EspJ does indeed bind NAD, the substrate for the ADP-ribosylation 
reaction, and that this interaction is dependent on predicted key ART domain residues. 
Subsequent analysis of wild type versus ART mutant (R79A/D187A) EspJ revealed that 
these residues were essential for EspJ-mediated inhibition of opsono-phagocytosis and 
actin polymerisation. An intact ART domain is also required for EspJ disruption of SFK 
localisation and activation. 
It is important to note that the EspJ-mediated inhibition of FcγRIIa phagocytosis and 
EPEC pedestal formation is more severe than that observed with SFK inhibitors (Fitzer-
Attas et al., 2000). Whilst Philips et al report inhibition of pedestals with the SFK 
inhibitor PP2 (Phillips et al., 2004), Swimm et al report no inhibition with PP2 but 
observed inhibition with more broad range tyrosine kinase inhibitor PD (Swimm et al., 
2004). Indeed for both FcγR-phagocytosis and pedestal formation, additional kinases are 
suggested to be able to mediate the required phosphorylation in the absence of SFKs 
(Bommarius et al., 2007; Fitzer-Attas et al., 2000). Thus EspJ must be able to affect 
several kinase families or alternatively to block their recruitment through interaction with 
FcγRIIa or Tir. Given that EspJ has been observed to colocalise with SFKs but not Tir, 
the latter option seems unlikely. SFK and Abl family kinases form remarkably similar 
conformations in the inactive state with the SH2 and SH3 domains packed against the 
kinase domain (Nagar et al., 2003). In addition they share significant sequence identity in 
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the SH1, SH2 and SH3 regions raising the interesting possibility that EspJ could affect 
both families in their inactive forms. Although, in this study we did not observe 
convincing recruitment of Abl-GFP, active Abl family kinases have previously been 
shown to localise to and mediate TirEPEC pedestal formation (Swimm et al., 2004).  
An interesting hypothesis is that inhibition of Tir-mediated actin polymerisation by EspJ 
could be a mechanism to protect cells from super-infection and/or damage. This 
phenomena has previously been shown for EPEC which can inhibit T3SS translocation 
and pedestal formation of a second wave of infection (Mills et al., 2008). Indeed, EspZ 
has been shown to block translocation by the second wave of bacteria (Berger et al., 
2012). It is not unusual for EPEC to translocate several effectors with complementary 
functions, as observed for the inhibition of NFκB signalling (Wong et al., 2011), and so 
EspJ could potentially contribute to this phenotype by disrupting TirEPEC-dependent 
signalling.  
In addition to EPEC/EHEC, many other pathogenic bacteria and viruses have evolved 
strategies to usurp the host cytoskeleton machinery resulting in altered morphology or 
adhesion and/or defective phagocytosis. These strategies allow pathogens to enhance 
their own adhesion or spread, trigger their internalisation or ensure they remain 
extracellular and often involve manipulation of host cell tyrosine kinases. For example, 
Yersinia inhibits phagocytic signalling to remain extracellular using the concerted actions 
of effector proteins targeting RhoGTPases and tyrosine phosphorylation dependent 
signalling (Trosky et al., 2008). Shigella initiates host cell signalling to induce membrane 
ruffles facilitating their invasion requiring Src and Abl/Arg kinases (Burton et al., 2003; 
Mounier et al., 2009). Shigella also manipulates actin polymerisation once internalised to 
promote cell-cell spread by actin-based propulsion. This is mediated by recruitment of N-
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WASP although Abl/Arg contribute to this process through N-WASP phosphorylation 
(Burton et al., 2005; Suzuki et al., 1998) 
Interestingly, the TirEPEC Y474 phosphorylation site required for pedestal formation, is 
highly similar to phosphorylation sites present in Vaccinia virus membrane protein A36R 
and Helicobacter pylori T4SS effector CagA. Vaccinia virus is a member of the 
Poxviridae of large dsDNA enveloped viruses and mimics receptor tyrosine kinase 
signalling to induce actin tails underneath virions as a strategy for infection of 
neighbouring cells (Cudmore et al., 1995; Frischknecht et al., 1999). The viral integral 
membrane protein A36R is phosphorylated at two tyrosine sites, Y112 and Y132, by 
redundant kinases including SFKs, Abl and Arg (Frischknecht et al., 1999; Newsome et 
al., 2004; Newsome et al., 2006; van Eijl et al., 2000). Phosphorylation of Y112 results 
in recruitment of Nck and subsequently WIP, N-WASP and the Arp2/3 complex 
(Frischknecht et al., 1999; Moreau et al., 2000). The Y112 pathway accounts for the 
majority of A36R-mediated actin polymerisation although additional phosphorylation at 
Y132 further enhances signalling through recruiting Grb2 and perhaps stabilising the 
signalling complex (Scaplehorn et al., 2002). Vaccinia actin tail formation has clear 
similarities to the EPEC pedestal formation pathway which also involves 
phosphorylation of Y474 by SFK and/or redundant kinases resulting in Nck, WIP and N-
WASP recruitment and Arp2/3 complex dependent actin polymerisation. As such it 
would be interesting to determine whether EspJ also inhibits Vaccinia actin tail 
formation. 
H. pylori is a gastric pathogen and manipulates tyrosine kinases through the T4SS 
effector CagA. CagA is phosphorylated by SFK and Abl/Arg with pleiotropic effects 
within the cell including cytoskeletal rearrangements and cell elongation (Tegtmeyer & 
Backert, 2011). Interestingly, phosphorylated CagA then initiates a negative feeback loop 
 193 
to inhibit Src activity. CagA-pY binds and activates Csk which then phosphorylates Src 
on Y527 inducing the inactive conformation (Tsutsumi et al., 2003). This study has 
shown that in addition to utilising host tyrosine kinases for actin polymerisation 
pathways, EPEC acts to inhibit the SFKs by translocating the effector EspJ.  
The widespread use of host cell kinases by pathogenic bacteria and viruses has recently 
raised the interesting suggestion that kinase inhibitors, initially developed for cancer 
treatment, could be used to treat infections (Napier et al., 2012). Furthermore, inhibition 
of Abl/Arg with Gleevec has been shown to impact upon Shigella, Vaccinia, and 
Mycobacterium tuberculosis infection strategies (Napier et al., 2011; Reeves et al., 
2005). Thus, if EspJ can inhibit both SFK and Abl/Arg to efficiently disrupt actin 
polymerisation pathways, molecular understanding of this activity will have implications 
for the treatment of infections and cancer.  
The effects of EspJ activity have been observed on phagocytic signalling during infection 
and pedestal formation upon ectopic expression. However, as tyrosine phosphorylation is 
fundamental in the regulation and propagation of many cell signalling pathways the 
physiological role of EspJ may not yet be fully uncovered. SFKs function in many 
signalling pathways including downstream of T cell (Smith-Garvin et al., 2009) and B 
cell (Gauld & Cambier, 2004) immunoreceptors, in cytokine responses (Hayakawa & 
Naoe, 2006) and integrin signalling (Playford & Schaller, 2004). Immune responses to 
the A/E mouse pathogen Citrobacter rodentium involve the influx of both innate 
(Spehlmann et al., 2009) and adaptive immune cells (Higgins et al., 1999) and a key role 
of the humoral IgG response (Maaser et al., 2004). Given the involvement of SFKs in 
many immune pathways, EspJ may function to downregulate immune recognition or 
killing but the precise role and mechanism is unclear. Recently it was shown that Tir also 
downregulates host responses to infection dependent on phosphorylation of Tir ITIM 
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(Yan et al., 2012). Tir recruits SHP-1 and enhances SHP-1 interaction with TRAF-6 
preventing TRAF-6 ubiquitination and innate immune signalling (Yan et al., 2012). It 
would be interesting to determine the effect of EspJ on this SFK tyrosine 
phosphorylation-dependent signalling and downstream innate immune responses. 
Interestingly, in vivo infection with C. rodentium ΔespJ showed increased bacterial loads 
and prolonged infection dynamics compared to infection with the parental wild type 
strain (Dahan et al., 2005). Potentially the lack of EspJ could increase Tir-dependent 
dampening of the immune response resulting in an extension of the infection. This data 
highlights the need for further understanding of the full impact of EspJ on cellular 
signalling and its role in infection processes. 
 
Figure 51. A model for EspJ activity during infection 
Tir is translocated before EspJ and so initial pedestal formation proceeds with recruitment of 
SFK, receptor phosphorylation and Nck, WIP, N-WASP and Arp2/3 complex-dependent actin 
polymerisation. Once EspJ is present within the cell it disrupts the recruitment and activation of 
SFKs inhibiting receptor tyrosine phosphorylation resulting in an inhibition of FcγR-mediated 
phagocytosis in infected cells. Through disrupting Tir/SFK dependent signalling EspJ could 
prevent super-infection of cells and/or Tir-dependent dampening of immune responses. EspJ also 
promotes adhesion/survival potentially through manipulation of SFK activity.  
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Whilst an intact ART domain is required for EspJ-mediated inhibition of FcγR 
phagocytosis and inhibition of receptor phosphorylation, it has not yet known whether 
R79 and D187 are required for other EspJ phenotypes. It is important to determine 
whether protection from detachment and inhibition of CR3 dependent phagocytosis result 
from EspJ SFK disruption or whether EspJ has multiple activities. This is a common 
theme for effector proteins where several cellular targets and signalling pathways are 
disrupted by the same protein. For example, NleH disrupts NFκB signalling and inhibits 
apoptosis dependent on its amino- and carboxy-termini respectively (Gao et al., 2009; 
Hemrajani et al., 2010).  
The mechanism of internalisation via the CR3 receptor is thought to differ significantly 
to that of the FcγRIIa (Caron & Hall, 1998). The CR3 is an integrin receptor comprising 
of αm (CD11b) and β2 (CD18) chains, and requires activation before phagocytosis is 
permissive (Hughes & Pfaff, 1998). CR3 mediated phagocytosis was initially shown to 
be morphologically distinct from that of the FcγR and described as the particle ‘sinking’ 
into the cell although more recent reports have shown extensive pseudopodia and ruffles 
to be involved in this process (Allen & Aderem, 1996; Patel & Harrison, 2008). CR3 
dependent internalisation relies on the Rho GTPase RhoA and its downstream effectors 
ROCK, myosin II and mDia as well as RhoG and the Arp2/3 complex(Caron & Hall, 
1998; Colucci-Guyon et al., 2005; May et al., 2000; Olazabal et al., 2002; Tzircotis et 
al., 2011).  
Disruption of CR3 mediated internalisation has been shown by inhibition of PKC and 
Arg but not by inhibition of SFKs or general tyrosine inhibitors (Allen & Aderem, 1996; 
Wetzel et al., 2012). However, further observations with components of the FcγR 
pathway suggest some shared dependencies. For example, inhibition of CR3-mediated 
internalisation was observed with overexpression of the SFK Hck and dominant negative 
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Hck leading to a suggestion that adaptor function of SFKs is required (Le Cabec et al., 
2002). Additionally, although CR3 internalisation was not disrupted in syk -/- 
macrophages (Kiefer et al., 1998), dominant negative Syk or Syk knockdown did inhibit 
this pathway (Kiefer et al., 1998). Internalisation of C3bi opsonised particles was 
inhibited in rac1-/-rac2-/- or vav1-/-vav3-/- macrophages suggesting a role for Rac in this 
pathway (Hall et al., 2006). Interestingly, Syk can be activated through co-opting of 
ITAM bearing receptors following integrin ligation (Mocsai et al., 2006) raising the 
possibility that EspJ could inhibit CR3 pathways through inhibition of ITAM-dependent 
signalling.  
In the continuation of this work it will be important to ascertain what effects EspJ has on 
the activity of SFKs and cell phosphoproteome during infection using mass spectrometry 
and specific immunoblotting approaches. For example, it will be interesting to determine 
whether changes in the phosphorylation levels of key Src targets, e.g. FAK and cortactin, 
are observed and whether this relates to the protection from cell detachment. Another key 
element that remains to be established is whether EspJ has catalytic activity, either ADP-
ribosylation or another NAD dependent reaction. For example, the NAD binding SIRT6 
was recently shown to remove long chain fatty acyl groups from target proteins which 
could be relevant to the disruption of membrane associated kinases (Jiang et al., 2013). 
Alternatively, NAD binding of EspJ could be required for the binding of SFKs or other 
host cell targets. Further experiments should therefore include analysis of SFKs from 
EspJ-expressing cells to determine whether any PTMs can be detected. This could be 
done by immunoprecipitating the SFKs, from cells co-transfected with a control vector or 
a vector for EspJ expression, and analysing the SFKs by mass spectrometry. Another key 
experiment would be functional analysis of SFKs from EspJ-expressing cells to directly 
determine whether their kinase activity is inhibited. As inhibition was not observed with 
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a commercial kit using recombinant proteins, an approach using immunoprecipitated 
SFKs and in vitro phosphorylation of a known target, e.g. Tir, should be investigated. 
Although the use of overexpression has provided valuable data, the extension of this 
study should aim to analyse the impact of EspJ in more relevant experimental systems. 
For example, during EPEC infections of polarised gut epithelial cells (eg. Caco-2 cells) 
or using M-cell like culturing systems where Caco-2 cells cocultured with lymphocytes 
gain M-cell characteristics including particle internalisation for luminal sampling 
(Kerneis et al., 1997). It would therefore be interesting to use these cells to determine 
whether EspJ has any affect on immune sampling during infection. Additionally, 
mutation of ART domain residues in the EPEC chromosomal espJ would allow analysis 
of the EspJ ART domain at physiological expression levels. 
Although there are further questions relating to the enzymatic activity and kinase 
specificity in EspJ mechanism of action, this study has made significant advances in our 
knowledge of manipulation of host cell signalling by EspJ. This effector inhibits receptor 
SFK recruitment, tyrosine phosphorylation, SH2 dependent adaptor protein recruitment 
and downstream actin polymerisation affecting both FcγR and TirEPEC pathways. 
Importantly, inhibition of the FcγR and TirEPEC pathways was also observed with the S. 
enterica subsp. salamae homologue SeoC. Although EspJ was initially reported for its 
role in the inhibition of opsono-phagocytosis the full extent of host cell signalling effects 
during infection by diverse pathogens remains to be determined making this an exciting 
time to study this family of effector proteins.  
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